Science.gov

Sample records for battery german patent

  1. Anhydrous hydrogen fluoride electrolyte battery. [Patent application

    DOEpatents

    Not Available

    1972-06-26

    It is an object of the invention to provide a primary cell or battery using ammonium fluoride--anhydrous hydrogen fluoride electrolyte having improved current and power production capabilities at low temperatures. It is operable at temperatures substantially above the boiling point of hydrogen fluoride. (GRA)

  2. Battery separators. (Latest citations from the US Patent Bibliographic file with exemplary claims). NewSearch

    SciTech Connect

    Not Available

    1994-10-01

    The bibliography contains citations of selected patents concerning materials and methods used to manufacture battery separators. Microporous films and sheets, glass fibers, textile fabrics, and synthetic fibers are included. Coatings for improvement of battery performance and life are discussed. (Contains a minimum of 241 citations and includes a subject term index and title list.)

  3. 76 FR 18194 - Notice of Patent Application Deadline for Advanced Battery Technology Related Patents for...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-04-01

    ... Electrolytes for Lithium/Air Batteries (US 7,585,579). 2. ARL 02-06--Solvent Systems Comprising a Mixture of Lactams and Esters for Non-Aqueous Electrolytes and Non-Aqueous Electrolyte Cells Comprising the Same (US...,172,834 B1). 4. ARL 02-27 D1--Non-aqueous solvent electrolyte battery with additive alkali metal...

  4. Patenting inventions in the field of biology and chemistry: German and European patent law and case law.

    PubMed

    Vossius, V

    1997-10-01

    Patent law is intended to provide protection for new and inventive achievements in technology. Technical progress is considered to be the purpose and aim of patent law. The main objective of patent law is to protect patentable results according to the latest state of science and research. It is most important to encourage the inventor to completely publish his knowledge. As a reward for this the inventor is granted a right of exclusion which is limited in time: the patent. It is not the purpose of patent law to enrich mere theory but to create industrially applicable knowledge for the public. This contribution deals with important problems to be considered by inventors in the patenting of inventions in the field of biology and chemistry. Such questions are related particularly to the accessibility of inventions and discoveries to patent protection, the various kinds (categories) of patents, the requirement of novelty, complete disclosure of the invention, patentability of DNA sequences and proteins, as well as inventive step.

  5. Development of a Test Battery for Assessing Phonological Awareness in German-Speaking Children

    ERIC Educational Resources Information Center

    Schaefer, Blanca; Fricke, Silke; Szczerbinski, Marcin; Fox-Boyer, Annette V.; Stackhouse, Joy; Wells, Bill

    2009-01-01

    The development of phonological awareness (PA), the ability to reflect on the sound structure of words independent of their meaning, has been extensively explored in English-speaking children. However, this is not the case for other languages. The aim of this study was to develop a comprehensive PA test battery for German-speaking preschool…

  6. 76 FR 3118 - Notice of Availability of Advanced Battery Technology Related Patents for Exclusive, Partially...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-01-19

    ... early registration is encouraged. 1. ARL 01-37--Choosing Electrolytes for Lithium/Air Batteries (US 7... Electrolytes and Non-Aqueous Electrolyte Cells Comprising the Same (US 7,442,471 B1). 3. ARL 02-27--Additive... solvent electrolyte battery with additive alkali metal salt of a mixed anhydride combination of...

  7. Investigations on sediment toxicity of German rivers applying a standardized bioassay battery.

    PubMed

    Hafner, Christoph; Gartiser, Stefan; Garcia-Käufer, Manuel; Schiwy, Sabrina; Hercher, Christoph; Meyer, Wiebke; Achten, Christine; Larsson, Maria; Engwall, Magnus; Keiter, Steffen; Hollert, Henner

    2015-11-01

    River sediments may contain a huge variety of environmental contaminants and play a key role in the ecological status of aquatic ecosystems. Contaminants adsorbed to sediments and suspended solids may contribute directly or after remobilization to an adverse ecological and chemical status of surface water. In this subproject of the joint research project DanTox, acetonic Soxhlet extracts from three German river sediments from the River Rhine (Altrip and Ehrenbreitstein with moderate contamination) and River Elbe (Veringkanal Hamburg heavily contaminated) were prepared and redissolved in dimethyl sulfoxide (DMSO). These extracts were analyzed with a standard bioassay battery with organisms from different trophic levels (bacteria, algae, Daphnia, fish) as well as in the Ames test and the umuC test for bacterial mutagenicity and genotoxicity according to the respective OECD and ISO guidelines. In total, 0.01% (standard) up to 0.25% (only fish embryo test) of the DMSO sediment extract was dosed to the test systems resulting in maximum sediment equivalent concentrations (SEQ) of 2 up to 50 g l(-1). The sediment of Veringkanal near Hamburg harbor was significantly more toxic in most tests compared to the sediment extracts from Altrip and Ehrenbreitstein from the River Rhine. The most toxic effect found for Veringkanal was in the algae test with an ErC50 (72 h) of 0.00226 g l(-1) SEQ. Ehrenbreitstein and Altrip samples were about factor 1,000 less toxic. In the Daphnia, Lemna, and acute fish toxicity tests, no toxicity at all was found at 2 g l(-1) SEQ. corresponding to 0.01% DMSO. Only when increasing the DMSO concentration the fish embryo test showed a 22-fold higher toxicity for Veringkanal than for Ehrenbreitstein and Altrip samples, while the toxicity difference was less evident for the Daphnia test due to the overlaying solvent toxicity above 0.05% dimethyl sulfoxide (DMSO). The higher toxicities observed with the Veringkanal sample are supported by the PAH and PCB

  8. Modern evaluation of patents

    NASA Astrophysics Data System (ADS)

    Ignat, V.

    2016-08-01

    The number of patents is not so important as the market value. The market value is especially important for licensing of patents, make-or-buy decisions for technology procurement, corporate finance. Patents can be used as collateral for financing. Patents and credit approvals: without patents only 46% and with patents 54%. The value share of knowledge-based components to industrial products already reached 50% and it is still rising. OECD called these developments under the slogan "knowledge economy”. German Norm-DIN 77100 provides a working method for monetary evaluation of a patent. The value of a patent arises from its use. A patent can be used to protect or to earn licensing revenues. An evaluation expertise is required in areas, such as marketing, finance, R & D and strategic planning. As an indicator of the value of a patent is often used the number of citations. The number of a patent citation refers to its meaning and value. Other indicators would be: size of the patent family, validity of the patent, result of objections against patent application, number and quality of claims. The analysis of 9.000 patents resulted that only 7.2% worth over 10 million euro and 68% below 1 million euro. The cost method: it is considered the cost that would be incurred for the development and patenting of a similar invention. The market method: are used the prices that have been achieved in comparable with recently transactions. The Income method: the potential reward is measured, which can arise from a patent. The evaluation will be in the following areas: legal status, technology, market conditions, finance and strategy. Each question relates to a different parameter of a value.

  9. A new test battery to assess aphasic disturbances and associated cognitive dysfunctions -- German normative data on the aphasia check list.

    PubMed

    Kalbe, Elke; Reinhold, Nadine; Brand, Matthias; Markowitsch, Hans J; Kessler, Josef

    2005-10-01

    Aphasia, defined as an acquired impairment of linguistic abilities, can be accompanied by a diversity of neuropsychological dysfunction. Accordingly, the necessity to include cognitive testing in the diagnosis of aphasia is increasingly recognized. Here we present the Aphasia Check List (ACL), a new test battery for the assessment of aphasic and associated cognitive disorders. The language part of the battery provides a differentiated profile of important linguistic abilities. In addition, the ACL includes nonverbal screening tests for three neuropsychological domains: memory, attention, and reasoning. Dysfunctions in these domains have been observed in aphasic patients and can have an impact on language function. The ACL is applicable to patients with language disturbances of different etiologies, different stages of disease, and to patients with mild to severe aphasia. As the entire test duration is only about 30 minutes, the ACL is also economically valuable. It thus presents an adequate starting point in aphasia diagnosis for a wide range of patients. Here we describe the construction of the ACL, and the normative study of its original German version with 154 aphasic patients and 106 healthy comparison subjects. The ACL cognition part revealed additional neuropsychological dysfunction in the aphasia group. We present the patterns of these dysfunctions and their correlations with language deficits.

  10. Long-term impacts of battery electric vehicles on the German electricity system

    NASA Astrophysics Data System (ADS)

    Heinrichs, H. U.; Jochem, P.

    2016-05-01

    The emerging market for electric vehicles gives rise to an additional electricity demand. This new electricity demand will affect the electricity system. For quantifying those impacts a model-based approach, which covers long-term time horizons is necessary in order to consider the long lasting investment paths in electricity systems and the market development of electric mobility. Therefore, we apply a bottom-up electricity system model showing a detailed spatial resolution for different development paths of electric mobility in Germany until 2030. This model is based on a linear optimization which minimizes the discounted costs of the electricity system. We observe an increase of electricity exchange between countries and electricity generated by renewable energy sources. One major result turns out to be that electric vehicles can be integrated in the electricity system without increasing the system costs when a controlled (postponing) charging strategy for electric vehicles is applied. The impact on the power plant portfolio is insignificant. Another important side effect of electric vehicles is their substantial contribution to decreasing CO2 emissions of the German transport sector. Hence, electric mobility might be an integral part of a sustainable energy system of tomorrow.

  11. Software Patents.

    ERIC Educational Resources Information Center

    Burke, Edmund B.

    1994-01-01

    Outlines basic patent law information that pertains to computer software programs. Topics addressed include protection in other countries; how to obtain patents; kinds of patents; duration; classes of patentable subject matter, including machines and processes; patentability searches; experimental use prior to obtaining a patent; and patent…

  12. Abstract Journals: A Survey of Patent Coverage.

    ERIC Educational Resources Information Center

    Rimmer, Brenda M.

    1988-01-01

    Describes a survey of 33 British, French, German, and U.S. abstract journals that examined their coverage of patent specifications. The standards for the identification of patent documents developed by the World Intellectual Property Organization are discussed, and an appendix provides a listing of the patent coverage by the country of each…

  13. Patenting DNA.

    PubMed

    Bobrow, Martin; Thomas, Sandy

    2002-12-01

    The protection of inventions based on human DNA sequences has been achieved mainly through application of the patent system. Over the past decade, there has been continuing debate about whether this use of intellectual property rights is acceptable. Companies and universities have been active during this period in filing thousands of patent applications. Although many have argued that to claim a DNA sequence in a patent is to claim a discovery, patent law allows discoveries that are useful to be claimed as part of an invention. As the technology to isolate DNA sequences has advanced, the criterion for inventiveness, necessary for any invention to be eligible for filing, has become more difficult to justify in the case of claims to DNA sequences. Moreover, the discovery that a gene is associated with a particular disease is, it is argued, to discover a fact about the world and undeserving of the status of an invention. Careful examination of the grounds for allowing the patenting of DNA sequences as research tools suggests such rewards will rarely be justified. The patenting of DNA sequences as chemical intermediates necessary for the manufacture of therapeutic proteins is, however, reasonable given that the information within the sequence is applied to produce a tangible substance which has application as a medicine. Despite the legal, technical and political complexities of applying the flexibilities with the current law, it is argued that much could be achieved in the area of patenting DNA by raising the thresholds for patentability.

  14. US photovoltaic patents: 1991--1993

    SciTech Connect

    Pohle, L

    1995-03-01

    This document contains US patents on terrestrial photovoltaic (PV) power applications, including systems, components, and materials as well as manufacturing and support functions. The patent entries in this document were issued from 1991 to 1993. The entries were located by searching USPA, the database of the US Patent Office. The final search retrieved all patents under the class ``Batteries, Thermoelectric and Photoelectric`` and the subclasses ``Photoelectric,`` ``Testing,`` and ``Applications.`` The search also located patents that contained the words ``photovoltaic(s)`` or ``solar cell(s)`` and their derivatives. After the initial list was compiled, most of the patents on the following subjects were excluded: space photovoltaic technology, use of the photovoltaic effect for detectors, and subjects only peripherally concerned with photovoltaic. Some patents on these three subjects were included when ft appeared that those inventions might be of use in terrestrial PV power technologies.

  15. Study of bipolar batteries

    NASA Astrophysics Data System (ADS)

    Clifford, J. E.

    1984-06-01

    The status of development of bipolar batteries with an aqueous electrolyte was determined. Included in the study were lead-acid, nickel-cadmium, nickel-zinc, nickel-iron, and nickel-hydrogen batteries. The technical and patent literature is reviewed and a bibliography covering the past 15 years is presented. Literature data are supplemented by a survey of organizations. The principal interest was in bipolar lead-acid batteries and more recently in bipolar nickel-hydrogen batteries for space applications.

  16. Lithium Germanate (Li2 GeO3 ): A High-Performance Anode Material for Lithium-Ion Batteries.

    PubMed

    Rahman, Md Mokhlesur; Sultana, Irin; Yang, Tianyu; Chen, Zhiqiang; Sharma, Neeraj; Glushenkov, Alexey M; Chen, Ying

    2016-12-23

    A simple, cost-effective, and easily scalable molten salt method for the preparation of Li2 GeO3 as a new type of high-performance anode for lithium-ion batteries is reported. The Li2 GeO3 exhibits a unique porous architecture consisting of micrometer-sized clusters (secondary particles) composed of numerous nanoparticles (primary particles) and can be used directly without further carbon coating which is a common exercise for most electrode materials. The new anode displays superior cycling stability with a retained charge capacity of 725 mAh g(-1) after 300 cycles at 50 mA g(-1) . The electrode also offers excellent rate capability with a capacity recovery of 810 mAh g(-1) (94 % retention) after 35 cycles of ascending steps of current in the range of 25-800 mA g(-1) and finally back to 25 mA g(-1) . This work emphasizes the importance of exploring new electrode materials without carbon coating as carbon-coated materials demonstrate several drawbacks in full devices. Therefore, this study provides a method and a new type of anode with high reversibility and long cycle stability.

  17. Patent Family Databases.

    ERIC Educational Resources Information Center

    Simmons, Edlyn S.

    1985-01-01

    Reports on retrieval of patent information online and includes definition of patent family, basic and equivalent patents, "parents and children" applications, designated states, patent family databases--International Patent Documentation Center, World Patents Index, APIPAT (American Petroleum Institute), CLAIMS (IFI/Plenum). A table…

  18. US Photovoltaic Patents, 1988--1990

    SciTech Connect

    Not Available

    1991-12-01

    This document contains US patents on terrestrial photovoltaic (PV) power applications, including systems, components, and materials, as well as manufacturing and support functions. The patent entries in this document were issued from 1988 through 1990. The entries were located by searching USPA, the data base of the US Patent Office. The final search retrieved all patents under the class ``Batteries, Thermoelectric and Photoelectric`` and the subclasses ``Photoelectric,`` ``Testing,`` and ``Applications.`` The search also located patents that contained the words ``photovoltaic(s)`` or ``solar cell(s)`` and their derivatives. A manual search of the patents in the Solar Energy Research Institute (SERI) patent file augmented the data base search. After the initial list was compiled, most of the patents on the following subjects were excluded: space photovoltaic technology, use of the photovoltaic effect for detectors and subjects only peripherally concerned with photovoltaics. Some patents on these three subjects were included when it appeared that those inventions might be of use in terrestrial PV power technologies.

  19. US Photovoltaic Patents, 1988--1990

    SciTech Connect

    Not Available

    1991-12-01

    This document contains US patents on terrestrial photovoltaic (PV) power applications, including systems, components, and materials, as well as manufacturing and support functions. The patent entries in this document were issued from 1988 through 1990. The entries were located by searching USPA, the data base of the US Patent Office. The final search retrieved all patents under the class Batteries, Thermoelectric and Photoelectric'' and the subclasses Photoelectric,'' Testing,'' and Applications.'' The search also located patents that contained the words photovoltaic(s)'' or solar cell(s)'' and their derivatives. A manual search of the patents in the Solar Energy Research Institute (SERI) patent file augmented the data base search. After the initial list was compiled, most of the patents on the following subjects were excluded: space photovoltaic technology, use of the photovoltaic effect for detectors and subjects only peripherally concerned with photovoltaics. Some patents on these three subjects were included when it appeared that those inventions might be of use in terrestrial PV power technologies.

  20. Patent and product piracy

    NASA Astrophysics Data System (ADS)

    Ignat, V.

    2016-08-01

    Advanced industrial countries are affected by technology theft. German industry annually loses more than 50 billion euros. The main causes are industrial espionage and fraudulent copying patents and industrial products. Many Asian countries are profiteering saving up to 65% of production costs. Most affected are small medium enterprises, who do not have sufficient economic power to assert themselves against some powerful countries. International organizations, such as Interpol and World Customs Organization - WCO - work together to combat international economic crime. Several methods of protection can be achieved by registering patents or specific technical methods for recognition of product originality. They have developed more suitable protection, like Hologram, magnetic stripe, barcode, CE marking, digital watermarks, DNA or Nano-technologies, security labels, radio frequency identification, micro color codes, matrix code, cryptographic encodings. The automotive industry has developed the method “Manufactures against Product Piracy”. A sticker on the package features original products and it uses a Data Matrix verifiable barcode. The code can be recorded with a smartphone camera. The smartphone is connected via Internet to a database, where the identification numbers of the original parts are stored.

  1. Patenting medical inventions.

    PubMed

    Schwertner, H A

    1994-12-01

    Medical, dental, nursing, and biomedical personnel often perform critical research that can lead to patents. Similarly, patentable discoveries can be made during the normal course of medical practice, e.g., the development of new biocompatible polymers, improved dental materials, new or modified catheters, new laboratory diagnostic tests, and improved medical devices. Many inventions may not be patented in federal organizations due to the lack of information available on the patenting process. In this article, the financial benefits that can be derived from patenting inventions are discussed, as well as the different types of patents that can be obtained, the conditions for patentability, bars or restrictions to obtaining a patent, the importance of proper record keeping, and the steps to take toward getting an invention patented.

  2. Whole-genome patenting.

    PubMed

    O'Malley, Maureen A; Bostanci, Adam; Calvert, Jane

    2005-06-01

    Gene patenting is now a familiar commercial practice, but there is little awareness that several patents claim ownership of the complete genome sequence of a prokaryote or virus. When these patents are analysed and compared to those for other biological entities, it becomes clear that genome patents seek to exploit the genome as an information base and are part of a broader shift towards intangible intellectual property in genomics.

  3. [Patenting human genes].

    PubMed

    Brdicka, R

    2002-05-10

    The problem of patenting of human genes, which was discussed at the Workshop organized by OECD, has become very actual due to granted patents that concern testing of genetic disposition for breast cancer. Companies that had made large investments into this research clearly support patenting of their discoveries. But such patents can reduce general accessibility of genetic testing. Existing laws, and namely the Directive of the European Council unfortunately are not unambiguous and allow rather free explanation.

  4. Universities That Litigate Patents

    ERIC Educational Resources Information Center

    Rooksby, Jacob H.

    2012-01-01

    American research universities frequently obtain and license patents to their faculty members' inventions. While university licensing is carefully tracked and thoroughly studied, little is known about university decisions to assertively litigate their patents through filing patent infringement lawsuits in federal court. Which universities…

  5. [Patents on life? No patent on life!].

    PubMed

    van Raden, L

    1998-03-01

    Inventions related to living material are in principle patentable as well as inventions in the "classical" fields of technology as long as they are new, industrially applicable and involve an inventive step. A patent gives to its owner for a limited period of time the exclusive right to prevent others from using his patented new technical know-how. Starting point of patent protection in the field of genetic engineering is a genetic information or a genetically induced characteristic of an organism; there is no such thing as a "Patent on Life". As far as inventions relate to genetically modified organisms, patents give to their owners no additional property rights that might exclude the applicability e.g. of the laws on animal protection. Intellectual property like any other property is subject to the limits set up by law. It is neither scientifically correct nor does it help in finding a solution for the conflict within society to shift the--undoubtedly necessary--discussion about research and application in the field of genetic engineering to a discussion about patent law.

  6. Electric-vehicle batteries

    NASA Astrophysics Data System (ADS)

    Oman, Henry; Gross, Sid

    1995-02-01

    Electric vehicles that can't reach trolley wires need batteries. In the early 1900's electric cars disappeared when owners found that replacing the car's worn-out lead-acid battery costs more than a new gasoline-powered car. Most of today's electric cars are still propelled by lead-acid batteries. General Motors in their prototype Impact, for example, used starting-lighting-ignition batteries, which deliver lots of power for demonstrations, but have a life of less than 100 deep discharges. Now promising alternative technology has challenged the world-wide lead miners, refiners, and battery makers into forming a consortium that sponsors research into making better lead-acid batteries. Horizon's new bipolar battery delivered 50 watt-hours per kg (Wh/kg), compared with 20 for ordinary transport-vehicle batteries. The alternatives are delivering from 80 Wh/kg (nickel-metal hydride) up to 200 Wh/kg (zinc-bromine). A Fiat Panda traveled 260 km on a single charge of its zinc-bromine battery. A German 3.5-ton postal truck traveled 300 km with a single charge in its 650-kg (146 Wh/kg) zinc-air battery. Its top speed was 110 km per hour.

  7. Patent Deployment Strategies and Patent Value in LED Industry

    PubMed Central

    Wu, Ming-Fu; Chang, Keng-Wei; Zhou, Wei; Hao, Juan; Yuan, Chien-Chung; Chang, Ke-Chiun

    2015-01-01

    This study applies two variables in the measurement of company patent deployment strategies: patent family depth and earn plan ratio. Patent family depth represents the degree to which certain fields and markets are valued by the patent owner. Earn plan ratio defined as the ratio of the number of patent forward citations to patent family size. Earn plan ratio indicates the degree to which a patent family could be cited by later innovators and competitors. This study applies a logistic regression model in the analysis LED industry data. The results demonstrate that patent value has a positive relationship with the patent family depth, and earn plan ratio. PMID:26098313

  8. Patents and nanomedicine.

    PubMed

    Bawa, Raj

    2007-06-01

    Big pharma's business model, which relies on a few blockbusters to generate profits, is clearly broken. Patent expiration on numerous blockbusters in recent years is already altering the drug landscape. Drug companies are also facing other challenges that necessitate development and implementation of novel R&D strategies, including those that focus on nanotechnology and miniaturization. Clearly, there is enormous excitement and expectation regarding nanomedicine's potential impact. However, securing valid and defensible patent protection will be critical. Although early forecasts for nanomedicine commercialization are encouraging, there are numerous bottlenecks as well. One of the major hurdles is an emerging thicket of patent claims, resulting primarily from patent proliferation as well as continued issuance of surprisingly broad patents by the US Patent and Trademark Office (PTO). Adding to this confusion is the fact that the US National Nanotechnology Initiative's widely cited definition of nanotechnology is inaccurate and irrelevant from a nanomedicine perspective. It is also the cause of the inadequate patent classification system that was recently unveiled by the PTO. All of this is creating a chaotic, tangled patent landscape in various sectors of nanomedicine where the competing players are unsure of the validity and enforceability of numerous issued patents. If this trend continues, it could stifle competition and limit access to some inventions. Therefore, reforms are urgently needed at the PTO to address problems ranging from poor patent quality and questionable examination practices to inadequate search capabilities, rising attrition, poor employee morale and a skyrocketing patent application backlog. Only a robust patent system will stimulate the development of commercially viable nanomedicine products that can drastically improve a patient's quality of life and reduce healthcare costs.

  9. Organic cathode for a secondary battery

    SciTech Connect

    Bugga, R.V.; Distefano, S.; Williams, R.M.; Bankston, C.P.

    1990-10-30

    This patent describes a battery system. It comprises: a first body of liquid meal anode comprising a Group I metal; a record body of liquid cathode comprising a combination of Group I metal salt and Group III metal salt molten at the temperature of operation of the battery containing a minor amount of an organic carbonitrile depolarizer containing at least one adjacent ethylenic bond.

  10. 37 CFR 1.5 - Identification of patent, patent application, or patent-related proceeding.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2013-07-01 2013-07-01 false Identification of patent, patent application, or patent-related proceeding. 1.5 Section 1.5 Patents, Trademarks, and Copyrights..., the title of the invention, the date of filing the same, and, if known, the group art unit or...

  11. 37 CFR 1.5 - Identification of patent, patent application, or patent-related proceeding.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Identification of patent, patent application, or patent-related proceeding. 1.5 Section 1.5 Patents, Trademarks, and Copyrights..., the title of the invention, the date of filing the same, and, if known, the group art unit or...

  12. 37 CFR 1.5 - Identification of patent, patent application, or patent-related proceeding.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2012-07-01 2012-07-01 false Identification of patent, patent application, or patent-related proceeding. 1.5 Section 1.5 Patents, Trademarks, and Copyrights..., the title of the invention, the date of filing the same, and, if known, the group art unit or...

  13. 37 CFR 1.5 - Identification of patent, patent application, or patent-related proceeding.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Identification of patent, patent application, or patent-related proceeding. 1.5 Section 1.5 Patents, Trademarks, and Copyrights..., the title of the invention, the date of filing the same, and, if known, the group art unit or...

  14. 37 CFR 1.5 - Identification of patent, patent application, or patent-related proceeding.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2011-07-01 2011-07-01 false Identification of patent, patent application, or patent-related proceeding. 1.5 Section 1.5 Patents, Trademarks, and Copyrights..., the title of the invention, the date of filing the same, and, if known, the group art unit or...

  15. Environmentally conscious patent histories

    NASA Astrophysics Data System (ADS)

    Crouch, Dennis D.; Crouch, Henry L.

    2004-02-01

    There is a need for investigators, legislators, and business leaders to understand the magnitude of innovation and discovery in the field of environmentally conscious technologies (ECTs). Knowledge of the "big picture" is important to providing a national and global account of actual environmental stewardship over the last twenty-five years. A recitation of the Environmental Protection Agency (EPA) supported Acts which have been enacted into law reveals one facet of the multifaceted dynamic of environmental consciousness. The popular discussion and debate, as well as partisan lobbying, which created the political forces leading to environmentally conscious legislation is another facet. A third facet is the corporate response to the threats and opportunities predicted by CEO"s and others through environmental scanning. This paper examines changes in environmentally conscious inventive effort by comparing data from United States Patents issued from 1976 through 2003. Patents are useful tool for measuring technological innovation because they are publicly available records of innovative activity. Although not all inventions result in patent applications, the monopoly rights granted on the invention give the inventor a strong incentive to obtain patents on any viable product or process. Among the results, we found a significant increase in patents relating to environmentally conscious products and processes during the period in question. Specifically, a dramatic increase in patent activity was seen for the decade of the 1990"s. Surprisingly, the patenting rate from 2000 to 2003 seems to have stabilized. Additionally public discussion of ECTs appears to have a positive impact on patent filings.

  16. Patent Law's Reproducibility Paradox.

    PubMed

    Sherkow, Jacob S

    2017-01-01

    Clinical research faces a reproducibility crisis. Many recent clinical and preclinical studies appear to be irreproducible--their results cannot be verified by outside researchers. This is problematic for not only scientific reasons but also legal ones: patents grounded in irreproducible research appear to fail their constitutional bargain of property rights in exchange for working disclosures of inventions. The culprit is likely patent law’s doctrine of enablement. Although the doctrine requires patents to enable others to make and use their claimed inventions, current difficulties in applying the doctrine hamper or even actively dissuade reproducible data in patents. This Article assesses the difficulties in reconciling these basic goals of scientific research and patent law. More concretely, it provides several examples of irreproducibility in patents on blockbuster drugs--Prempro, Xigris, Plavix, and Avastin--and discusses some of the social costs of the misalignment between good clinical practice and patent doctrine. Ultimately, this analysis illuminates several current debates concerning innovation policy. It strongly suggests that a proper conception of enablement should take into account after-arising evidence. It also sheds light on the true purpose--and limits--of patent disclosure. And lastly, it untangles the doctrines of enablement and utility.

  17. Searching bioremediation patents through Cooperative Patent Classification (CPC).

    PubMed

    Prasad, Rajendra

    2016-03-01

    Patent classification systems have traditionally evolved independently at each patent jurisdiction to classify patents handled by their examiners to be able to search previous patents while dealing with new patent applications. As patent databases maintained by them went online for free access to public as also for global search of prior art by examiners, the need arose for a common platform and uniform structure of patent databases. The diversity of different classification, however, posed problems of integrating and searching relevant patents across patent jurisdictions. To address this problem of comparability of data from different sources and searching patents, WIPO in the recent past developed what is known as International Patent Classification (IPC) system which most countries readily adopted to code their patents with IPC codes along with their own codes. The Cooperative Patent Classification (CPC) is the latest patent classification system based on IPC/European Classification (ECLA) system, developed by the European Patent Office (EPO) and the United States Patent and Trademark Office (USPTO) which is likely to become a global standard. This paper discusses this new classification system with reference to patents on bioremediation.

  18. Internet Patent Databases: Everyone Is a Patent Searcher Now.

    ERIC Educational Resources Information Center

    Wohrley, Andrew A.; Mitchell, Cindy

    1997-01-01

    Patent information has never been so available, at such low cost, to so many people. Describes patent databases accessible on the Web (Micropatent, Source Translation and Optimization Questel-Orbit QPAT, Internet Patents/Community of Science, and the U.S. Patent and Trademark Office), lists their strengths and weaknesses, and recommends the best…

  19. Patenting malarial vaccine.

    PubMed

    Wiwanitkit, Viroj

    2008-01-01

    Malaria is an important tropical infection affecting millions of world population each year. Malarial vaccine development is the hope for successful control of malaria. Knowledge on malaria vaccine has been considered patentable subject for decades. Due to the present advance biotechnology, the number of patent applications related to malarial vaccine is growing exponentially. Several malarial vaccine candidates have been recently identified and the genetic manipulation of these candidates is becoming more efficient with the advancement of new biotechnologies. This review summarizes some of the recent published patents on malarial vaccines covering antigens, candidate epitopes and recombinant processing.

  20. Patent ductus arteriosus

    MedlinePlus

    ... the middle Patent ductus arteriosis (PDA) - series References Fraser CD, Carberry KE. Congenital heart disease. In: Townsend ... Read More Heart failure - overview Neonatal respiratory distress syndrome Pediatric heart surgery Premature infant Patient Instructions Pediatric ...

  1. Patent urachus repair

    MedlinePlus

    Patent urachal tube repair ... belly. Next, the surgeon will find the urachal tube and remove it. The bladder opening will be ... surgeon uses the tools to remove the urachal tube and close off the bladder and area where ...

  2. Trends in Nanopharmaceutical Patents

    PubMed Central

    Antunes, Adelaide; Fierro, Iolanda; Guerrante, Rafaela; Mendes, Flavia; Alencar, Maria Simone de M.

    2013-01-01

    Investment in nanotechnology is now a given constant by governments, research centers and companies in both more developed countries and emerging markets. Due to their characteristics, such as high stability, ability to enable antigen identification on specific cells in the human body and controlling the release of drugs and, therefore, improving therapies, nanoparticles have been the subject of research and patent applications in the pharmaceutical field. According to the Organization for Economic Co-operation and Development (OCDE), patent data can be used as a source of information in order to measure science and technology activities. Thereby, this paper presents an analysis based on patent documents related to nanotechnology in the pharmaceutical sector. As a result, the analysis of patents demonstrate primarily that nanobiotechnology attracts high levels of R&D investments, including nanoparticle-based chemotherapeutic agents/drugs, monoclonal antibody nanoparticle complexes and their role in drug delivery or contrast agents with non-toxic effects. PMID:23535336

  3. Retrieving Patent Information Online

    ERIC Educational Resources Information Center

    Kaback, Stuart M.

    1978-01-01

    This paper discusses patent information retrieval from online files in terms of types of questions, file contents, coverage, timeliness, and other file variations. CLAIMS, Derwent, WPI, APIPAT and Chemical Abstracts Service are described. (KP)

  4. German Studies in America. German Studies Notes.

    ERIC Educational Resources Information Center

    Sander, Volkmar; Osterle, Heinz D.

    This volume contains two papers, "German Studies in America," by Volkmar Sander, and "Historicism, Marxism, Structuralism: Ideas for German Culture Courses," by Heinz D. Osterle. The first paper discusses the position of German studies in the United States today. The greatest challenge comes from low enrollments; therefore,…

  5. Testing Communicative Competence: Notes on a Battery of English Language Tests for Adult Students.

    ERIC Educational Resources Information Center

    Amato, Antonio

    1979-01-01

    This article consists of a battery of tests designed to evaluate the communicative competence of German students studying English in Volkshochschule. The battery includes tests of reading comprehension, written production, listening comprehension, vocabulary and structures, and oral production. (CFM)

  6. 76 FR 40339 - Patent Prosecution Highway (PPH) Program

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-07-08

    ... Patent and Trade Mark Office (DPMA), National Board of Patents and Registration of Finland (NBPR), Russian Patent Office (ROSPATENT), Hungarian Patent Office (HPO), Spanish Patent and Trademark...

  7. Selling Complementary Patents: Experimental Investigation

    SciTech Connect

    Bjornstad, David J; Santore, Rudy; McKee, Michael

    2010-02-01

    Production requiring licensing groups of complementary patents implements a coordination game among patent holders, who can price patents by choosing among combinations of fixed and royalty fees. Summed across patents, these fees become the total producer cost of the package of patents. Royalties, because they function as excise taxes, add to marginal costs, resulting in higher prices and reduced quantities of the downstream product and lower payoffs to the patent holders. Using fixed fees eliminates this inefficiency but yields a more complex coordination game in which there are multiple equilibria, which are very fragile in that small mistakes can lead the downstream firm to not license the technology, resulting in inefficient outcomes. We report on a laboratory market investigation of the efficiency effects of coordinated pricing of patents in a patent pool. We find that pool-like pricing agreements can yield fewer coordination failures in the pricing of complementary patents.

  8. A Teacher's Notebook: German.

    ERIC Educational Resources Information Center

    National Association of Independent Schools, Boston, MA.

    This guide for teachers of German at independent schools is a result of a collective effort of a number of experienced German teachers during the year 1973. It is directed mainly toward the new teacher as a quick source of reference for all aspects of instruction of German at the secondary level. Contents include: (1) "Why Study German?," (2)…

  9. New electric-vehicle batteries

    SciTech Connect

    Oman, H.

    1994-12-31

    Electric vehicles that can`t reach trolley wires need batteries. In the early 1900`s electric cars disappeared when owners found that replacing the car`s worn-out lead-acid battery costs more than a new gasoline-powered car. Most of today`s electric cars are still propelled by lead-acid batteries. General Motors` Impact, for example, uses starting-lighting-ignition batteries, which deliver lots of power for demonstrations, but have a life of less than 100 deep discharges. Now promising alternative technology has challenged the world-wide lead miners, refiners, and battery makers into forming a consortium that sponsors research into making better lead-acid batteries. Horizon`s new bipolar battery delivered 50 watt-hours per kg (Wh/kg), compared with 20 for ordinary transport-vehicle batteries. The alternatives are delivering from 80 Wh/kg (nickel-metal hydride) up to 200 Wh/kg (zinc-bromine). A Fiat Panda travelled 260 km on a single charge of its zinc-bromine battery. A German 3.5-ton postal truck travelled 300 km with a single charge in its 650-kg (146 Wh/kg) zinc-air battery. Its top speed was 110 km per hour. 12 refs.

  10. Edison's vacuum technology patents

    NASA Astrophysics Data System (ADS)

    Waits, Robert K.

    2003-07-01

    During 1879 Thomas Edison's Menlo Park, New Jersey laboratory developed the means to evacuate glass lamp globes to less than a mTorr in 20 min and in mid-1880 began production of carbon-filament incandescent lamps. Among Edison's nearly 1100 U.S. patents are five for vacuum pump improvements, and at least eight others that are vacuum-related; all applied for between 1880 and 1886. Inspired by an 1878 article by De La Rue and Müller [Philos. Trans. R. Soc. London, Ser. A 169, 155 (1878)] on studies of glow discharges, Edison devised a combination pump using the Geissler pump as a rough pump and the Sprengel pump for continuous exhaustion. Edison's patents described means to control the mercury flow and automate the delivery of the mercury to banks of up to a hundred pumps. Other patents described various means to remove residual gases during lamp processing.

  11. Biotools: Patenting DNA sequences

    SciTech Connect

    Yablonsky, M.D.; Hone, W.J.

    1995-07-01

    The decision, known as In re Deuel{sup 2}, rejects the PTO`s interpretation of a previous decision of the Federal Circuit and makes it more possible that a {open_quotes}nucleic acid of a particular sequence{close_quotes} - commonly known as a gene sequence - may be patentable. 15 refs.

  12. Framing the patent troll debate.

    PubMed

    Risch, Michael

    2014-02-01

    The patent troll debate has reached a fevered pitch in the USA. This editorial seeks to frame the debate by pointing out the lack of clarity in defining patent trolls and their allegedly harmful actions. It then frames the debate by asking currently unanswered questions: Where do troll patents come from? What are the effects of troll assertions? Will policy changes improve the system?

  13. Biotechnology patents: new move confuses US patents world.

    PubMed

    Budiansky, Stephen

    1983-03-17

    Patent attorneys are perplexed and dismayed over a surprise decision by the U.S. Patent Office to drop its earlier objections to the second Cohen-Boyer patent application, covering basic processes in recombinant DNA technology. The patent proceedings, which were closed to public access at the request of Stanford University, have resulted in confusion over the meaning of the patent law's disclosure requirement as it applies to new organisms. Meanwhile, evidence of a prior Ph.D. thesis has called into question the originality of the Cohen-Boyer process.

  14. Patent Searching for Librarians and Inventors.

    ERIC Educational Resources Information Center

    Wherry, Timothy Lee

    Information on patents is provided for librarians and laypersons requiring an understanding of the system and the processes involved. Chapter 1 discusses successful patents; terms and concepts; patent types; copyright; trademark; requirements; patent examiners; patent pending; expiration; patentee and assignee; and reissued patents. Chapter 2…

  15. Rubella (German Measles)

    MedlinePlus

    ... Old Feeding Your 1- to 2-Year-Old Rubella (German Measles) KidsHealth > For Parents > Rubella (German Measles) ... to Call the Doctor en español Rubéola About Rubella Rubella — commonly known as German measles or 3- ...

  16. Patents - An Information Resource.

    DTIC Science & Technology

    1980-09-01

    available abstracting services will be compared ard techniques for searching, including automated systems, will be described. Participants, thus having...as they stand or, if use is not permissible, to be avoided. Just as no scientist can keep up with all the articles published in his general subject...field, be It organic chemistry or radio astronomy, so no development engineer can possibly keep up with all the patent literature. Overall something

  17. 78 FR 52939 - Prospective Grant of Exclusive Patent License: Use of Scopolamine to Treat Depression

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-27

    ... Scopolamine to Treat Depression AGENCY: National Institutes of Health, HHS. ACTION: Notice. SUMMARY: This... 25, 2005, titled ``Scopolamine for the Treatment of Depression and Anxiety'' [HHS Ref. No. E-175-2004... Treatment of Depression and Anxiety'' [HHS Ref. No. E-175-2004/0-EP-03]; 3. German Patent 1896025,...

  18. Button batteries

    MedlinePlus

    ... page: //medlineplus.gov/ency/article/002764.htm Button batteries To use the sharing features on this page, please enable ... in the United States. Where Found These devices use button batteries: Calculators Cameras Hearing aids Penlights Watches Symptoms If ...

  19. [CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)].

    PubMed

    Luck, T; Riedel-Heller, S G; Wiese, B; Stein, J; Weyerer, S; Werle, J; Kaduszkiewicz, H; Wagner, M; Mösch, E; Zimmermann, T; Maier, W; Bickel, H; van den Bussche, H; Jessen, F; Fuchs, A; Pentzek, M

    2009-10-01

    The CERAD-NP battery represents well-established tests for the neuropsychological diagnosis of characteristic cognitive deficits in Alzheimer's dementia. However, the use of neuropsychological tests requires reliable standard values for the population under consideration, taking sociodemographic characteristics like age, education and gender into account. This report presents age-, education- and gender-specific reference values for the subtests verbal fluency, word list memory, word list recall and word list recognition as well as the word list savings score of the CERAD-NP battery. The study sample consists of 2891 general practitioners' patients from Germany aged 75 years and older. The study participants had a mean age of 80.2 years (SD=3.6); thus, this report provides reliable reference values for the neuropsychological diagnosis of dementia in older age groups.

  20. German Measles (Rubella)

    MedlinePlus

    ... Spread the Word Shop AAP Find a Pediatrician Health Issues Conditions Injuries & Emergencies Vaccine Preventable Diseases Healthy Children > Health Issues > Vaccine Preventable Diseases > German Measles (Rubella) Health Issues ...

  1. Rechargeable alkaline manganese dioxide/zinc batteries

    NASA Astrophysics Data System (ADS)

    Kordesh, K.; Weissenbacher, M.

    The rechargeable alkaline manganese dioxide/zinc MnO 2/Zn) system, long established commercial as a primay battery, has reached a high level of performance as a secondary battery system. The operating principles are presented and the technological achievements are surveyed by referencing the recent publications and patent literature. A review is also given of the improvements obtained with newly formulated cathodes and anodes and specially designed batteries. Supported by modelling of the cathode and anode processes and by statistical evidence during cycling of parallel/series-connected modules, the envisioned performance of the next generation of these batteries is described. The possibility of extending the practical use of the improved rechargeable MnO 2/Zn system beyond the field of small electronics into the area of power tools, and even to kW-sized power sources, is demonstrated. Finally, the commercial development in comparison with other rechargeable battery systems is examined.

  2. Patenting genome research tools and the law.

    PubMed

    Eisenberg, Rebecca

    2003-01-01

    Patenting genes encoding therapeutic proteins was relatively uncontroversial in the early days of biotechnology. Controversy arose in the era of high-throughput DNA sequencing, when gene patents started to look less like patents on drugs and more like patents on scientific information. Evolving scientific and business strategies for exploiting genomic information raised concerns that patents might slow subsequent research. The trend towards stricter enforcement of the utility and disclosure requirements by the patent offices should help clarify the current confusion.

  3. Preferred supplier contracts in post-patent prescription drug markets.

    PubMed

    Blankart, Carl Rudolf; Stargardt, Tom

    2016-02-22

    In recent years, the expiration of patents for large drug classes has increased the importance of post-patent drug markets. However, previous research has focused solely on patent drug markets. In this study, the authors evaluate the influence of preferred supplier contracts, the German approach to tendering, in post-patent drug markets using a hierarchical market share attraction model. The authors find that preferred supplier contracts are a powerful strategic instrument for generic manufacturers in a highly competitive environment. They quantify the effects of signing a preferred supplier contract and show that brand-name manufacturers are vulnerable to tendering. Therefore, brand-name manufacturers should readjust their strategies and consider including preferred supplier contracts in their marketing mix. In addition, the authors employ a simulation to demonstrate that a first-mover advantage might be gained from signing a preferred supplier contract. Furthermore, their results can be used as a blueprint for decision makers in the pharmaceutical industry to assess the market share effects of different contracting strategies regarding preferred supplier contracts.

  4. Recent patents on molecular cytogenetics.

    PubMed

    Iourov, Ivan Y; Vorsanova, Svetlana G; Yurov, Yuri B

    2008-01-01

    The questions surrounding patenting of DNA sequences encoding specific proteins are relatively well reviewed in the available literature. However, neither applications nor molecular cytogenetic techniques, which use these sequences as a probe, have been reviewed in the light of the patenting. Furthermore, the patenting of the use of numerous probes, which are produced on different types of repetitive genome elements (i.e. satellite DNA or telomeric DNA sequences) and those generated by chromosome microdissection has not been reviewed. Molecular cytogenetic techniques are one of the most applied in current bioscience (as to June 2007, over 40,000 papers in browseable scientific databases mention one or several molecular cytogenetic techniques). Therefore, reviewing recent patents in this field is of general interest for numerous researchers in different areas of biology and medicine. Here, we address world-wide patents on DNA sequences used as molecular cytogenetic probes and molecular cytogenetic techniques to define current state and perspectives of this biomedical direction.

  5. [Patent rights and biotechnological inventions].

    PubMed

    Lobato García-Miján, M

    1998-01-01

    In spite of all the controversy surrounding it and the problems encountered in the process leading to its adoption, the Directive on the legal protection of biotechnology inventions does not feature anything substantially new compared to the criteria used by patent offices in determining whether inventions of this type can be patented. The Directive's originality stems not so much from the interpretation given of patenting requirements but rather from the legal importance attached to issues of public policy or morality. It sets out and interprets for the member states of the European Union what is meant by the term. However, in our opinion this regulation of morality reflects above all else an attempt to satisfy the views of sectors opposed to the Directive. Clearly, there is some doubt as to whether in practice patents for genetic material can be turned down because they run counter to morality, except in blatant cases of immorality (applications for patents for human embryos, etc).

  6. Patent Pools: Intellectual Property Rights and Competition

    PubMed Central

    Rodriguez, Victor

    2010-01-01

    Patent pools do not correct all problems associated with patent thickets. In this respect, patent pools might not stop the outsider problem from striking pools. Moreover, patent pools can be expensive to negotiate, can exclude patent holders with smaller numbers of patents or enable a group of major players to form a cartel that excludes new competitors. For all the above reasons, patent pools are subject to regulatory clearance because they could result in a monopoly. The aim of this article is to present the relationship between patents and competition in a broad context. PMID:20200607

  7. Battery separators.

    PubMed

    Arora, Pankaj; Zhang, Zhengming John

    2004-10-01

    The ideal battery separator would be infinitesimally thin, offer no resistance to ionic transport in electrolytes, provide infinite resistance to electronic conductivity for isolation of electrodes, be highly tortuous to prevent dendritic growths, and be inert to chemical reactions. Unfortunately, in the real world the ideal case does not exist. Real world separators are electronically insulating membranes whose ionic resistivity is brought to the desired range by manipulating the membranes thickness and porosity. It is clear that no single separator satisfies all the needs of battery designers, and compromises have to be made. It is ultimately the application that decides which separator is most suitable. We hope that this paper will be a useful tool and will help the battery manufacturers in selecting the most appropriate separators for their batteries and respective applications. The information provided is purely technical and does not include other very important parameters, such as cost of production, availability, and long-term stability. There has been a continued demand for thinner battery separators to increase battery power and capacity. This has been especially true for lithiumion batteries used in portable electronics. However, it is very important to ensure the continued safety of batteries, and this is where the role of the separator is greatest. Thus, it is essential to optimize all the components of battery to improve the performance while maintaining the safety of these cells. Separator manufacturers should work along with the battery manufacturers to create the next generation of batteries with increased reliability and performance, but always keeping safety in mind. This paper has attempted to present a comprehensive review of literature on separators used in various batteries. It is evident that a wide variety of separators are available and that they are critical components in batteries. In many cases, the separator is one of the major factors

  8. Dry cell battery poisoning

    MedlinePlus

    Batteries - dry cell ... Acidic dry cell batteries contain: Manganese dioxide Ammonium chloride Alkaline dry cell batteries contain: Sodium hydroxide Potassium hydroxide Lithium dioxide dry cell batteries ...

  9. Automated mapping system patented

    NASA Astrophysics Data System (ADS)

    A patent on a satellite system dubbed Mapsat, which would be able to map the earth from space and would thereby reduce the time and cost of mapping on a smaller scale, has been issued to the U.S. Geological Survey.The Mapsat concept, invented by Alden F. Colvocoresses, a research cartographer at the USGS National Center, is based on Landsat technology but uses sensors that acquire higher-resolution image data in either a stereo or monoscopic mode. Stereo data can be processed relatively simply with automation to produce images for interpretation or to produce maps. Monoscopic and multispectral data can be processed in a computer to derive information on earth resources. Ground control, one of the most expensive phases of mapping, could be kept to a minimum.

  10. [Sample German LAPS.

    ERIC Educational Resources Information Center

    Rosenthal, Bianca

    Four learning activity packages (LAPS) for use in secondary school German programs contain instructional materials which enable students to improve their basic linguistic skills. The units include: (1) "Grusse," (2) "Ich Heisse...Namen," (3) "Tune into Your Career: Business Correspondence 'Auf Deutch'," and (4) "Understanding German Culture."…

  11. Patenting the Life Sciences at the European Patent Office

    PubMed Central

    Gates, Christina

    2014-01-01

    The European patent system is very much like those of the United States and other major countries. Patent applications can be filed as a first filing, as a priority application, or as a national phase of a Patent Cooperation Treaty application. The applications are searched, rigorously examined, and ultimately granted, with the time periods varying somewhat depending on the application type. The object of this article is to highlight some of the differences between the U.S. and European systems, particularly as they relate to life sciences. PMID:25342060

  12. German influence in USSR

    NASA Astrophysics Data System (ADS)

    Chertok, B.

    2004-08-01

    In June 1945 this author was one of the organizers of the, first in the postwar history, Soviet-German institute RABE. The main task of its activity was to study the history of the German rocket technology developments and rebuild the technology of the long range ballistic missiles V-2. This work was supported by the Soviet military authorities and also by the Soviet government. In the Turingia region of Germany a big institute, "Nordhausen", was established, in which Soviet and German specialists jointly worked on the rocket technology problems. In November 1947 a big group of German specialists was transferred to the Soviet Union. All the works in Germany were cancelled. German specialists took part in the preparation and running of the flight test of rocket V-2 in October-November of 1947 on Kapustin Yar test range. Until the beginning of the 50s a big group of German specialists worked in the daughter institute of the leading Soviet research institute on rocket technique, NII-88, under the management of Helmut Grettrupe, one of the former von Braun employees. They worked out the design of ballistic missiles of range up to 800 km with principally new guidance system. Germans also took part in the development of the technology of fluid rocket engine production. In 1952-1953 German specialists returned to Germany and rocket technology in the USSR matured independently. The Soviet and German scientists cooperation resumed in 1960s after manned space flights were started. The author was one of the leading participants in those joint works.

  13. 78 FR 31885 - Patent Term Extension

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-05-28

    ... Patent and Trademark Office Patent Term Extension ACTION: Proposed collection; comment request. SUMMARY... term restoration portion of the Drug Price Competition and Patent Term Restoration Act of 1984 (Pub. L... (USPTO) to extend the term of protection under a patent to compensate for delay during regulatory...

  14. Developing a Systematic Patent Search Training Program

    ERIC Educational Resources Information Center

    Zhang, Li

    2009-01-01

    This study aims to develop a systematic patent training program using patent analysis and citation analysis techniques applied to patents held by the University of Saskatchewan. The results indicate that the target audience will be researchers in life sciences, and aggregated patent database searching and advanced search techniques should be…

  15. Patenting drought tolerance in organisms.

    PubMed

    Somvanshi, Vishal S

    2009-01-01

    Dehydration is a major form of osmotic stress in cells. Physiological and molecular basis of dehydration stress responses in cells and organisms has been intensively researched over past years. Almost all of the patented dehydration stress tolerance genes from different organisms were used in engineering drought tolerance in crop plants. In spite of the moral, religious and ethical controversies surrounding use of foreign DNA sequences in crop plants, the numbers of such patents has grown tremendously in recent years. In future, we might witness another rise in patents on use of dehydration stress related gene sequences in creating environmental stress tolerant biological control agents for plant disease and insect pest management in agriculture. This review summarizes some of the recent published patents related to drought tolerance genes and their use.

  16. Embryonic stem cell patents and human dignity.

    PubMed

    Resnik, David B

    2007-09-01

    This article examines the assertion that human embryonic stem cells patents are immoral because they violate human dignity. After analyzing the concept of human dignity and its role in bioethics debates, this article argues that patents on human embryos or totipotent embryonic stem cells violate human dignity, but that patents on pluripotent or multipotent stem cells do not. Since patents on pluripotent or multipotent stem cells may still threaten human dignity by encouraging people to treat embryos as property, patent agencies should carefully monitor and control these patents to ensure that patents are not inadvertently awarded on embryos or totipotent stem cells.

  17. Embryonic Stem Cell Patents and Human Dignity

    PubMed Central

    Resnik, David B.

    2009-01-01

    This article examines the assertion that human embryonic stem cells patents are immoral because they violate human dignity. After analyzing the concept of human dignity and its role in bioethics debates, this article argues that patents on human embryos or totipotent embryonic stem cells violate human dignity, but that patents on pluripotent or multipotent stem cells do not. Since patents on pluripotent or multipotent stem cells may still threaten human dignity by encouraging people to treat embryos as property, patent agencies should carefully monitor and control these patents to ensure that patents are not inadvertently awarded on embryos or totipotent stem cells. PMID:17922198

  18. Are DNA patents bad for medicine?

    PubMed

    Resnik, David B

    2003-08-01

    This paper considers the potential benefits and harms of DNA patenting for biomedical research and medical practice. It argues that, all things considered, the benefits of patenting DNA outweigh the harms, although societies should adopt policies designed to prevent or mitigate the harms associated with patenting. Some of these policies include: (1) reinforcing the research exemption for academic researchers, (2) raising the "bar" for the criteria of patentability, (3) restricting the scope of patents, (4) disclosing conflicts of interest related to DNA patents, (5) sharing the economic benefits of patenting with patients, and (6) providing insurance coverage for some types of genetic tests.

  19. The patenting of novel biotech products.

    PubMed

    Webber, Philip M

    2007-07-01

    Patent laws covering NCEs are well established in most developed countries. For such entities to be patentable, they must be novel, inventive and have some practical use. Furthermore, the patent applications must describe how to make the entities, and provide data to support the patent claims. The same criteria are being applied by Patent Offices to the patenting of the new generation of biotech products: genes, proteins, microorganisms, transgenic plants and transgenic animals. This feature review focuses on the patenting of these novel products.

  20. Recent patents in food nanotechnology.

    PubMed

    Pérez-Esteve, Edgar; Bernardos, Andrea; Martínez-Mañez, Ramón; Barat, José M

    2011-09-01

    Nanotechnology is a multidisciplinary field of current interest. The huge possibilities in most industries are making nanoscience grow at a rapid pace, but what is the real impact of nanotechnology in a traditional industry such as food? The study of patents published in the last 20 years provides the answer, and the results are quite surprising; the food industry is the fifth largest sector in terms of patents related to nanotechnology.

  1. The patenting of medical treatment.

    PubMed

    Loughlan, P L

    1995-04-03

    The Full Federal Court of Australia recently held, in a decisive break with long-established legal principle, that methods of medical treatment are patentable inventions. The judgment signals the advent of monopolies and therefore monopoly prices on new therapeutic procedures until now made freely available to the medical profession. It also heralds delays in the dissemination of information about discoveries of such procedures through teaching and publication until a patent application can be prepared for and made.

  2. Rightpollex: From Patent To Startup

    NASA Astrophysics Data System (ADS)

    Leba, Monica; Ionica, Andreea Cristina; Dobra, Remus

    2015-07-01

    RightPollex is an innovative product patented and developed by a multidisciplinary team from the University of Petrosani. The paper presents not only the idea and implementation possibilities of this patent, but also the current stage on the path towards the development of startups, an initiative of our university together with a private investor. The result of this initiative is JV Sensor Ventures that supports several startups.

  3. Universities and Patent Demands

    PubMed Central

    Cordova, Andrew K.; Feldman, Robin

    2015-01-01

    Research universities have made enormous contributions to the field of medicine and the treatment of human disease. Alone or in collaboration with pharmaceutical companies, academic researchers have added to the store of knowledge that has led to numerous life science breakthroughs. A new chapter may be opening for academic researchers, however, that could lead to a darker tale. ‘The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research, by Bubela et al., chronicles one such tale.’ The authors do an excellent job of bringing to life the twisting saga that engulfed numerous academic and non-profit Alzheimer's researchers over many years. The authors note that the story is an outlier, but sadly, that may not be the case. There are increasing signs that academic researchers and their institutions are being caught up in the rush for gold that is accompanying the proliferation of the non-practicing entity business model. As I have noted before, academic institutions have a dual role, as keepers of the academic flame and guardians of the public monies entrusted to them through state and federal research funding. The specter of taxpayer money being used, not to advance research and for the betterment of society, but as part of schemes to extract money from productive companies may not sit well with voters, and ultimately, with legislators. In that case, researchers and institutions themselves may have much to lose. PMID:27774221

  4. Universities and Patent Demands.

    PubMed

    Cordova, Andrew K; Feldman, Robin

    2015-11-01

    Research universities have made enormous contributions to the field of medicine and the treatment of human disease. Alone or in collaboration with pharmaceutical companies, academic researchers have added to the store of knowledge that has led to numerous life science breakthroughs. A new chapter may be opening for academic researchers, however, that could lead to a darker tale. 'The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research, by Bubela et al., chronicles one such tale.' The authors do an excellent job of bringing to life the twisting saga that engulfed numerous academic and non-profit Alzheimer's researchers over many years. The authors note that the story is an outlier, but sadly, that may not be the case. There are increasing signs that academic researchers and their institutions are being caught up in the rush for gold that is accompanying the proliferation of the non-practicing entity business model. As I have noted before, academic institutions have a dual role, as keepers of the academic flame and guardians of the public monies entrusted to them through state and federal research funding. The specter of taxpayer money being used, not to advance research and for the betterment of society, but as part of schemes to extract money from productive companies may not sit well with voters, and ultimately, with legislators. In that case, researchers and institutions themselves may have much to lose.

  5. power battery

    NASA Astrophysics Data System (ADS)

    Yunyun, Zhang; Guoqing, Zhang; Weixiong, Wu; Weixiong, Liang

    2014-07-01

    Under hard acceleration or on a hill climb of (hybrid) electronic vehicles, the battery temperature would increase rapidly. High temperature decreases the battery cycle life, increases the thermal runaway, and even causes a battery to explode, that making the management of battery temperature an important consideration in the safety using of electronic vehicles. A study of increasing heat transfer area from the beginning design phase has been conducted to determine and enhance the heat dissipation on the battery surface. Both experiment and simulation methods were used to analyze the cooling performance under identical battery capacities and heights. Optimal external dimensions and cell sizes with the consideration of better battery workability was obtained from the analysis. The heat transfer coefficients were investigated in order to regulate the battery temperature under safety operating range. It was found that the temperature of the experiment battery would be controlled under safety critical when the cell was designed for 180 mm × 30 mm × 185 mm sizes and the surface heat transfer coefficient was 20 W m-2 K-1 at least.

  6. Patent Law for Computer Scientists

    NASA Astrophysics Data System (ADS)

    Closa, Daniel; Gardiner, Alex; Giemsa, Falk; Machek, Jörg

    More than five centuries ago the first patent statute was passed by the Venetian senate. It already had most of the features of modern patent law, recognizing the public interest in innovation and granting exclusive right in exchange for a full disclosure. Some 350 years later the industrial revolution led to globalisation. The wish to protect intellectual property on a more international level evolved and supranational treaties were negotiated. Patent laws are still different in many countries, however, and inventors are sometimes at a loss to understand which basic requirements should be satisfied if an invention is to be granted a patent. This is particularly true for inventions implemented on a computer. While roughly a third of all applications (and granted patents) relate, in one way or another, to a computer, applications where the innovation mainly resides in software or in a business method are treated differently by the major patent offices. The procedures at the USPTO, JPO and EPO and, in particular, the differences in the treatment of applications centring on software are briefly explained. In later sections of this book, a wealth of examples will be presented. The methodology behind the treatment of these examples is explained.

  7. German mining equipment

    SciTech Connect

    Not Available

    1993-10-01

    The German mining equipment industry developed to supply machines and services to the local mining industry, i.e., coal, lignite, salt, potash, ore mining, industrial minerals, and quarrying. The sophistication and reliability of its technology also won it worldwide export markets -- which is just as well since former major domestic mining sectors such as coal and potash have declined precipitously, and others such as ore mining have all but disappeared. Today, German mining equipment suppliers focus strongly on export sales, and formerly unique German mining technologies such as continuous mining with bucket wheel excavators and conveyors for open pits, or plowing of underground coal longwalls are widely used abroad. The status of the German mining equipment industry is reviewed.

  8. Considerations on patent valuation based on patent classification and citation in biotechnological field

    NASA Astrophysics Data System (ADS)

    Mihara, Kenji

    Regarding innovation measurement utilizing patent information, a number of researchers are making great efforts to measure a "patent value (patent quality)." For patent valuation, patent classification and citation are often utilized as patent information. Also, biotechnological field is attracting attention from the viewpoint of application to environmental or medical study, and considerable researches on patent valuation are ongoing in this technical field. However, it is not enough recognized that researchers cannot be too careful when they deal with classification information in the biotech field because patent classification structure in this field is not well-established. And also, it is not known enough that citation patterns of both academic papers and patent documents are so complicated that the patterns cannot be easily generalized. In this article, the issues above were verified from a position based on working experiences of biotech patent examiner at Japan Patent Office, and considerations and implications were given on what patent valuation should be.

  9. 37 CFR 1.315 - Delivery of patent.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Delivery of patent. 1.315 Section 1.315 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF... Patent § 1.315 Delivery of patent. The patent will be delivered or mailed upon issuance to...

  10. 37 CFR 1.315 - Delivery of patent.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2011-07-01 2011-07-01 false Delivery of patent. 1.315 Section 1.315 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF... Patent § 1.315 Delivery of patent. The patent will be delivered or mailed upon issuance to...

  11. Paintable Battery

    PubMed Central

    Singh, Neelam; Galande, Charudatta; Miranda, Andrea; Mathkar, Akshay; Gao, Wei; Reddy, Arava Leela Mohana; Vlad, Alexandru; Ajayan, Pulickel M.

    2012-01-01

    If the components of a battery, including electrodes, separator, electrolyte and the current collectors can be designed as paints and applied sequentially to build a complete battery, on any arbitrary surface, it would have significant impact on the design, implementation and integration of energy storage devices. Here, we establish a paradigm change in battery assembly by fabricating rechargeable Li-ion batteries solely by multi-step spray painting of its components on a variety of materials such as metals, glass, glazed ceramics and flexible polymer substrates. We also demonstrate the possibility of interconnected modular spray painted battery units to be coupled to energy conversion devices such as solar cells, with possibilities of building standalone energy capture-storage hybrid devices in different configurations. PMID:22745900

  12. Zinc electrode and rechargeable zinc-air battery

    SciTech Connect

    Ross, P.N. Jr.

    1989-06-27

    This patent describes an improved zinc electrode for a rechargeable zinc-air battery comprising an outer frame and a porous foam electrode support within the frame which is treated prior to the deposition of zinc thereon to inhibit the formation of zinc dendrites on the external surface thereof. The outer frame is provided with passageways for circulating an alkaline electrolyte through the treated zinc-coated porous foam. A novel rechargeable zinc-air battery system is also disclosed.

  13. Percutaneous catheter-based treatment of pulmonic stenosis and patent ductus arteriosus in a dog.

    PubMed

    Bussadori, Claudio; Domenech, Oriol; Longo, Antonio; Pradelli, Danitza; Bussadori, Roberto

    2002-11-01

    A 6-months old female German shepherd dog was referred for management of congenital heart disease. A diagnosis of pulmonic stenosis (PS) and patent ductus arteriosus (PDA) was confirmed by Doppler echocardiography and cardiac catheterisation. The conditions were treated during a single cardiac catheterisation procedure using percutaneous techniques. Gianturco coil embolisation was used to close the PDA, and the PS was relieved using a balloon valvuloplasty technique.

  14. German for physicists

    NASA Astrophysics Data System (ADS)

    Stein, Ben

    2009-04-01

    "German is the language of science" I remember my father telling me as a boy growing up in the Bronx in New York during the 1970s. As I watched astronomy programmes on TV with my father and older brothers, I imagined having to speak ceaselessly in fluent German if I was ever to become a scientist as a grown-up. But when I started my studies at university in New York in the 1980s, I realized my father's advice - sought from weekly trips to the neighbourhood public library - was way out of date. Not only did my physics professors present their research in English at conferences all around the world, but they also published in English-language journals - thus seemingly not needing a single word of German.

  15. Recent Patents in Oncolytic Virotherapy.

    PubMed

    Ahmad, Tauqeer; Venkataraman, Srividhya; AbouHaidar, Mounir; Hefferon, Kathleen L

    2016-01-01

    Recent innovative and advanced developments in the diagnosis and treatment of human diseases as well as enhanced in-depth understanding of virus molecular biology have opened novel avenues with respect to the patent landscape. Included are viruses utilized in the development of anticancer agents, agents that are employed against the spread of infectious viral diseases, RNA silencing agents and virus-derived expression vectors that can be used for over-expression of therapeutic proteins or as gene therapy vehicles. The current review describes several recent patents pertaining to virus sequences and their medical and biotechnological applications.

  16. Patent Abstract Digest. Volume I.

    DTIC Science & Technology

    1979-04-30

    COMMAND United States Patent ij fill 4,102,610 Taboada et al. [45] Jul. 25,1i978 154] CONSTANT VOLUME SEAL-FREE 3.522,794 7/1970 DNJl................318...MATCHING [561 Rafaree. Cited SPACER U.S. PATENT DOCUMENTS [751 Inventors: Sidney Michael Cole. Waved 7; Paul 3.533.607 1/1971 Lehrreld . ...... 331/34 tA...Schwadron 11) let. CV ....................... F16K 21/18; FI7C 13/02; Aiistant Examiner-A. Michael Chambers GOlF 23/24 Attorney Agent, orFirm-Joseph E

  17. Impact of bioethics on patentability of inventions.

    PubMed

    Devaiah, Vishwas H

    2010-01-01

    This paper examines the impact of bioethics on patent claims. The increase in research activities involving human biological materials, and the rush to commercialise inventions derived from such biological materials, can at times result in unethical conduct of research. Questions arise as to whether patent law should concern itself with tainted research that has resulted in an invention or whether it should grant patent rights solely on the basis of the technical improvements resulting from such research. This paper highlights the significance of ethical practice in biomedical research, an issue that may influence the decision to grant patents on inventions. It explores the relation between morality, bioethics and patents from the perspective of the objectives of the patent system and current developments in the law on patents. The inclusion of the morality provision in patent law introduces a mechanism through which inventions derived from tainted research can be filtered at an early stage.

  18. 48 CFR 1327.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 48 Federal Acquisition Regulations System 5 2014-10-01 2014-10-01 false Patent and copyright... GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1327.201 Patent and copyright infringement liability....

  19. 48 CFR 27.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 48 Federal Acquisition Regulations System 1 2013-10-01 2013-10-01 false Patent and copyright... REGULATION GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 27.201 Patent and copyright infringement liability....

  20. 48 CFR 1427.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 48 Federal Acquisition Regulations System 5 2014-10-01 2014-10-01 false Patent and copyright... INTERIOR GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1427.201 Patent and copyright infringement liability....

  1. 48 CFR 1327.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 48 Federal Acquisition Regulations System 5 2012-10-01 2012-10-01 false Patent and copyright... GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1327.201 Patent and copyright infringement liability....

  2. 48 CFR 1327.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 48 Federal Acquisition Regulations System 5 2013-10-01 2013-10-01 false Patent and copyright... GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1327.201 Patent and copyright infringement liability....

  3. 48 CFR 27.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 48 Federal Acquisition Regulations System 1 2012-10-01 2012-10-01 false Patent and copyright... REGULATION GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 27.201 Patent and copyright infringement liability....

  4. 7 CFR 1210.367 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Patents, copyrights, inventions, and publications....367 Patents, copyrights, inventions, and publications. Any patents, copyrights, inventions, product... such patents, copyrights, inventions, product formulations, or publications shall be considered...

  5. 7 CFR 1210.367 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Patents, copyrights, inventions, and publications....367 Patents, copyrights, inventions, and publications. Any patents, copyrights, inventions, product... such patents, copyrights, inventions, product formulations, or publications shall be considered...

  6. 48 CFR 1327.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 5 2010-10-01 2010-10-01 false Patent and copyright... GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1327.201 Patent and copyright infringement liability....

  7. 48 CFR 27.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 1 2010-10-01 2010-10-01 false Patent and copyright... REGULATION GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 27.201 Patent and copyright infringement liability....

  8. 48 CFR 1327.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 5 2011-10-01 2011-10-01 false Patent and copyright... GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1327.201 Patent and copyright infringement liability....

  9. 7 CFR 1210.367 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Patents, copyrights, inventions, and publications....367 Patents, copyrights, inventions, and publications. Any patents, copyrights, inventions, product... such patents, copyrights, inventions, product formulations, or publications shall be considered...

  10. 48 CFR 1427.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 48 Federal Acquisition Regulations System 5 2013-10-01 2013-10-01 false Patent and copyright... INTERIOR GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1427.201 Patent and copyright infringement liability....

  11. 48 CFR 27.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 1 2011-10-01 2011-10-01 false Patent and copyright... REGULATION GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 27.201 Patent and copyright infringement liability....

  12. 48 CFR 1427.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 5 2010-10-01 2010-10-01 false Patent and copyright... INTERIOR GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1427.201 Patent and copyright infringement liability....

  13. 7 CFR 1210.367 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Patents, copyrights, inventions, and publications....367 Patents, copyrights, inventions, and publications. Any patents, copyrights, inventions, product... such patents, copyrights, inventions, product formulations, or publications shall be considered...

  14. 48 CFR 27.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 48 Federal Acquisition Regulations System 1 2014-10-01 2014-10-01 false Patent and copyright... REGULATION GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 27.201 Patent and copyright infringement liability....

  15. 48 CFR 1427.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 5 2011-10-01 2011-10-01 false Patent and copyright... INTERIOR GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1427.201 Patent and copyright infringement liability....

  16. 48 CFR 1427.201 - Patent and copyright infringement liability.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 48 Federal Acquisition Regulations System 5 2012-10-01 2012-10-01 false Patent and copyright... INTERIOR GENERAL CONTRACTING REQUIREMENTS PATENTS, DATA, AND COPYRIGHTS Patents and Copyrights 1427.201 Patent and copyright infringement liability....

  17. 7 CFR 1210.367 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Patents, copyrights, inventions, and publications....367 Patents, copyrights, inventions, and publications. Any patents, copyrights, inventions, product... such patents, copyrights, inventions, product formulations, or publications shall be considered...

  18. Bipolar battery

    DOEpatents

    Kaun, Thomas D.

    1992-01-01

    A bipolar battery having a plurality of cells. The bipolar battery includes: a negative electrode; a positive electrode and a separator element disposed between the negative electrode and the positive electrode, the separator element electrically insulating the electrodes from one another; an electrolyte disposed within at least one of the negative electrode, the positive electrode and the separator element; and an electrode containment structure including a cup-like electrode holder.

  19. Zebra batteries

    NASA Astrophysics Data System (ADS)

    Sudworth, J. L.

    By using molten sodium chloroaluminate as secondary electrolyte, a series of solid transition metal chlorides can be used as positive electrodes in cells with sodium as the negative and beta-alumina as the solid electrlyte. Nickel chloride is preferred and Zebra batteries based on this cell reaction have been developed to the pilot-line production stage. The batteries have a number of features which make them attractive for electric-vehicle applications. Thus, the cells can be assebled in the discharged state eliminating the need to handle liquid sodium. By locating the positive electrode inside the beta-alumina tube, square cell cases can be used giving maximum packing efficiency in batteries. The absence of corrosion in the cell leads to a long life and high reliability. For electric-vehicle applications safety is very imporant, and crash testing has shown that even serious damage to the battery in a crash situation would not present a significant additional hazard to the driver or passengers. The remaining technical challenges are to increase the specific power of the battery towards the end of discharge and to demonstrate that the processes, which have been developed for cell and battery production, are capable of meeting the cost targets.

  20. 77 FR 4509 - Patent Public Advisory Committee Public Hearings on the Proposed Patent Fee Schedule

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-01-30

    .... Dated: January 24, 2012. David J. Kappos, Under Secretary of Commerce for Intellectual Property and... United States Patent and Trademark Office 37 CFR Chapter I Patent Public Advisory Committee Public Hearings on the Proposed Patent Fee Schedule AGENCY: United States Patent and Trademark Office,...

  1. The patentability of human beings: the effect of a proposed exclusion in the Patents Act 1953.

    PubMed

    MacBean, Alexandra

    2002-11-01

    The author critically examines the debate over whether "human beings" ought to be patentable. The article outlines the choices between excluding just the patenting of whole organisms or parts of organisms. After considering New Zealand, Canadian, and European Union Patent law, the author concludes that at very least New Zealand must statutorily prevent the patenting of whole organisms.

  2. [Gene and gene sequence patenting].

    PubMed

    Bergel, S D

    1998-01-01

    According to the author, the patenting of elements isolated or copied from the human body boils down to the issue of genes and gene sequences. He describes the current situation from the comparative law standpoint (U.S. and Spanish law mainly) and then esamines the biotechnology industry's position.

  3. The US patent system is broken.

    PubMed

    Pieczenik, George

    2013-08-01

    In discussions in this issue of RBM Online relating to a patent granted to Auxogyn, Professor Renee Reijo Pera claims this is not about a "broken patent system". I shall demonstrate how dysfunctional the patent system has become and how much in denial 'inventor' Renee Reijo Pera is about her invention differing from a naturally occurring phenomenon.

  4. Patents and human rights: a heterodox analysis.

    PubMed

    Gold, E Richard

    2013-01-01

    Much international debate over access to medicines focuses on whether patent law accords with international human rights law. This article argues that this is the wrong question to ask. Following an analysis of both patent and human rights law, this article suggests that the better approach is to focus on national debates over the best calibration of patent law to achieve national objectives.

  5. 14 CFR 1274.911 - Patent rights.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 14 Aeronautics and Space 5 2011-01-01 2010-01-01 true Patent rights. 1274.911 Section 1274.911... FIRMS Other Provisions and Special Conditions § 1274.911 Patent rights. Patent Rights July 2002 (a... through 121.911 will be used.) (8) Subject Invention means any invention of a Recipient and/or...

  6. 14 CFR 1274.911 - Patent rights.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 14 Aeronautics and Space 5 2012-01-01 2012-01-01 false Patent rights. 1274.911 Section 1274.911... FIRMS Other Provisions and Special Conditions § 1274.911 Patent rights. Patent Rights July 2002 (a... through 121.911 will be used.) (8) Subject Invention means any invention of a Recipient and/or...

  7. 14 CFR 1274.911 - Patent rights.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 14 Aeronautics and Space 5 2013-01-01 2013-01-01 false Patent rights. 1274.911 Section 1274.911... FIRMS Other Provisions and Special Conditions § 1274.911 Patent rights. Patent Rights July 2002 (a... through 121.911 will be used.) (8) Subject Invention means any invention of a Recipient and/or...

  8. 48 CFR 35.012 - Patent rights.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 1 2010-10-01 2010-10-01 false Patent rights. 35.012 Section 35.012 Federal Acquisition Regulations System FEDERAL ACQUISITION REGULATION SPECIAL CATEGORIES OF CONTRACTING RESEARCH AND DEVELOPMENT CONTRACTING 35.012 Patent rights. For a discussion of patent rights,...

  9. 48 CFR 970.2703 - Patent rights.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 5 2011-10-01 2011-10-01 false Patent rights. 970.2703 Section 970.2703 Federal Acquisition Regulations System DEPARTMENT OF ENERGY AGENCY SUPPLEMENTARY REGULATIONS DOE MANAGEMENT AND OPERATING CONTRACTS Patents, Data, and Copyrights 970.2703 Patent rights....

  10. 48 CFR 970.2703 - Patent rights.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 5 2010-10-01 2010-10-01 false Patent rights. 970.2703 Section 970.2703 Federal Acquisition Regulations System DEPARTMENT OF ENERGY AGENCY SUPPLEMENTARY REGULATIONS DOE MANAGEMENT AND OPERATING CONTRACTS Patents, Data, and Copyrights 970.2703 Patent rights....

  11. 48 CFR 970.2703 - Patent rights.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 48 Federal Acquisition Regulations System 5 2012-10-01 2012-10-01 false Patent rights. 970.2703 Section 970.2703 Federal Acquisition Regulations System DEPARTMENT OF ENERGY AGENCY SUPPLEMENTARY REGULATIONS DOE MANAGEMENT AND OPERATING CONTRACTS Patents, Data, and Copyrights 970.2703 Patent rights....

  12. 48 CFR 970.2703 - Patent rights.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 48 Federal Acquisition Regulations System 5 2013-10-01 2013-10-01 false Patent rights. 970.2703 Section 970.2703 Federal Acquisition Regulations System DEPARTMENT OF ENERGY AGENCY SUPPLEMENTARY REGULATIONS DOE MANAGEMENT AND OPERATING CONTRACTS Patents, Data, and Copyrights 970.2703 Patent rights....

  13. 48 CFR 970.2703 - Patent rights.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 48 Federal Acquisition Regulations System 5 2014-10-01 2014-10-01 false Patent rights. 970.2703 Section 970.2703 Federal Acquisition Regulations System DEPARTMENT OF ENERGY AGENCY SUPPLEMENTARY REGULATIONS DOE MANAGEMENT AND OPERATING CONTRACTS Patents, Data, and Copyrights 970.2703 Patent rights....

  14. Know Your Laws. German.

    ERIC Educational Resources Information Center

    Watson, Joan Q.; Karch, Hannelore

    This German language version of "Know Your Laws" consists of 24 self-contained modules designed to acquaint the Florida adult student with laws she/he will meet in everyday life; fundamentals of local, state, and federal governments; and the criminal and juvenile justice systems. (The 130 objectives are categorized in the first three…

  15. Teaching German Modal Particles.

    ERIC Educational Resources Information Center

    Rosler, Dietmar

    1982-01-01

    Believes modern linguistics has done little to explore German modal particles because by focusing on sentences as the basic category for linguistic thinking these words did not seem to matter. Describes model which gives students experience with these particles in meaningful communication. (Author/BK)

  16. Teaching German with TPRS.

    ERIC Educational Resources Information Center

    Davidheiser, James

    2002-01-01

    Outlines the research leading to Total Physical Response (TRP) and later Total Physical Response Storytelling (TPRS) methods. Discusses the day-to-day use in the German classroom of TPRS by an experienced practitioner and explains the reasons for its success. Presents student evaluations of the method and the material available for its use. (AS)

  17. Storytelling and German Culture.

    ERIC Educational Resources Information Center

    Cooper, Connie S. Eigenmann

    The genre of fairytales, one structured form of storytelling, has been labeled "Marchen." German culture is orally transmitted in this generic form, and can be traced to a collection of 210 fairytales, the Grimm brothers'"Kinder-und Taus-Marchen," first published shortly after 1800. For this study, research questions were posed…

  18. Women in German Literature.

    ERIC Educational Resources Information Center

    Frederiksen, Elke

    This course description outlines the general and specific objectives for a course on "Women in German Literature," which investigates the changing literary and social roles of women from the beginning of the 19th Century to the present: women as seen by man, by another woman and in introspection. This course description was successfully used in a…

  19. Of patents and patent disputes: The TNFα patent files. Part 1: Humira.

    PubMed

    Storz, Ulrich

    2017-01-01

    This article discusses the patent strategy underlying the world's best selling drug, AbbVie's Humira®. Despite a non-optimal starting position, AbbVie has established an extensive portfolio to fend off biosimilar competition. This article is the first part of a trilogy that discusses IP issues related to anti-Tumor Necrosis factor α (TNFα) biologics.

  20. Patent data mining method and apparatus

    DOEpatents

    Boyack, Kevin W.; Grafe, V. Gerald; Johnson, David K.; Wylie, Brian N.

    2002-01-01

    A method of data mining represents related patents in a multidimensional space. Distance between patents in the multidimensional space corresponds to the extent of relationship between the patents. The relationship between pairings of patents can be expressed based on weighted combinations of several predicates. The user can select portions of the space to perceive. The user also can interact with and control the communication of the space, focusing attention on aspects of the space of most interest. The multidimensional spatial representation allows more ready comprehension of the structure of the relationships among the patents.

  1. DNA patenting: implications for public health research.

    PubMed Central

    Dutfield, Graham

    2006-01-01

    I weigh the arguments for and against the patenting of functional DNA sequences including genes, and find the objections to be compelling. Is an outright ban on DNA patenting the right policy response? Not necessarily. Governments may wish to consider options ranging from patent law reforms to the creation of new rights. There are alternative ways to protect DNA sequences that industry may choose if DNA patenting is restricted or banned. Some of these alternatives may be more harmful than patents. Such unintended consequences of patent bans mean that we should think hard before concluding that prohibition is the only response to legitimate concerns about the appropriateness of patents in the field of human genomics. PMID:16710549

  2. DNA patenting: implications for public health research.

    PubMed

    Dutfield, Graham

    2006-05-01

    I weigh the arguments for and against the patenting of functional DNA sequences including genes, and find the objections to be compelling. Is an outright ban on DNA patenting the right policy response? Not necessarily. Governments may wish to consider options ranging from patent law reforms to the creation of new rights. There are alternative ways to protect DNA sequences that industry may choose if DNA patenting is restricted or banned. Some of these alternatives may be more harmful than patents. Such unintended consequences of patent bans mean that we should think hard before concluding that prohibition is the only response to legitimate concerns about the appropriateness of patents in the field of human genomics.

  3. RADIOACTIVE BATTERY

    DOEpatents

    Birden, J.H.; Jordan, K.C.

    1959-11-17

    A radioactive battery which includes a capsule containing the active material and a thermopile associated therewith is presented. The capsule is both a shield to stop the radiations and thereby make the battery safe to use, and an energy conventer. The intense radioactive decay taking place inside is converted to useful heat at the capsule surface. The heat is conducted to the hot thermojunctions of a thermopile. The cold junctions of the thermopile are thermally insulated from the heat source, so that a temperature difference occurs between the hot and cold junctions, causing an electrical current of a constant magnitude to flow.

  4. Tubulin inhibitors: a patent survey.

    PubMed

    Nepali, Kunal; Ojha, Ritu; Sharma, Sahil; Bedi, Preet M S; Dhar, Kanaya L

    2014-05-01

    Tubulin is one of the most useful and strategic molecular targets for anticancer drugs. The dynamic process of microtubule assembly and disassembly can be blocked by various agents that bind to distinct sites in the β-tubulin subunit. By interfering with microtubule function in vitro, these agents arrest cells in mitosis, eventually leading to cell death, by both apoptosis and necrosis. So far, three binding domains have been identified a) the colchicine site close to the α/β interface, b) the area where the vinca alkaloids bind, and c) the taxane-binding pocket. This review compiles the patent literature up to 2013 and offers a detailed account of all the advances on Tubulin inhibitors (lead molecules) along with in depth knowledge about the number of novel scaffolds, modified analogs and derivatives of the lead molecules. Colchicine binding site remains the most explored site indicated by the patent survey as majority of the patents revolves around phenstatin and combretastatin based molecules where the key structural feature for tubulin inhibition is an appropriate arrangement of the two aromatic rings at an appropriate distance and optimal dihedral angle maximizing interactions with tubulin. A brief account of promising tubulin inhibitors in stages of clinical development and some strategies for the development of potent molecules overcoming the problem of drug resistance have also been discussed.

  5. Patent first, ask questions later: morality and biotechnology in patent law.

    PubMed

    Bagley, Margo A

    2003-12-01

    This Article explores the U.S. "patent first, ask questions later" approach to determining what subject matter should receive patent protection. Under this approach, the U.S. Patent and Trademark Office (USPTO or the Agency) issues patents on "anything under the sun made by man," and to the extent a patent's subject matter is sufficiently controversial, Congress acts retrospectively in assessing whether patents should issue on such interventions. This practice has important ramifications for morally controversial biotechnology patents specifically, and for American society generally. For many years a judicially created "moral utility" doctrine served as a type of gatekeeper of patent subject matter eligibility. The doctrine allowed both the USTPO and courts to deny patents on morally controversial subject matter under the fiction that such inventions were not "useful." The gate, however, is currently untended. A combination of the demise of the moral utility doctrine, along with expansive judicial interpretations of the scope of patent-eligible subject matter, has resulted in virtually no basis on which the USTPO or courts can deny patent protection to morally controversial, but otherwise patentable, subject matter. This is so despite position statements by the Agency to the contrary. Biotechnology is an area in which many morally controversial inventions are generated. Congress has been in react-mode following the issuance of a stream of morally controversial biotech patents, including patents on transgenic animals, surgical methods, and methods of cloning humans. With no statutory limits on patent eligibility, and with myriad concerns complicating congressional action following a patent's issuance, it is not Congress, the representative of the people, determining patent eligibility. Instead, it is patent applicants, scientific inventors, who are deciding matters of high public policy through the contents of the applications they file with the USTPO. This Article

  6. Space Battery

    DTIC Science & Technology

    2008-06-13

    Space Command SPACE AND MISSILE SYSTEMS CENTER STANDARD SPACE BATTERY APPROVED FOR PUBLIC RELEASE ...person shall be subject to a penalty for failing to comply with a collection of information if it does not display a currently valid OMB control ... release , distribution unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT 15. SUBJECT TERMS 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT

  7. Battery component

    SciTech Connect

    Goebel, F.; Batson, D.C.; Miserendino, A.J.; Boyle, G.

    1988-03-15

    A mechanical component for reserve type electrochemical batteries having cylindrical porous members is described comprising a disc having: (i) circular grooves in one flat side for accepting the porous members; and (ii) at least one radial channel in the opposite flat side in fluid communication with the grooves.

  8. Batteries: Overview of Battery Cathodes

    SciTech Connect

    Doeff, Marca M

    2010-07-12

    The very high theoretical capacity of lithium (3829 mAh/g) provided a compelling rationale from the 1970's onward for development of rechargeable batteries employing the elemental metal as an anode. The realization that some transition metal compounds undergo reductive lithium intercalation reactions reversibly allowed use of these materials as cathodes in these devices, most notably, TiS{sub 2}. Another intercalation compound, LiCoO{sub 2}, was described shortly thereafter but, because it was produced in the discharged state, was not considered to be of interest by battery companies at the time. Due to difficulties with the rechargeability of lithium and related safety concerns, however, alternative anodes were sought. The graphite intercalation compound (GIC) LiC{sub 6} was considered an attractive candidate but the high reactivity with commonly used electrolytic solutions containing organic solvents was recognized as a significant impediment to its use. The development of electrolytes that allowed the formation of a solid electrolyte interface (SEI) on surfaces of the carbon particles was a breakthrough that enabled commercialization of Li-ion batteries. In 1990, Sony announced the first commercial batteries based on a dual Li ion intercalation system. These devices are assembled in the discharged state, so that it is convenient to employ a prelithiated cathode such as LiCoO{sub 2} with the commonly used graphite anode. After charging, the batteries are ready to power devices. The practical realization of high energy density Li-ion batteries revolutionized the portable electronics industry, as evidenced by the widespread market penetration of mobile phones, laptop computers, digital music players, and other lightweight devices since the early 1990s. In 2009, worldwide sales of Li-ion batteries for these applications alone were US$ 7 billion. Furthermore, their performance characteristics (Figure 1) make them attractive for traction applications such as hybrid

  9. [Global patent overview of Ginkgo biloba preparation].

    PubMed

    Cheng, Xin-Min; Lei, Hai-Min; Liu, Wei

    2013-09-01

    With related global patent data as analysis samples, worldwide patent overview of Ginkgo biloba preparation is analyzed in application, applicant, technical distribution and so on. This research shows that the most important areas of G. biloba preparation are Europe and China. The European applicants start earliest along with developing smoothly, moreover, their patents have best quality. The Chinese applicants start late along with the fastest growing, and have already certain research capabilities, moreover, their patents' quality needs to be improved. This research result provides reference for development of G. biloba preparation. The author suggest that Chinese applicants learn techniques and layout experiences of other's patents fully to enhance the level of new drug development and patent protection.

  10. Inventions and patents: a practical tutorial.

    PubMed

    Tidwell, J Lille; Liotta, Lance A

    2012-01-01

    Patents are designed to protect and encourage creativity and innovation. Patenting a biomedical discovery can be a requirement before a pharmaceutical company or biotech entity will invest in the lengthy and costly clinical testing necessary to achieve patient benefit. Although scientists and clinicians are well versed in research publication requirements, patent descriptions and claims are formatted in a manner quite different from a research paper. Patents require (a) a series of logical statements clearly delineating the boundaries of the novel aspects of the invention and (b) sufficient disclosure of the invention so that it can be reproduced by others. Patents are granted only for inventions that meet three conditions: novelty, nonobviousness, and usefulness. This chapter provides basic guidelines and definitions of technology transfer: inventions, inventorship, and patent filing, which are summarized using a question and answer format.

  11. Are Patents Impeding Medical Care and Innovation?

    PubMed Central

    Gold, E. Richard; Kaplan, Warren; Orbinski, James; Harland-Logan, Sarah; N-Marandi, Sevil

    2010-01-01

    Background to the debate: Pharmaceutical and medical device manufacturers argue that the current patent system is crucial for stimulating research and development (R&D), leading to new products that improve medical care. The financial return on their investments that is afforded by patent protection, they claim, is an incentive toward innovation and reinvestment into further R&D. But this view has been challenged in recent years. Many commentators argue that patents are stifling biomedical research, for example by preventing researchers from accessing patented materials or methods they need for their studies. Patents have also been blamed for impeding medical care by raising prices of essential medicines, such as antiretroviral drugs, in poor countries. This debate examines whether and how patents are impeding health care and innovation. PMID:20052274

  12. PATENTS IN GENOMICS AND HUMAN GENETICS

    PubMed Central

    Cook-Deegan, Robert; Heaney, Christopher

    2010-01-01

    Genomics and human genetics are scientifically fundamental and commercially valuable. These fields grew to prominence in an era of growth in government and nonprofit research funding, and of even greater growth of privately funded research and development in biotechnology and pharmaceuticals. Patents on DNA technologies are a central feature of this story, illustrating how patent law adapts---and sometimes fails to adapt---to emerging genomic technologies. In instrumentation and for therapeutic proteins, patents have largely played their traditional role of inducing investment in engineering and product development, including expensive postdiscovery clinical research to prove safety and efficacy. Patents on methods and DNA sequences relevant to clinical genetic testing show less evidence of benefits and more evidence of problems and impediments, largely attributable to university exclusive licensing practices. Whole-genome sequencing will confront uncertainty about infringing granted patents but jurisprudence trends away from upholding the broadest and potentially most troublesome patent claims. PMID:20590431

  13. Metal-Air Batteries

    SciTech Connect

    Zhang, Jiguang; Bruce, Peter G.; Zhang, Gregory

    2011-08-01

    Metal-air batteries have much higher specific energies than most currently available primary and rechargeable batteries. Recent advances in electrode materials and electrolytes, as well as new designs on metal-air batteries, have attracted intensive effort in recent years, especially in the development of lithium-air batteries. The general principle in metal-air batteries will be reviewed in this chapter. The materials, preparation methods, and performances of metal-air batteries will be discussed. Two main metal-air batteries, Zn-air and Li-air batteries will be discussed in detail. Other type of metal-air batteries will also be described.

  14. Writing reports to facilitate patent applications.

    SciTech Connect

    Libman, George H.; Doerry, Armin Walter

    2004-06-01

    Brief disclosures may often be sufficient for the filing of a Technical Advance with Sandia's Intellectual Property Center, but still be inadequate to facilitate an optimum patent application where more detail and explanation are required. Consequently, the crafting of a patent application may require considerably more additional interaction between the application preparer and the inventors. This inefficiency can be considerably mitigated if the inventors address some critical aspects of a patent application when they write a technical report.

  15. Persistent Confusion and Controversy Surrounding Gene Patents

    PubMed Central

    Guerrini, Christi J.; Majumder, Mary A.; McGuire, Amy L.

    2016-01-01

    There is persistent confusion and controversy surrounding basic issues of patent law relevant to the genomics industry. Uncertainty and conflict can lead to the adoption of inefficient practices and exposure to liability. The development of patent-specific educational resources for industry members, as well as the prompt resolution of patentability rules unsettled by recent U.S. Supreme Court decisions, are therefore urgently needed. PMID:26849516

  16. 78 FR 72872 - Notice of Intent To Grant Partially Exclusive Patent License; ICAP Patent Brokerage, LLC

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-12-04

    ... exclusive license in the United States to practice the Government-Owned inventions described in U.S. Patent...//U.S. Patent No. 8,073,804: System and Method For Type 2 KASER (Knowledge Amplification by...

  17. 78 FR 51177 - Notice of Intent To Grant Partially Exclusive Patent License; ICAP Patent Brokerage, LLC

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-20

    ....//U.S. Patent No. 7,925,496: Method for Summarizing Natural Language Text.//U.S. Patent No. 8,217,382: Optical-Powered Flexible Photonic Bandgap Sensor Device. DATES: Anyone wishing to object to the grant...

  18. The German drought monitor

    NASA Astrophysics Data System (ADS)

    Zink, Matthias; Samaniego, Luis; Kumar, Rohini; Thober, Stephan; Mai, Juliane; Schäfer, David; Marx, Andreas

    2016-07-01

    The 2003 drought event in Europe had major implications on many societal sectors, including energy production, health, forestry and agriculture. The reduced availability of water accompanied by high temperatures led to substantial economic losses on the order of 1.5 Billion Euros, in agriculture alone. Furthermore, soil droughts have considerable impacts on ecosystems, forest fires and water management. Monitoring soil water availability in near real-time and at high-resolution, i.e., 4 × 4 km2, enables water managers to mitigate the impact of these extreme events. The German drought monitor was established in 2014 as an online platform. It uses an operational modeling system that consists of four steps: (1) a daily update of observed meteorological data by the German Weather Service, with consistency checks and interpolation; (2) an estimation of current soil moisture using the mesoscale hydrological model; (3) calculation of a quantile-based soil moisture index (SMI) based on a 60 year data record; and (4) classification of the SMI into five drought classes ranging from abnormally dry to exceptional drought. Finally, an easy to understand map is produced and published on a daily basis on www.ufz.de/droughtmonitor. Analysis of the ongoing 2015 drought event, which garnered broad media attention, shows that 75% of the German territory underwent drought conditions in July 2015. Regions such as Northern Bavaria and Eastern Saxony, however, have been particularly prone to drought conditions since autumn 2014. Comparisons with historical droughts show that the 2015 event is amongst the ten most severe drought events observed in Germany since 1954 in terms of its spatial extent, magnitude and duration.

  19. Battery Safety Basics

    ERIC Educational Resources Information Center

    Roy, Ken

    2010-01-01

    Batteries commonly used in flashlights and other household devices produce hydrogen gas as a product of zinc electrode corrosion. The amount of gas produced is affected by the batteries' design and charge rate. Dangerous levels of hydrogen gas can be released if battery types are mixed, batteries are damaged, batteries are of different ages, or…

  20. Batteries for Electric Vehicles

    NASA Technical Reports Server (NTRS)

    Conover, R. A.

    1985-01-01

    Report summarizes results of test on "near-term" electrochemical batteries - (batteries approaching commercial production). Nickel/iron, nickel/zinc, and advanced lead/acid batteries included in tests and compared with conventional lead/acid batteries. Batteries operated in electric vehicles at constant speed and repetitive schedule of accerlerating, coasting, and braking.

  1. Careers in Patent Law for Physics Majors

    NASA Astrophysics Data System (ADS)

    Oliver, Douglas L.

    2010-11-01

    An important question that many undergraduate physics students ask is, "What can one do with a physics degree?" Of course there are many answers to this question. Often a general reference to becoming a lawyer is given as a possible answer. This paper is intended to explain the field of patent law and how a physics degree can lead to an interesting and potentially lucrative career as a patent examiner, a patent agent, or a patent attorney. This information may be of interest to physics students as well as those who recruit or counsel physics students.

  2. The History of Patenting Genetic Material.

    PubMed

    Sherkow, Jacob S; Greely, Henry T

    2015-01-01

    The US Supreme Court's recent decision in Association for Molecular Pathology v. Myriad Genetics, Inc. declared, for the first time, that isolated human genes cannot be patented. Many have wondered how genes were ever the subjects of patents. The answer lies in a nuanced understanding of both legal and scientific history. Since the early twentieth century, "products of nature" were not eligible to be patented unless they were "isolated and purified" from their surrounding environment. As molecular biology advanced, and the capability to isolate genes both physically and by sequence came to fruition, researchers (and patent offices) began to apply patent-law logic to genes themselves. These patents, along with other biological patents, generated substantial social and political criticism. Myriad Genetics, a company with patents on BRCA1 and BRCA2, two genes critical to assessing early-onset breast and ovarian cancer risk, and with a particularly controversial business approach, became the antagonist in an ultimately successful campaign to overturn gene patents in court. Despite Myriad's defeat, some questions concerning the rights to monopolize genetic information remain. The history leading to that defeat may be relevant to these future issues.

  3. Patent law in dentistry: an overview.

    PubMed

    Bijle, Mohammed Nadeem A

    2011-01-01

    Dentistry in recent years has developed interest in the field of intellectual property rights (IPR) and Patents due to extensive research in the fraternity and existing competition. There have been various patent applications and grants in the field of dentistry abroad due to better understanding of IPR but India still has very few patent grants and applications on the subject matter. This review article in particular deals with the understanding of IPR and Patents as a whole, especially for dental professionals involved in research and development. Hence, this would also act as an asset for dental researchers to explore and expand their scope of activities, with special privileges empowered for their work.

  4. Patenting Stem Cell Technologies in Europe

    PubMed Central

    Sheard, Andrew

    2015-01-01

    European patent law as it applies to stem cell technologies is complex. The complexities have developed from different supranational sources of law during the last 50 years and from the various levels of exceptions to patentability embodied in the law. In relation to stem cells of human embryonic origin, the definition of a human embryo, although broad, is still in some respects unclear; and the definition of what constitutes the use of a human embryo for industrial or commercial purposes, which is excluded from patentability in Europe, is also remarkably broad. Further clarification is awaited from the courts and from the Boards of Appeal of the European Patent Office. PMID:25395376

  5. Patenting and licensing in genetic testing.

    PubMed

    Aymé, S; Matthijs, G; Soini, S

    2008-04-01

    Patents for inventions can be beneficial for society, if they drive innovation and promote progress. In most areas, the patenting system works satisfactorily. However, it must be recognized that in some instances it can also be problematic; this is the case in the field of genetics, and particularly in the area of genetic testing. As patents should serve their original purpose (promoting innovation through a fair reward system for the inventors), the European Society of Human Genetics (ESHG) suggests ways to improve the mechanisms that already form part of the patents system as a whole. In brief, the ESHG recommends limiting the breadth of the claims in genetic patents and, more practically, to reduce the number of patents by limiting the patentable subject matter, thereby improving the quality of the patents that will eventually be granted. There is also a suggestion to redefine the concept of utility in patent law, by taking account of downstream clinical experience. The ESHG sees no harm in the patenting of novel technical tools for genetic testing (eg PCR or chip technologies), as they can promote investment and still allow for invention around them. Many disputes between supporters of the patenting system and the public revolve around ethical issues. The European Patent Office should consider the benefit of having an ethics committee to consider issues of major interest, such as patents applied to genes. The problem of licensing should also be addressed. Practically, this means supporting the Organisation for Economic Co-operation and Development guidelines, which prescribe that licenses should be non-exclusive and easily obtainable, both in practical and in financial terms. To promote this, the practical exploration of alternative models for licensing, like patent pools and clearinghouses, is a prerequisite. To better track developments in this field, the establishment of a voluntary reporting system, whereby geneticists could report on any issues related to

  6. 78 FR 19416 - Revisions to Patent Term Adjustment

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-01

    ... United States Patent and Trademark Office 37 CFR Part 1 RIN 0651-AC84 Revisions to Patent Term Adjustment... changes to the patent term adjustment provisions in section 1(h) of the Act to correct and improve certain... patent term adjustment period is measured, and clarifies the date from which the three-year patent...

  7. 37 CFR 1.177 - Issuance of multiple reissue patents.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Issuance of multiple reissue patents. 1.177 Section 1.177 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES National Processing Provisions Reissues §...

  8. Enhancing the DNA Patent Database

    SciTech Connect

    Walters, LeRoy B.

    2008-02-18

    Final Report on Award No. DE-FG0201ER63171 Principal Investigator: LeRoy B. Walters February 18, 2008 This project successfully completed its goal of surveying and reporting on the DNA patenting and licensing policies at 30 major U.S. academic institutions. The report of survey results was published in the January 2006 issue of Nature Biotechnology under the title “The Licensing of DNA Patents by US Academic Institutions: An Empirical Survey.” Lori Pressman was the lead author on this feature article. A PDF reprint of the article will be submitted to our Program Officer under separate cover. The project team has continued to update the DNA Patent Database on a weekly basis since the conclusion of the project. The database can be accessed at dnapatents.georgetown.edu. This database provides a valuable research tool for academic researchers, policymakers, and citizens. A report entitled Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health was published in 2006 by the Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, Board on Science, Technology, and Economic Policy at the National Academies. The report was edited by Stephen A. Merrill and Anne-Marie Mazza. This report employed and then adapted the methodology developed by our research project and quoted our findings at several points. (The full report can be viewed online at the following URL: http://www.nap.edu/openbook.php?record_id=11487&page=R1). My colleagues and I are grateful for the research support of the ELSI program at the U.S. Department of Energy.

  9. Die Deutschen in Wisconsin (Germans in Wisconsin).

    ERIC Educational Resources Information Center

    Wisconsin State Dept. of Public Instruction, Madison.

    The following curriculum units comprise this course book: (1) Germans in a New Home, (2) Contributions of the Germans in Wisconsin, (3) A Letter to Germany, (4) Germans Come to Kingston, (5) First a Soldier, Then a Man of the Church (about Heinrich von Rohr), (6) A Visiting German, and (7) Germans and Music. Each unit begins with a reading of…

  10. Using Patent Classification to Discover Chemical Information in a Free Patent Database: Challenges and Opportunities

    ERIC Educational Resources Information Center

    Ha¨rtinger, Stefan; Clarke, Nigel

    2016-01-01

    Developing skills for searching the patent literature is an essential element of chemical information literacy programs at the university level. The present article creates awareness of patents as a rich source of chemical information. Patent classification is introduced as a key-component in comprehensive search strategies. The free Espacenet…

  11. 37 CFR 1.33 - Correspondence respecting patent applications, patent reexamination proceedings, and other...

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Correspondence respecting... Attorney Or Agent § 1.33 Correspondence respecting patent applications, patent reexamination proceedings, and other proceedings. (a) Correspondence address and daytime telephone number. When filing...

  12. 37 CFR 1.33 - Correspondence respecting patent applications, patent reexamination proceedings, and other...

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2013-07-01 2013-07-01 false Correspondence respecting... Attorney Or Agent § 1.33 Correspondence respecting patent applications, patent reexamination proceedings, and other proceedings. (a) Correspondence address and daytime telephone number. When filing...

  13. Battery depletion monitor

    SciTech Connect

    Lee, Y.S.

    1982-01-26

    A cmos inverter is used to compare pacemaker battery voltage to a referenced voltage. When the reference voltage exceeds the measured battery voltage, the inverter changes state to indicate battery depletion.

  14. Recent patents in flavor microencapsulation.

    PubMed

    Feng, Tao; Xiao, Zuobing; Tian, Huaixiang

    2009-11-01

    Many aroma compounds, used to flavor food products, are used in a solid state, after encapsulation. Synthetic or natural polymers are the common matrices used to entrap these volatiles. This paper reviews the recent patents of versatile matrices and methods used in flavor microencapsulation. The encapsulation ratio depends on both the carriers' physicochemical properties and the characteristics of the aroma compound. The patents about flavor encapsulation methods are spray drying, fluidized bed coating, melt extrusion, complex coacervation, aqueous diffusion and novel fat-coating etc. All these methods have both advantages and disadvantages. In brief, spray drying is very convenient but unsuitable for heat sensitive flavor and stored with moisture instability. Fluidized bed coating is costly but having better storage stability. Melt extrusion is suitable for large-scale production but having bad particle size distribution. Complex coacervation has good capsule size uniformity but controversial safety. Aqueous diffusion has excellent safety but low efficient encapsulation. Novel fat-coating has good encapsulation efficiency but uncontrollable size distribution.

  15. Neglected knowledge in geophysics: Patents - how to find them, how to use them and how to apply for them

    NASA Astrophysics Data System (ADS)

    Wollny, K. G.

    2013-12-01

    Geophysical departments of universities or major geophysical research institutes around the world hardly ever file for a patent, even if pioneering and marketable work is done - this is what research in patent databases shows. Patents for methods, apparatuses or scientific instruments developed during scientific projects are mostly filed by companies, i.e. more than 90% of approximately 185,000 patent documents added by May 2013 to the International Patent Classification (IPC) class G01V, which the United Nations' World Intellectual Property Organisation (WIPO) has set up mainly for inventions with key aspects in geophysics. Even inventions born of cooperations between research institutes or universities and well-known geophysical companies where both act as equal partners almost never make it to the G01V. University departments responsible for intellectual property management explain that geoscientists prefer to publish their results in journals rather than in the form of patent applications even if these departments support them and parallel publication is protected legally. This means geoscientists miss the opportunity to protect their intellectual work and to tap its economic potential. But even if scientists don't want to apply for patents, patent documents constitute a wealth of knowledge that should be used much more frequently in research e.g. to stay on top of developments in one's own scientific field. Most important databases are for free, search functionality is self-explanatory and the amount of information to be extracted is enormous. All in all, about 80 million multilingual patent documents are currently available online e.g. in DEPATIS database from the German Patent and Trade Mark Office (DPMA) or ESPACENET from the European Patent Office (EPO). From a researcher's perspective, they might also be interesting for detailed technical background information, interdisciplinary solutions for similar problems, to learn about inventions too advanced for

  16. Headstart German Program. Module 8.

    ERIC Educational Resources Information Center

    Defense Language Inst., Monterey, CA.

    This is the eighth module of 10 in the German Headstart program. Each of the 2 units in the module contains objectives, exercises, and a self-evaluation quiz. In addition, there are several supplementary exercises and self-evaluations. This module deals with a single situation, visiting a German family in their home. The exercises are intended to…

  17. 77 FR 14766 - Patents for Humanity Program (Formerly Humanitarian Program)

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-03-13

    ... Humanitarian Technologies and Licensing Through the Intellectual Property System'' published September 20, 2010... United States Patent and Trademark Office Patents for Humanity Program (Formerly Humanitarian Program) ACTION: Proposed collection; comment request. SUMMARY: The United States Patent and Trademark...

  18. Grant Patents on Animals? An Ethical and Legal Battle Looms.

    ERIC Educational Resources Information Center

    Wheeler, David L.

    1987-01-01

    Rulings on applications for animal patents being considered by the U.S. Patent and Trademark Office could profoundly influence university patent and research income. Many animal-rights advocates have expressed philosophical objections to genetic engineering of animals. (MLW)

  19. 77 FR 37879 - Cooperative Patent Classification External User Day

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-25

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE Patent and Trademark Office Cooperative Patent Classification External User Day AGENCY: United States... Office (USPTO) is hosting a Cooperative Patent Classification (CPC) External User Day event at...

  20. Battery cell feedthrough apparatus

    DOEpatents

    Kaun, Thomas D.

    1995-01-01

    A compact, hermetic feedthrough apparatus comprising interfitting sleeve portions constructed of chemically-stable materials to permit unique battery designs and increase battery life and performance.

  1. Patent Office Hands Blackboard a Setback

    ERIC Educational Resources Information Center

    Mangan, Katherine

    2008-01-01

    In March the U.S. Patent and Trademark Office issued a preliminary decision that could have significant ramifications for universities that use course-management software, as well as for the companies that make it. The "nonfinal" decision rejects all 44 claims Blackboard Inc. made for its controversial patent of an online-learning system.…

  2. Investigation of At-Risk Patent Filings

    ERIC Educational Resources Information Center

    Livne, O.

    2003-01-01

    The author presents an investigation of patent-application filings made without external financial support, or "at-risk", based on inventions disclosed to the University of California from fiscal years 1991 to 2000. The success of the at-risk patent applications filed on these invention disclosures is examined from the perspective of…

  3. Patents and access to essential drugs.

    PubMed

    Loff, Bebe

    2003-01-01

    This paper provides a brief overview of historical developments in patent law including its recent incorporation into world trade law. The impact of patents on access to essential drugs will be discussed. The relationship between intellectual property rights and the right to health will be considered.

  4. 43 CFR 402.10 - Patent.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 43 Public Lands: Interior 1 2014-10-01 2014-10-01 false Patent. 402.10 Section 402.10 Public Lands: Interior Regulations Relating to Public Lands BUREAU OF RECLAMATION, DEPARTMENT OF THE INTERIOR SALE OF LANDS IN FEDERAL RECLAMATION PROJECTS Public Lands § 402.10 Patent. When a purchaser has complied...

  5. 43 CFR 402.10 - Patent.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 43 Public Lands: Interior 1 2011-10-01 2011-10-01 false Patent. 402.10 Section 402.10 Public Lands: Interior Regulations Relating to Public Lands BUREAU OF RECLAMATION, DEPARTMENT OF THE INTERIOR SALE OF LANDS IN FEDERAL RECLAMATION PROJECTS Public Lands § 402.10 Patent. When a purchaser has complied...

  6. 43 CFR 402.10 - Patent.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 43 Public Lands: Interior 1 2012-10-01 2011-10-01 true Patent. 402.10 Section 402.10 Public Lands: Interior Regulations Relating to Public Lands BUREAU OF RECLAMATION, DEPARTMENT OF THE INTERIOR SALE OF LANDS IN FEDERAL RECLAMATION PROJECTS Public Lands § 402.10 Patent. When a purchaser has complied...

  7. Clearing a path through the patent thicket.

    PubMed

    Holman, Chris

    2006-05-19

    Patents do not always promote innovation, particularly when they restrict access to fundamental scientific discoveries and the tools of basic research. However, there are legal and policy approaches that may help to ameliorate problems associated with patenting these sorts of inventions.

  8. 75 FR 20561 - Patent Term Extension

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-20

    ... drug products, medical devices, food additives, and color additives are eligible for extension. The..., or a method of manufacturing the approved product. In addition, the application for patent term.... The term of a patent which claims a product, a method of using a product, or a method of...

  9. Recognizing chemicals in patents: a comparative analysis.

    PubMed

    Habibi, Maryam; Wiegandt, David Luis; Schmedding, Florian; Leser, Ulf

    2016-01-01

    Recently, methods for Chemical Named Entity Recognition (NER) have gained substantial interest, driven by the need for automatically analyzing todays ever growing collections of biomedical text. Chemical NER for patents is particularly essential due to the high economic importance of pharmaceutical findings. However, NER on patents has essentially been neglected by the research community for long, mostly because of the lack of enough annotated corpora. A recent international competition specifically targeted this task, but evaluated tools only on gold standard patent abstracts instead of full patents; furthermore, results from such competitions are often difficult to extrapolate to real-life settings due to the relatively high homogeneity of training and test data. Here, we evaluate the two state-of-the-art chemical NER tools, tmChem and ChemSpot, on four different annotated patent corpora, two of which consist of full texts. We study the overall performance of the tools, compare their results at the instance level, report on high-recall and high-precision ensembles, and perform cross-corpus and intra-corpus evaluations. Our findings indicate that full patents are considerably harder to analyze than patent abstracts and clearly confirm the common wisdom that using the same text genre (patent vs. scientific) and text type (abstract vs. full text) for training and testing is a pre-requisite for achieving high quality text mining results.

  10. 37 CFR 501.9 - Patent protection.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... employee may request rights in that country subject to the conditions stated in § 501.7(b) that may be... UNIFORM PATENT POLICY FOR RIGHTS IN INVENTIONS MADE BY GOVERNMENT EMPLOYEES § 501.9 Patent protection. (a... States by or on behalf of the agency for such invention. A controversy over the respective rights of...

  11. Patent foramen ovale: clinical manifestations and treatment.

    PubMed

    Kedia, Gautam; Tobis, Jonathan; Lee, Michael S

    2008-01-01

    A persistent patent foramen ovale produces an intermittent intra-atrial right-to-left shunt and occurs in approximately 25% of the general population. Although the vast majority of people with patent foramen ovale are asymptomatic, a patent foramen ovale is believed to act as a pathway for chemicals or thrombus that can result in a variety of clinical manifestations, including stroke, migraine headache, decompression sickness, high-altitude pulmonary edema, and platypnea-orthodeoxia syndrome. The optimal management of patients with patent foramen ovale who experience cryptogenic stroke is unclear. Percutaneous closure appears to have a low risk profile and has been considered in high-risk patients who are not candidates for randomized clinical trials. Randomized clinical trials that are underway should help define the best management of patent foramen ovale, as well as the true safety and efficacy of percutaneous closure devices.

  12. Canada's Patented Medicines (Notice of Compliance) Proceedings and Intellectual Property.

    PubMed

    Bian, Henry; McCourt, Conor

    2015-01-08

    Canada's Patent Register is a tool created by the Patented Medicines (Notice of Compliance) Regulations to help innovators protect their inventions relating to pharmaceuticals. This tool exists at the intersection between the intellectual property and drug approval regimes. By listing a patent on the Patent Register, an innovator can prevent a generic manufacturer from entering the marketplace rather than having to wait for his or her patent to be infringed. This article provides information on the requirements for listing a patent on the Patent Register and an overview of how the Patent Medicines (Notice of Compliance) Regulations affect the drug approval process.

  13. Piezonuclear battery

    DOEpatents

    Bongianni, Wayne L.

    1992-01-01

    A piezonuclear battery generates output power arising from the piezoelectric voltage produced from radioactive decay particles interacting with a piezoelectric medium. Radioactive particle energy may directly create an acoustic wave in the piezoelectric medium or a moderator may be used to generate collision particles for interacting with the medium. In one embodiment a radioactive material (.sup.252 Cf) with an output of about 1 microwatt produced a 12 nanowatt output (1.2% conversion efficiency) from a piezoelectric copolymer of vinylidene fluoride/trifluorethylene.

  14. Congenital Extrahepatic Abdominal Arteriovenous Fistula and Apparent Patent Ductus Venosus in a Dog.

    PubMed

    White, Robert N; Murphy, Kate; Renfrew, Helen; Shales, Chris

    2015-01-01

    A 3 mo old male German shepherd dog presented with a 2 wk history of diarrhea with possible melena followed by inappetence and progressive abdominal distension. Clinical findings, serum biochemical analysis, and abdominal ultrasound were highly suggestive of an extrahepatic abdominal arteriovenous fistula and concurrent patent ductus venosus, which were confirmed during an abdominal exploratory surgery. Renal biopsies taken at the time of surgery confirmed a chronic glomerulopathy. The dog made a good initial recovery from the procedure but was euthanatized 6 wk postoperatively for medically unresponsive renal disease.

  15. Patents, medicine, and the interests of patients: applying general principles to gene patenting.

    PubMed

    2003-01-01

    New technologies and the translation of research into clinical medicine are essential to patient care. Those who develop useful drugs, diagnostic and screening tests, and medical technologies have the right to expect a fair return for their efforts and risks. Current interpretations of patent law (particularly regarding gene patenting), however, have the potential to impede both medical advances and patient care. Patenting policies must balance the open exchange and use of information with making the pursuit of such knowledge financially rewarding. The Committee on Ethics and the Committee on Genetics of the American College of Obstetricians and Gynecologists maintain that patents on medical or surgical procedures are ethically unacceptable. Physicians may obtain patents on surgical and diagnostic instruments that they have developed, but such instruments should be made available to others at a fair and reasonable cost. Patents for genes as "compositions of matter" enable patent holders to control future applications of the genes and should not be granted. Patents should be granted only for specified uses or applications of genes or sequences. If composition-of-matter patents on genes continue to be enforceable, such patents on genes with clinical applications should be subject to federal regulation and oversight to ensure availability on reasonable terms for research and clinical use.

  16. Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia

    PubMed Central

    Berthels, Nele; Matthijs, Gert; Van Overwalle, Geertrui

    2011-01-01

    Recent reports in Europe and the United States raise concern about the potential negative impact of gene patents on the freedom to operate of diagnosticians and on the access of patients to genetic diagnostic services. Patents, historically seen as legal instruments to trigger innovation, could cause undesired side effects in the public health domain. Clear empirical evidence on the alleged hindering effect of gene patents is still scarce. We therefore developed a patent categorization method to determine which gene patents could indeed be problematic. The method is applied to patents relevant for genetic testing of spinocerebellar ataxia (SCA). The SCA test is probably the most widely used DNA test in (adult) neurology, as well as one of the most challenging due to the heterogeneity of the disease. Typically tested as a gene panel covering the five common SCA subtypes, we show that the patenting of SCA genes and testing methods and the associated licensing conditions could have far-reaching consequences on legitimate access to this gene panel. Moreover, with genetic testing being increasingly standardized, simply ignoring patents is unlikely to hold out indefinitely. This paper aims to differentiate among so-called ‘gene patents' by lifting out the truly problematic ones. In doing so, awareness is raised among all stakeholders in the genetic diagnostics field who are not necessarily familiar with the ins and outs of patenting and licensing. PMID:21811306

  17. … but You Are Not German." -- Afro-German Culture and Literature in the German Language Classroom

    ERIC Educational Resources Information Center

    Schenker, Theresa; Munro, Robert

    2016-01-01

    Units and classes dedicated to multiculturalism in Germany have predominantly focused on Turkish-German literature and culture. Afro-Germans have been a minority whose culture and literature have only marginally been included in German classes, even though Afro-Germans have been a part of Germany for centuries and have undergone efforts at…

  18. Summary of trends in photovoltaic patent activity

    NASA Astrophysics Data System (ADS)

    Levine, L. C.

    1984-06-01

    Information on patent activity for inventions concerning photovoltaic cell technology is given. Such information can aid in the assessment of the status and direction of technological development. A total of 729 US patents that issued between mid-1962 and the end of 1982, were individually examined and classified into several technical categories. Computerized analysis of trends in patent activity among major technical categories was performed. The level of inventive activity increased dramatically in the mid-1970's. It appears to have peaked in 1978 and remained steady through 1980. The data indicates that, beginning in 1978, an increasing proportion of inventions were among approaches other than the conventional Cz type cells, specifically thin film and concentrator cells. Thin film and Cz type photovoltaic cells represent two thirds of the patents analyzed. Among thin film patents, silicon and cadmium containing cells represent about two thirds of the patents analyzed. Further insight into recent trends could be obtained by adding more recently issued patents to the data base.

  19. AVC/H.264 patent portfolio license

    NASA Astrophysics Data System (ADS)

    Horn, Lawrence A.

    2005-08-01

    MPEG LA, LLC offers a joint patent license for the AVC (a/k/a H.264) Standard (ISO/IEC IS 14496-10:2004). Like MPEG LA's other licenses, the AVC Patent Portfolio License is offered for the convenience of the marketplace as an alternative enabling users to access essential intellectual property owned by many patent holders under a single license rather than negotiating licenses with each of them individually. The AVC Patent Portfolio License includes essential patents owned by Electronics and Telecommunications Research Institute (ETRI); France Telecom, societe anonyme; Fujitsu Limited; Koninklijke Philips Electronics N.V.; LG Electronics Inc.; Matsushita Electric Industrial Co., Ltd.; Microsoft Corporation; Mitsubishi Electric Corporation; Robert Bosch GmbH; Samsung Electronics Co., Ltd.; Sedna Patent Services, LLC; Sharp Kabushiki Kaisha; Siemens AG; Sony Corporation; The Trustees of Columbia University in the City of New York; Toshiba Corporation; and Victor Company of Japan, Limited. MPEG LA's objective is to provide worldwide access to as much AVC essential intellectual property as possible for the benefit of AVC users. Therefore, any party that believes it has essential patents is welcome to submit them for evaluation of their essentiality and inclusion in the License if found essential.

  20. AVC/H.264 patent portfolio license

    NASA Astrophysics Data System (ADS)

    Skandalis, Dean A.

    2006-08-01

    MPEG LA, LLC offers a joint patent license for the AVC (a/k/a H.264) Standard (ISO/IEC IS 14496-10:2004). Like MPEG LA's other licenses, the AVC Patent Portfolio License is offered for the convenience of the marketplace as an alternative enabling users to access essential intellectual property owned by many patent holders under a single license rather than negotiating licenses with each of them individually. The AVC Patent Portfolio License includes essential patents owned by DAEWOO Electronics Corporation; Electronics and Telecommunications Research Institute (ETRI); France Telecom, societe anonyme; Fujitsu Limited; Hitachi, Ltd.; Koninklijke Philips Electronics N.V.; LG Electronics Inc.; Matsushita Electric Industrial Co., Ltd.; Microsoft Corporation; Mitsubishi Electric Corporation; Robert Bosch GmbH; Samsung Electronics Co., Ltd.; Sedna Patent Services, LLC; Sharp Kabushiki Kaisha; Siemens AG; Sony Corporation; The Trustees of Columbia University in the City of New York; Toshiba Corporation; UB Video Inc.; and Victor Company of Japan, Limited. Another is expected also to join as of August 1, 2006. MPEG LA's objective is to provide worldwide access to as much AVC essential intellectual property as possible for the benefit of AVC users. Therefore, any party that believes it has essential patents is welcome to submit them for evaluation of their essentiality and inclusion in the License if found essential.

  1. Galileo Probe Battery System

    NASA Technical Reports Server (NTRS)

    Dagarin, B. P.; Taenaka, R. K.; Stofel, E. J.

    1997-01-01

    The conclusions of the Galileo probe battery system are: the battery performance met mission requirements with margin; extensive ground-based and flight tests of batteries prior to probe separation from orbiter provided good prediction of actual entry performance at Jupiter; and the Li-SO2 battery was an important choice for the probe's main power.

  2. The German Drought Monitor

    NASA Astrophysics Data System (ADS)

    Marx, Andreas; Zink, Matthias; Pommerencke, Julia; Kumar, Rohini; Thober, Stephan; Samaniego, Luis

    2015-04-01

    Soil moisture droughts reduce the amount of water available to plant growth potentially leading e.g. to crop failure or increased forest fire risk. The threat of human livelihoods in developing countries and large economic losses in developed ones are severe consequences of these events. Monitoring the current state of soil water content allows to improve water management to mitigate the associated damages. Since summer 2014, the German Drought Monitor (GDM, available at: www.ufz.de/droughtmonitor) has been established using an operational hydrological modeling system, which consists of 3 steps: (1) the daily download of meteorological forcing data, consistency check and interpolation of this data, (2) running the mesoscale Hydrologic Model (mHM; Samaniego et al. 2010) and saving the state variables at the end of the model run as restart-file for the next days run, and (3) calculation of the soil moisture index (SMI, Samaniego et al. 2013, JHM) and visualization of the drought data. The hydrological model mHM was used to generate daily soil moisture fields for the period 1954-2013 over the entire area of Germany at a high spatial resolution of 4 x 4 km². The model requires daily precipitation, temperature, and potential evapotranspiration as forcing. A three-layer soil scheme was used to model the soil moisture dynamics over the entire root zone depth. Based on the 60 year simulation of soil moisture, the frequency distributions have been calculated for each grid cell to derive the soil moisture index. In this beta version, we do a monthly online update of the SMI. Furthermore, a trend analysis of drought events for 69 German subregions since 1954 was conducted. It showed that for most parts of Germany, the frequency of abnormally dry conditions increased while the stronger drought situations with SMI<0.2 decreased at the same time. For the coming year, a stakeholder consultation is planned. The aim is to clarify for whom a drought monitor would be useful, what

  3. A new model for gene patents

    SciTech Connect

    Not Available

    1993-04-02

    When the National Institutes of Health (NIH) filed for patents on thousands of gene fragments in 1991, it created a furor because it was attempting to assert broad rights to sequences whose functions were unknown. The cDNA fragments NIH researchers had discovered were simply short stretches of presumably expressed genes, yet the patent the agency was seeking would give it rights both to the full genes themselves and to all their possible future uses. If NIH prevailed, researchers argued, it would potentially discourage further work on those genes. Now the head of the genome project at the Department of Energy (DOE) - NIH's partner in the program - has proposed an alternative approach to gene patenting. At a meeting last week of a congressional Office of Technology Assessment panel that is preparing a report on this issue, DOE's David Galas revealed that University of Washington genome researcher Leroy Hood is preparing to file a patent application that could serve as a model for such patents in the future. Hood's team has been sequencing the genes encoding the beta chain of the human T cell receptor. Mutations in the T cell receptor genes may lead to any of a number of autoimmune diseases, including rheumatoid arthritis and multiple sclerosis. A broad patent on the genes could therefore conceivably cover not only techniques for diagnosing autoimmune diseases but also of therapies for the conditions, and indeed anything involving T cell activity. But Hood's patent application won't make such broad claims. Instead, Hood, with DOE's support, will not seek to patent the genes but will claim only the specific uses of developing the diagnostic and therapeutic tools for dealing with specific autoimmune diseases. By restricting patents just to known uses the problems of gene ownership are neatly avoided.

  4. Whither ink jet? Current patent trends

    NASA Astrophysics Data System (ADS)

    Pond, Stephen F.; Karz, Robert S.

    1995-04-01

    The status and potential of ink jet technology is discernible in its major technical literature forum: worldwide patents. Most ink jet technical activity is focused in commercial research and development laboratories where proprietary considerations make patents the norm for publication. Currently there are about 2,000 ink jet disclosures issued annually with over 200 enterprises represented. Ink jet patent activity is increasing about 25% per year driven by a rapidly expanding base of products, applications, and revenue. An analysis of the ink jet patent literature reveals a few major themes (i.e. continuous ink jet, piezoelectric drop-on-demand, and thermal ink jet) and numerous minor ones (i.e. electrohydro-dynamic extraction, magnetic drop-on-demand, Hertz continuous, acoustic ink printing). Patents bear witness to transformations in the industry as dominant players of the 1970's have given way to new leaders in the 1990's. They also foretell important commercial developments in ink jet's near term future. When studied in aggregate, the patent record reveals patterns for the industry in general as well as for individual companies. It becomes possible to use the patent data base not only to identify technical approaches and problems for specific firms, but also to track progress and monitor changing strategies. In addition, international filing patterns can provide insights into industry priorities. This paper presents an overview of ink jet technology as revealed by the patent literature. It will include a 25 year perspective, a review of trends over the past five years, and a survey of today's most active companies and their technical approaches. With this analysis, it will be shown that the information inherent in the patent record is more than the sum of its individual disclosures. Indeed, by using it, we can outlook whither goes ink jet.

  5. Lithium Ion Batteries

    NASA Technical Reports Server (NTRS)

    1997-01-01

    Lithium ion batteries, which use a new battery chemistry, are being developed under cooperative agreements between Lockheed Martin, Ultralife Battery, and the NASA Lewis Research Center. The unit cells are made in flat (prismatic) shapes that can be connected in series and parallel to achieve desired voltages and capacities. These batteries will soon be marketed to commercial original-equipment manufacturers and thereafter will be available for military and space use. Current NiCd batteries offer about 35 W-hr/kg compared with 110 W-hr/kg for current lithium ion batteries. Our ultimate target for these batteries is 200 W-hr/kg.

  6. Alkaline battery operational methodology

    DOEpatents

    Sholklapper, Tal; Gallaway, Joshua; Steingart, Daniel; Ingale, Nilesh; Nyce, Michael

    2016-08-16

    Methods of using specific operational charge and discharge parameters to extend the life of alkaline batteries are disclosed. The methods can be used with any commercial primary or secondary alkaline battery, as well as with newer alkaline battery designs, including batteries with flowing electrolyte. The methods include cycling batteries within a narrow operating voltage window, with minimum and maximum cut-off voltages that are set based on battery characteristics and environmental conditions. The narrow voltage window decreases available capacity but allows the batteries to be cycled for hundreds or thousands of times.

  7. Mark Twain and "The Awful German Language."

    ERIC Educational Resources Information Center

    Hedderich, Norbert

    2003-01-01

    Analyzes Mark Twain's 1869 essay "The Awful German Language" in terms of Twain's comments on morphological, syntactical, lexical, and phonological features of German. The topic is presented in the context of Twain's German language learning experience. Relevance of the article for German language instruction today is also described.…

  8. Thermal batteries: A technology review and future directions

    SciTech Connect

    Guidotti, R.A.

    1995-07-01

    Thermally activated (``thermal``) batteries have been used for ordnance applications (e.g., proximity fuzes) since World War II and, subsequent to that, in nuclear weapons. This technology was developed by the Germans as a power source for their V2 rockets. It was obtained by the Allies by interrogation of captured German scientists after the war. The technology developed rapidly from the initial primitive systems used by the Germans to one based on Ca/CaCrO{sub 4}. This system was used very successfully into the late 1970s, when it was replaced by the Li-alloy/FeS{sub 2} electrochemical system. This paper describes the predominant electrochemical couples that have been used in thermal batteries over the years. Major emphasis is placed on the chemistry and electrochemistry of the Ca/CaCrO{sub 4} and Li-alloy/FeS{sub 2} systems. The reason for this is to give the reader a better appreciation for the advances in thermal-battery technology for which these two systems are directly responsible. Improvements to date in the current Li-alloy/FeS{sub 2} and related systems are discussed and areas for possible future research and development involving anodes, cathodes, electrolytes, and insulations are outlined. New areas where thermal-battery technology has potential applications are also examined.

  9. Patent border wars: defining the boundary between scientific discoveries and patentable inventions.

    PubMed

    Holman, Christopher M

    2007-12-01

    Drawing an appropriate boundary between unpatentable natural phenomena and patentable inventions is crucial in preventing the patent laws from unduly restricting access to fundamental scientific discoveries. Some would argue that, particularly in the U.S., patents are being issued that purport to claim a novel product or process but that, in effect, encompass any practical application of a fundamental biological principle. Examples include gene patents, which Congress is considering banning, and patents relating to biological correlations and pathways, such as the patents at issue in the headline-grabbing LabCorp v. Metabolite and Ariad v. Eli Lilly litigations. In view of the mounting concern, it seems likely that Congress and/or the courts will address the issue, and perhaps substantially shift the boundary.

  10. Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

    PubMed

    Huys, Isabelle; Van Overwalle, Geertrui; Matthijs, Gert

    2011-10-01

    The paper focuses on the fundamental debate that is going on in Europe and the United States about whether genes and genetic diagnostic methods are to be regarded as inventions or subject matter eligible for patent protection, or whether they are discoveries or principles of nature and thus excluded from patentability. The study further explores some possible scenarios of American influences on European patent applications with respect to genetic diagnostic methods. Our analysis points out that patent eligibility for genes and genetic diagnostic methods, as discussed in the United States in the Association of Molecular Pathology versus US Patent and Trademark Office decision, is based on a different reasoning compared with the European Patent Convention.

  11. High Performance Cathodes for Li-Air Batteries

    SciTech Connect

    Xing, Yangchuan

    2013-08-22

    The overall objective of this project was to develop and fabricate a multifunctional cathode with high activities in acidic electrolytes for the oxygen reduction and evolution reactions for Li-air batteries. It should enable the development of Li-air batteries that operate on hybrid electrolytes, with acidic catholytes in particular. The use of hybrid electrolytes eliminates the problems of lithium reaction with water and of lithium oxide deposition in the cathode with sole organic electrolytes. The use of acid electrolytes can eliminate carbonate formation inside the cathode, making air breathing Li-air batteries viable. The tasks of the project were focused on developing hierarchical cathode structures and bifunctional catalysts. Development and testing of a prototype hybrid Li-air battery were also conducted. We succeeded in developing a hierarchical cathode structure and an effective bifunctional catalyst. We accomplished integrating the cathode with existing anode technologies and made a pouch prototype Li-air battery using sulfuric acid as catholyte. The battery cathodes contain a nanoscale multilayer structure made with carbon nanotubes and nanofibers. The structure was demonstrated to improve battery performance substantially. The bifunctional catalyst developed contains a conductive oxide support with ultra-low loading of platinum and iridium oxides. The work performed in this project has been documented in seven peer reviewed journal publications, five conference presentations, and filing of two U.S. patents. Technical details have been documented in the quarterly reports to DOE during the course of the project.

  12. 7 CFR 1220.254 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Patents, copyrights, inventions, and publications... Miscellaneous § 1220.254 Patents, copyrights, inventions, and publications. (a) Any patents, copyrights..., franchising, or other uses of such patents, copyrights, inventions, or publications, inure to the benefit...

  13. 7 CFR 1250.542 - Patents, copyrights, trademarks, and information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Patents, copyrights, trademarks, and information... AGRICULTURE EGG RESEARCH AND PROMOTION Rules and Regulations Patents, Copyrights, Trademarks, and Information § 1250.542 Patents, copyrights, trademarks, and information. Patents, copyrights, trademarks,...

  14. 7 CFR 1250.542 - Patents, copyrights, trademarks, and information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Patents, copyrights, trademarks, and information... AGRICULTURE EGG RESEARCH AND PROMOTION Rules and Regulations Patents, Copyrights, Trademarks, and Information § 1250.542 Patents, copyrights, trademarks, and information. Patents, copyrights, trademarks,...

  15. 7 CFR 1220.254 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Patents, copyrights, inventions, and publications... Miscellaneous § 1220.254 Patents, copyrights, inventions, and publications. (a) Any patents, copyrights..., franchising, or other uses of such patents, copyrights, inventions, or publications, inure to the benefit...

  16. 7 CFR 1220.254 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Patents, copyrights, inventions, and publications... Miscellaneous § 1220.254 Patents, copyrights, inventions, and publications. (a) Any patents, copyrights..., franchising, or other uses of such patents, copyrights, inventions, or publications, inure to the benefit...

  17. 7 CFR 1220.254 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Patents, copyrights, inventions, and publications... Miscellaneous § 1220.254 Patents, copyrights, inventions, and publications. (a) Any patents, copyrights..., franchising, or other uses of such patents, copyrights, inventions, or publications, inure to the benefit...

  18. 7 CFR 1250.542 - Patents, copyrights, trademarks, and information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Patents, copyrights, trademarks, and information... AGRICULTURE EGG RESEARCH AND PROMOTION Rules and Regulations Patents, Copyrights, Trademarks, and Information § 1250.542 Patents, copyrights, trademarks, and information. Patents, copyrights, trademarks,...

  19. 7 CFR 1250.542 - Patents, copyrights, trademarks, and information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Patents, copyrights, trademarks, and information... AGRICULTURE EGG RESEARCH AND PROMOTION Rules and Regulations Patents, Copyrights, Trademarks, and Information § 1250.542 Patents, copyrights, trademarks, and information. Patents, copyrights, trademarks,...

  20. 7 CFR 1250.542 - Patents, copyrights, trademarks, and information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Patents, copyrights, trademarks, and information... AGRICULTURE EGG RESEARCH AND PROMOTION Rules and Regulations Patents, Copyrights, Trademarks, and Information § 1250.542 Patents, copyrights, trademarks, and information. Patents, copyrights, trademarks,...

  1. 37 CFR 11.9 - Limited recognition in patent matters.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Limited recognition in patent matters. 11.9 Section 11.9 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE... application is filed as provided in PCT Art. 49, Rule 90 and § 1.455 of this subchapter, or before...

  2. 37 CFR 11.9 - Limited recognition in patent matters.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2011-07-01 2011-07-01 false Limited recognition in patent matters. 11.9 Section 11.9 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE... office with which the international application is filed as provided in PCT Art. 49, Rule 90 and §...

  3. 37 CFR 11.9 - Limited recognition in patent matters.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2012-07-01 2012-07-01 false Limited recognition in patent matters. 11.9 Section 11.9 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE... office with which the international application is filed as provided in PCT Art. 49, Rule 90 and §...

  4. 37 CFR 11.9 - Limited recognition in patent matters.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2013-07-01 2013-07-01 false Limited recognition in patent matters. 11.9 Section 11.9 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE... application is filed as provided in PCT Art. 49, Rule 90 and § 1.455 of this subchapter, or before...

  5. Report of the AD HOC Committee on Patent Documentation.

    ERIC Educational Resources Information Center

    Urbach, Peter; And Others

    The Committee was established in September 1967 to study and make recommendations on Recommendation XXIX and XXX of the Report of the President's Commission on the Patent System. Based on interviews with Patent Office officials, patent examiners and classifiers and a review of Patent Office studies and documents, the Committee concluded that the…

  6. Preliminary analysis of patent trends for magnetic fusion technology

    SciTech Connect

    Levine, L.O.; Ashton, W.B.; Campbell, R.S.

    1984-02-01

    This study presents a preliminary analysis of development trends in magnetic fusion technology based on data from US patents. The research is limited to identification and description of general patent activity and ownership characteristics for 373 patents. The results suggest that more detailed studies of fusion patents could provide useful R and D planning information.

  7. 37 CFR 1.46 - Assigned inventions and patents.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Assigned inventions and... for A Patent § 1.46 Assigned inventions and patents. In case the whole or a part interest in the invention or in the patent to be issued is assigned, the application must still be made or authorized to...

  8. 43 CFR 3864.1-1 - Application for patent.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 43 Public Lands: Interior 2 2011-10-01 2011-10-01 false Application for patent. 3864.1-1 Section... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Millsite Patents § 3864.1-1 Application for patent. (a) Land entered as a millsite must be shown to be...

  9. 37 CFR 1.215 - Patent application publication.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... publication. 1.215 Section 1.215 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES National Processing Provisions Publication of Applications § 1.215 Patent application publication. (a) The publication of an application...

  10. 37 CFR 1.215 - Patent application publication.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... publication. 1.215 Section 1.215 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES National Processing Provisions Publication of Applications § 1.215 Patent application publication. (a) The publication of an application...

  11. 37 CFR 1.215 - Patent application publication.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... publication. 1.215 Section 1.215 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES National Processing Provisions Publication of Applications § 1.215 Patent application publication. (a) The publication of an application...

  12. 75 FR 30773 - United States Patent Applicant Survey

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-02

    ... Patent and Trademark Office United States Patent Applicant Survey ACTION: Proposed collection; comment request. SUMMARY: The United States Patent and Trademark Office (USPTO), as part of its continuing effort... United States Patent Applicant Survey as part of the continuing effort to better predict the...

  13. 43 CFR 3862.8 - Patents for mining claims.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 43 Public Lands: Interior 2 2011-10-01 2011-10-01 false Patents for mining claims. 3862.8 Section... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode Mining Claim Patent Applications § 3862.8 Patents for mining claims....

  14. 43 CFR 3862.8 - Patents for mining claims.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 43 Public Lands: Interior 2 2014-10-01 2014-10-01 false Patents for mining claims. 3862.8 Section... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode Mining Claim Patent Applications § 3862.8 Patents for mining claims....

  15. 43 CFR 3862.8 - Patents for mining claims.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 43 Public Lands: Interior 2 2013-10-01 2013-10-01 false Patents for mining claims. 3862.8 Section... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode Mining Claim Patent Applications § 3862.8 Patents for mining claims....

  16. 43 CFR 3862.8 - Patents for mining claims.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 43 Public Lands: Interior 2 2012-10-01 2012-10-01 false Patents for mining claims. 3862.8 Section... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode Mining Claim Patent Applications § 3862.8 Patents for mining claims....

  17. 48 CFR 1852.227-84 - Patent rights clauses.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 6 2010-10-01 2010-10-01 true Patent rights clauses. 1852... 1852.227-84 Patent rights clauses. The contracting officer shall insert the following provision as prescribed in 1827.303-70(e): Patent Rights Clauses (DEC 1989) This solicitation contains the patent...

  18. 77 FR 14686 - Claims for Patent and Copyright Infringement

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-03-13

    ... history of each patent, if it is available to the claimant. Indicate whether the patent has been the... corresponding foreign patents and patent applications and full copies of the same. (11) Pertinent prior art known to the claimant not contained in the USPTO file, for example, publications and foreign prior...

  19. 43 CFR 3862.8-1 - Land descriptions in patents.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 43 Public Lands: Interior 2 2011-10-01 2011-10-01 false Land descriptions in patents. 3862.8-1 Section 3862.8-1 Public Lands: Interior Regulations Relating to Public Lands (Continued) BUREAU OF LAND... Claim Patent Applications § 3862.8-1 Land descriptions in patents. The land description in a patent...

  20. 78 FR 62367 - Changes To Implement the Patent Law Treaty

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-10-21

    ...The Patent Law Treaties Implementation Act of 2012 (PLTIA) amends the patent laws to implement the provisions of the Hague Agreement Concerning International Registration of Industrial Designs (Hague Agreement) in title I, and the Patent Law Treaty (PLT) in title II. The PLT harmonizes and streamlines formal procedures pertaining to the filing and processing of patent applications. This final......

  1. ACTA Technology Presents EPA with Patent Copy

    EPA Pesticide Factsheets

    US EPA SBIR awardee, ACTA Technology, presented James H. Johnson, Director of the US EPA National Center for Environmental Research, and April Richards, Program Manager of the US EPA's SBIR Program, with a copy of their Red Ribbon patent.

  2. 37 CFR 501.9 - Patent protection.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... rights as are specified in § 501.6(a)(2), but this shall be without prejudice to acquiring the rights... filing of an application for patent, take the rights specified in that paragraph without prejudice to...

  3. Patenting genes: a fast and furious primer.

    PubMed

    Askland, Andrew

    2003-01-01

    Patents have been issued in the United States for genes and gene sequences since 1980. Patent protection has provided incentives to aggressively probe the genome of humans and non-humans alike in search of profitable applications. Yet it is not clear that patent protection should have been afforded to genes and gene sequences and it is increasingly clear that patent protection, as currently formulated, is not an appropriate means to realize the full benefits of genetic research. As we stand on the threshold of a genetically enhanced future, in which we shall have the power to consciously steer our evolution as a species, we need to carefully consider how to shape the benefits of genetic research and how to recognize and contain its detriments.

  4. Genomic patenting and the utility requirement.

    PubMed

    Calvert, Jane

    2004-12-01

    This paper analyses the ways in which genomic knowledge is portrayed as useful knowledge in gene patenting in order to fulfil the 'utility'/'industrial applicability' requirement for patentability. It gives examples of utility claims in gene patents and asks whether genomics (as opposed to genetics) changes our ideas about what is useful and what can be patented. It puts forward a provisional classification of different types of utility and argues that merely identifying the physiological function of a gene diverges radically from our commonsense understanding of what it is for an invention to be useful. Furthermore, social, political and ethical issues inevitably arise when discussing the utility requirement, because an invention cannot be useful in isolation from a social context.

  5. Recent patents on electrophoretic displays and materials.

    PubMed

    Christophersen, Marc; Phlips, Bernard F

    2010-11-01

    Electrophoretic displays (EPDs) have made their way into consumer products. EPDs enable displays that offer the look and form of a printed page, often called "electronic paper". We will review recent apparatus and method patents for EPD devices and their fabrication. A brief introduction into the basic display operation and history of EPDs is given, while pointing out the technological challenges and difficulties for inventors. Recently, the majority of scientific publications and patenting activity has been directed to micro-segmented EPDs. These devices exhibit high optical reflectance and contrast, wide viewing angle, and high image resolution. Micro-segmented EPDs can also be integrated with flexible transistors technologies into flexible displays. Typical particles size ranges from 200 nm to 2 micrometer. Currently one very active area of patenting is the development of full-color EPDs. We summarize the recent patenting activity for EPDs and provide comments on perceiving factors driving intellectual property protection for EPD technologies.

  6. Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.

    PubMed

    Crespi, R Stephen

    2005-01-01

    Over the last two decades, the ethical implications of patents for biological materials and processes have been the subject of spirited public debate between the many individuals and groups on which the patent system impacts. Whereas copyright, trade marks, and other species of Intellectual Property Rights (IPR) are widely acceptable, the patent system evokes criticism from many quarters, especially in relation to the legal protection of inventions in the Life Sciences. Some of these criticisms expressed by prestigious public organisations are addressed here from the patent professional standpoint.

  7. Thermal battery. [solid metal halide electrolytes with enhanced electrical conductance after a phase transition

    DOEpatents

    Carlsten, R.W.; Nissen, D.A.

    1973-03-06

    The patent describes an improved thermal battery whose novel design eliminates various disadvantages of previous such devices. Its major features include a halide cathode, a solid metal halide electrolyte which has a substantially greater electrical conductance after a phase transition at some temperature, and a means for heating its electrochemical cells to activation temperature.

  8. Patents | NCI Technology Transfer Center | TTC

    Cancer.gov

    Timely reporting of discoveries is critical, because patent protection may be lost if an invention is publicly disclosed prior to filing a patent application. A public disclosure may include Talks, presentations, posters; Publications, including titles and abstracts posted on websites; Internet postings; Graduate student theses, job interviews; andDiscussions with non-NIH personnel without a Confidential Disclosure Agreement (CDA) in place. | [google6f4cd5334ac394ab.html

  9. Competition policy in patent cases and antitrust.

    PubMed

    Sobel, Gerald

    2003-01-01

    The article that follows examines the competition policy reflected in the decisions of the Court of Appeals for the Federal Circuit in its patent cases. The court's views on this subject have been manifested most plainly in decisions that have transformed the law concerning infringement under the doctrine of equivalents and claim construction. In both categories, the court narrowed patent scope by reason of its desire to protect competitors. The article argues that the court's premise in prescribing narrower claim scope reflected an incomplete view of competition policy. The court's analysis overlooked the benefits to competition provided by patents, which stimulate inventions and their development. The article traces the development of antitrust jurisprudence and demonstrates how respect for the contribution of patents to competition and skepticism of free-riding has evolved, particularly beginning in the 1970s. The article draws a parallel between the Court's reasoning about competition policy, on the one hand, and the rejected views of Justices Hugo Black and William O. Douglas and abandoned patent-antitrust jurisprudence, on the other. The Federal Circuit's decision in Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., Ltd., 234 F.3d 558 (Fed. Cir. 2000), on the subject of equivalents is considered in the paper. In that decision, the majority adopted a new rule that completely barred infringement under the doctrine of equivalents of any claim limitation where, in prosecution, there had been a narrowing amendment relating to patentability. In the past, prosecution estoppel foreclosing equivalents had been subject to a "flexible bar," which, in some circumstances, allowed for equivalence notwithstanding such an amendment. The article points out that because almost all patents are amended during prosecution, the effect would be to allow widespread copying of patented inventions by trivial modifications of any narrowed claim limitation. The incentive to innovate

  10. Patenting human genes and stem cells.

    PubMed

    Martin-Rendon, Enca; Blake, Derek J

    2007-01-01

    Cell lines and genetically modified single cell organisms have been considered patentable subjects for the last two decades. However, despite the technical patentability of genes and stem cell lines, social and legal controversy concerning their 'ownership' has surrounded stem cell research in recent years. Some granted patents on stem cells with extremely broad claims are casting a shadow over the commercialization of these cells as therapeutics. However, in spite of those early patents, the number of patent applications related to stem cells is growing exponentially. Both embryonic and adult stem cells have the ability to differentiate into several cell lineages in an organism as a result of specific genetic programs that direct their commitment and cell fate. Genes that control the pluripotency of stem cells have been recently identified and the genetic manipulation of these cells is becoming more efficient with the advance of new technologies. This review summarizes some of the recent published patents on pluripotency genes, gene transfer into stem cells and genetic reprogramming and takes the hematopoietic and embryonic stem cell as model systems.

  11. Genetic engineering and the patent office

    SciTech Connect

    Sheldon, J.G.; Anderson, D.L.

    1987-10-01

    Higher life forms created through genetic engineering are now recognized as potentially patentable. On 7 April 1987, the US Patent and Trademark Office announced that it now considers non-naturally occurring non-human multi-cellular living organisms, including animals, to be patentable subject matter. The response to this announcement has been an emotion controversy centering on the patent office. The announcement has become the lightning rod for all of the practical and moral questions surrounding the overwhelming potential of genetic engineering. Environmentalists claim that genetic engineering will ruin the ecology. The Humane Society of the US, headquartered in Washington, DC, claims that genetic engineering will cause undo suffering to animals produced through genetic experiments and may ultimately lead to the demise of overly engineered animal species. Religious fundamentalists claim that genetic engineering is wrongfully tinkering with the handiwork of the Almighty. While it may be good that such questions are being raised, the patent office is being wrongly singled out as the source of the problem. This paper discusses the legal problems that patents on new lifeforms have caused.

  12. AVC/H.264 patent portfolio license

    NASA Astrophysics Data System (ADS)

    Horn, Lawrence A.

    2004-11-01

    MPEG LA, LLC recently announced terms of a joint patent license for the AVC (a/k/a H.264) Standard (ISO/IEC IS 14496-10: Information technology -- Coding of audio-visual objects -- Part 10: Advanced Video Coding | ITU-T Rec. H.264: Series H: Audiovisual and Multimedia Systems: Infrastructure of audiovisual services -- Coding of moving video: Advanced video coding for generic audiovisual services). Like MPEG LA"s other licenses, the AVC Patent Portfolio License is offered for the convenience of the marketplace as an alternative enabling users to access essential intellectual property owned by many patent holders under a single license rather than negotiating licenses with each of them individually. The AVC Patent Portfolio License includes essential patents owned by Columbia Innovation Enterprises; Electronics and Telecommunications Research Institute (ETRI); France Télécom, société anonyme; Fujitsu Limited; Koninklijke Philips Electronics N.V.; Matsushita Electric Industrial Co., Ltd.; Microsoft Corporation; Mitsubishi Electric Corporation; Robert Bosch GmbH; Samsung Electronics Co., Ltd.; Sharp Kabushiki Kaisha; Sony Corporation; Toshiba Corporation; and Victor Company of Japan, Limited. MPEG LA"s objective is to provide worldwide access to as much AVC essential intellectual property as possible for the benefit of AVC users. Therefore, any party that believes it has essential patents is welcome to submit them for evaluation of their essentiality and inclusion in the License if found essential.

  13. Quick charge battery

    SciTech Connect

    Parise, R.J.

    1998-07-01

    Electric and hybrid electric vehicles (EVs and HEVs) will become a significant reality in the near future of the automotive industry. Both types of vehicles will need a means to store energy on board. For the present, the method of choice would be lead-acid batteries, with the HEV having auxiliary power supplied by a small internal combustion engine. One of the main drawbacks to lead-acid batteries is internal heat generation as a natural consequence of the charging process as well as resistance losses. This limits the re-charging rate to the battery pack for an EV which has a range of about 80 miles. A quick turnaround on recharge is needed but not yet possible. One of the limiting factors is the heat buildup. For the HEV the auxiliary power unit provides a continuous charge to the battery pack. Therefore heat generation in the lead-acid battery is a constant problem that must be addressed. Presented here is a battery that is capable of quick charging, the Quick Charge Battery with Thermal Management. This is an electrochemical battery, typically a lead-acid battery, without the inherent thermal management problems that have been present in the past. The battery can be used in an all-electric vehicle, a hybrid-electric vehicle or an internal combustion engine vehicle, as well as in other applications that utilize secondary batteries. This is not restricted to only lead-acid batteries. The concept and technology are flexible enough to use in any secondary battery application where thermal management of the battery must be addressed, especially during charging. Any battery with temperature constraints can benefit from this advancement in the state of the art of battery manufacturing. This can also include nickel-cadmium, metal-air, nickel hydroxide, zinc-chloride or any other type of battery whose performance is affected by the temperature control of the interior as well as the exterior of the battery.

  14. Battery cell for a primary battery

    SciTech Connect

    Hakkinen, A.

    1984-12-11

    A battery cell for a primary battery, particularly a flat cell battery to be activated on being taken into use, e.g., when submerged into water. The battery cell comprises a positive current collector and a negative electrode. A separator layer which, being in contact with the negative electrode, is disposed between said negative electrode and the positive current collector. A depolarizing layer containing a depolarizing agent is disposed between the positive current collector and the separate layer. An intermediate layer of a porous, electrically insulating, and water-absorbing material is disposed next to the positive current collector and arranged in contact with the depolarizing agent.

  15. 37 CFR 1.704 - Reduction of period of adjustment of patent term.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... adjustment of patent term. 1.704 Section 1.704 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND... of Patent Term Adjustment of Patent Term Due to Examination Delay § 1.704 Reduction of period of adjustment of patent term. (a) The period of adjustment of the term of a patent under §§ 1.703(a) through...

  16. Use of optical storage for patent image retrieval: the U.S. Patent and Trademark Office's automated patent system

    NASA Astrophysics Data System (ADS)

    Jacobson, Stephen R.

    1990-08-01

    The Automated Patent System (APS) was designed, among other things, to assist the patent examiner in performing the patent search. It is a fully distributed system that uses custom-built high-resolution dual-display intelligent workstations, optical file servers, mainframes, and support computers networked together using Ethernet technology. The system is composed of two parts which are highly integrated: a full text search system and a patent image retrieval system. When fully deployed, APS will have an image data base of up to 30 terabytes being accessed from over 1000 workstations. The U.S. Patent and Trademark Office (PTO) has had problems with their optical drives, and although they are fairly stable today, we still experience a moderately high hardware failure rate. The optical drive problems include media instability, hardware design errors, vendor problems, and configuration control failures. We intend to purchase additional drives in the future, and are re-evaluating the exclusive use of optical storage in light of recent advances in magnetic storage technology.

  17. A Moral Economy of Patents: Case of Finnish Research Universities' Patent Policies

    ERIC Educational Resources Information Center

    Kauppinen, Ilkka

    2014-01-01

    The primary objective of this paper is to demonstrate the usefulness of the concept of moral economy for higher education studies through a study of Finnish research universities' patent policies. Patent policies not only stimulate the commercialization of research, they also set norms for behavior and aim to clarify how to distribute rights and…

  18. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?

    PubMed

    Sampat, Bhaven N; Amin, Tahir

    2013-08-01

    The 1995 Trade Related Intellectual Property Rights (TRIPS) agreement required developing countries to grant product patents in pharmaceuticals. Developing countries have since explored various measures to ameliorate potential negative effects of the new laws on public health. A prominent example is India, whose post-TRIPS patent laws include a provision, section 3(d), that restricts patents on incremental pharmaceutical innovations. Its critics and supporters alike suggest that this provision makes Indian patent law very different from that in other jurisdictions. Yet there are concerns that given resource constraints facing the Indian patent office, this novel feature of Indian patent laws on the books may not have an effect on Indian patent prosecution in practice. We test this by examining the prosecution outcomes of 2,803 applications filed in both India and Europe, coded by whether they include claims that trigger 3(d) considerations. We find that having the 3(d) provision on the books does not translate into very different patent outcomes in practice in India, relative to Europe, a jurisdiction without this provision.

  19. Can patents prohibit research? On the social epistemology of patenting and licensing in science.

    PubMed

    Biddle, Justin B

    2014-03-01

    A topic of growing importance within philosophy of science is the epistemic implications of the organization of research. This paper identifies a promising approach to social epistemology--nonideal systems design--and uses it to examine one important aspect of the organization of research, namely the system of patenting and licensing and its role in structuring the production and dissemination of knowledge. The primary justification of patenting in science and technology is consequentialist in nature. Patenting should incentivize research and thereby promote the development of knowledge, which in turn facilitates social progress. Some have disputed this argument, maintaining that patenting actually inhibits knowledge production. In this paper, I make a stronger argument; in some areas of research in the US--in particular, research on GM seeds--patents and patent licenses can be, and are in fact being, used to prohibit some research. I discuss three potential solutions to this problem: voluntary agreements, eliminating patents, and a research exemption. I argue against eliminating patents, and I show that while voluntary agreements and a research exemption could be helpful, they do not sufficiently address the problems of access that are discussed here. More extensive changes in the organization of research are necessary.

  20. Biological Diversity in the Patent System

    PubMed Central

    Oldham, Paul; Hall, Stephen; Forero, Oscar

    2013-01-01

    Biological diversity in the patent system is an enduring focus of controversy but empirical analysis of the presence of biodiversity in the patent system has been limited. To address this problem we text mined 11 million patent documents for 6 million Latin species names from the Global Names Index (GNI) established by the Global Biodiversity Information Facility (GBIF) and Encyclopedia of Life (EOL). We identified 76,274 full Latin species names from 23,882 genera in 767,955 patent documents. 25,595 species appeared in the claims section of 136,880 patent documents. This reveals that human innovative activity involving biodiversity in the patent system focuses on approximately 4% of taxonomically described species and between 0.8–1% of predicted global species. In this article we identify the major features of the patent landscape for biological diversity by focusing on key areas including pharmaceuticals, neglected diseases, traditional medicines, genetic engineering, foods, biocides, marine genetic resources and Antarctica. We conclude that the narrow focus of human innovative activity and ownership of genetic resources is unlikely to be in the long term interest of humanity. We argue that a broader spectrum of biodiversity needs to be opened up to research and development based on the principles of equitable benefit-sharing, respect for the objectives of the Convention on Biological Diversity, human rights and ethics. Finally, we argue that alternative models of innovation, such as open source and commons models, are required to open up biodiversity for research that addresses actual and neglected areas of human need. The research aims to inform the implementation of the 2010 Nagoya Protocol on Access to Genetic Resources and the Equitable Sharing of Benefits Arising from their Utilization and international debates directed to the governance of genetic resources. Our research also aims to inform debates under the Intergovernmental Committee on Intellectual

  1. The diffusion of generics after patent expiry in Germany.

    PubMed

    Fischer, Katharina Elisabeth; Stargardt, Tom

    2016-11-01

    To identify the influences on the diffusion of generics after patent expiry, we analyzed 65 generic entries using prescription data of a large German sickness fund between 2007 and 2012 in a sales model. According to theory, several elements are responsible for technology diffusion: (1) time reflecting the rate of adaption within the social system, (2) communication channels, and (3) the degree of incremental innovation, e.g., the modifications of existing active ingredient's strength. We investigated diffusion in two ways: (1) generic market share (percentage of generic prescriptions of all prescriptions of a substance) and, (2) generic sales quantity (number of units sold) over time. We specified mixed regression models. Generic diffusion takes considerable time. An average generic market share of about 75 % was achieved not until 48 months. There was a positive effect of time since generic entry on generic market share (p < 0.001) and sales (p < 0.001). Variables describing the communication channels and the degree of innovation influenced generic market share (mostly p < 0.001), but not generic sales quantity. Market structure, e.g., the number of generic manufacturers (p < 0.001) and prices influenced both generic market share and sales. Imperfections in generic uptake through informational cascades seem to be largely present. Third-party payers could enhance means to promote generic diffusion to amplify savings through generic entry.

  2. [German demography: a taboo subject?].

    PubMed

    Soullie, J

    1995-06-14

    The author first notes that, though the population of Germany has increased significantly in size since the Second World War, fertility has been below replacement levels for some time. Furthermore, this strong rate of growth has been accompanied by major variations from one generation to the next, although these trends have received very little attention from German scholars. It is noted that, since the rate of natural increase has been negative since 1972, this growth must have been caused exclusively by immigration. The seriousness of the demographic situation in the former East German states is noted. Current projections indicate a decline in total population size of about 13 million over the next 50 years. Policy options faced by the German authorities are discussed. This article was previously published in the April 15, 1995 issue of Chroniques Economiques.

  3. Analysis of Patent Databases Using VxInsight

    SciTech Connect

    BOYACK,KEVIN W.; WYLIE,BRIAN N.; DAVIDSON,GEORGE S.; JOHNSON,DAVID K.

    2000-12-12

    We present the application of a new knowledge visualization tool, VxInsight, to the mapping and analysis of patent databases. Patent data are mined and placed in a database, relationships between the patents are identified, primarily using the citation and classification structures, then the patents are clustered using a proprietary force-directed placement algorithm. Related patents cluster together to produce a 3-D landscape view of the tens of thousands of patents. The user can navigate the landscape by zooming into or out of regions of interest. Querying the underlying database places a colored marker on each patent matching the query. Automatically generated labels, showing landscape content, update continually upon zooming. Optionally, citation links between patents may be shown on the landscape. The combination of these features enables powerful analyses of patent databases.

  4. The ethics of patenting human embryonic stem cells.

    PubMed

    Chapman, Audrey R

    2009-09-01

    Just as human embryonic stem cell research has generated controversy about the uses of human embryos for research and therapeutic applications, human embryonic stem cell patents raise fundamental ethical issues. The United States Patent and Trademark Office has granted foundational patents, including a composition of matter (or product) patent to the Wisconsin Alumni Research Foundation (WARF), the University of Wisconsin-Madison's intellectual property office. In contrast, the European Patent Office rejected the same WARF patent application for ethical reasons. This article assesses the appropriateness of these patents placing the discussion in the context of the deontological and consequentialist ethical issues related to human embryonic stem cell patenting. It advocates for a patent system that explicitly takes ethical factors into account and explores options for new types of intellectual property arrangements consistent with ethical concerns.

  5. Battery cell feedthrough apparatus

    DOEpatents

    Kaun, T.D.

    1995-03-14

    A compact, hermetic feedthrough apparatus is described comprising interfitting sleeve portions constructed of chemically-stable materials to permit unique battery designs and increase battery life and performance. 8 figs.

  6. Lithium Battery Diaper Ulceration.

    PubMed

    Maridet, Claire; Taïeb, Alain

    2016-01-01

    We report a case of lithium battery diaper ulceration in a 16-month-old girl. Gastrointestinal and ear, nose, and throat lesions after lithium battery ingestion have been reported, but skin involvement has not been reported to our knowledge.

  7. Ionene membrane battery separator

    NASA Technical Reports Server (NTRS)

    Moacanin, J.; Tom, H. Y.

    1969-01-01

    Ionic transport characteristics of ionenes, insoluble membranes from soluble polyelectrolyte compositions, are studied for possible application in a battery separator. Effectiveness of the thin film of separator membrane essentially determines battery lifetime.

  8. Batteries: Widening voltage windows

    NASA Astrophysics Data System (ADS)

    Xu, Kang; Wang, Chunsheng

    2016-10-01

    The energy output of aqueous batteries is largely limited by the narrow voltage window of their electrolytes. Now, a hydrate melt consisting of lithium salts is shown to expand such voltage windows, leading to a high-energy aqueous battery.

  9. Auto Battery Safety Facts

    MedlinePlus

    ... inside the battery to spill through the vents. Use a battery carrier when available and always handle with extreme care. This publication is copyrighted. This sheet may be ... reprint, excerption or use is not permitted without written consent. Because of ...

  10. Protecting new ideas and inventions in nanomedicine with patents.

    PubMed

    Bawa, Raj; Bawa, S R; Maebius, Stephen B; Flynn, Ted; Wei, Chiming

    2005-06-01

    New paradigms are shrinking our world. Tiny is in and patents are essential for success in nanomedicine. In fact, patents are already shaping this nascent and rapidly evolving field. For the past decade a swarm of patent applications pertaining to nanomedicine has been arriving at the US Patent and Trademark Office (PTO). As companies develop products and processes and begin to seek commercial applications for their inventions, securing valid and defensible patent protection will be vital to their long-term survival. As we enter the "golden era" of medicine, or nanomedicine, in the next decade with the field maturing and the promised breakthroughs accruing, patents will generate licensing revenue, provide leverage in deals and mergers, and reduce the likelihood of infringement. Because development of nanobiotechnology- and nanomedicine-related products is extremely research intensive, without the market exclusivity offered by a US patent, development of these products and their commercial viability in the marketplace will be significantly hampered. In this article, we highlight critical issues relating to patenting nanomedicine products. Effects of the "nanopatent land grab" that is underway in nanomedicine by "patent prospectors" are examined as startups and corporations compete to lock up broad patents in these critical early days. Because nanomedicine is multidisciplinary, patenting presents unique opportunities and poses numerous challenges. Although patents are being sought more actively and enforced more vigorously, the entire patent system is under greater scrutiny and strain, with the PTO continuing to struggle with evaluating nanomedicine-related patent applications.

  11. Handbook of Battery Materials

    NASA Astrophysics Data System (ADS)

    Besenhard, J. O.

    1999-04-01

    Batteries find their applications in an increasing range of every-day products: discmen, mobile phones and electric cars need very different battery types. This handbook gives a concise survey about the materials used in modern battery technology. The physico-chemical fundamentals are as well treated as are the environmental and recycling aspects. It will be a profound reference source for anyone working in the research and development of new battery systems, regardless if chemist, physicist or engineer.

  12. Battery Review Board

    NASA Technical Reports Server (NTRS)

    Vaughn, Chester

    1993-01-01

    The topics covered are presented in viewgraph form: NASA Battery Review Board Charter; membership, board chronology; background; statement of problem; summary of problems with 50 AH standard Ni-Cd; activities for near term programs utilizing conventional Ni-Cd; present projects scheduled to use NASA standard Ni-Cd; other near-term NASA programs requiring secondary batteries; recommended direction for future programs; future cell/battery procurement strategy; and the NASA Battery Program.

  13. Recent survey on nanosuspension: a patent overview.

    PubMed

    Jethara, Sahilhusen I; Patel, Alpesh D; Patel, Mukesh R; Patel, Mukesh S; Patel, Kanu R

    2015-01-01

    The major goals of designing nanosuspension of nanosize materials are increasing due to their tremendous potential as a drug delivery system with the wide range of applications. Nanosuspension is a unique tool for improving the bioavailability of poorly soluble drugs. Nanosuspension drug delivery has wide range of application like oral, injectable, transdermal, inhalation, peroral, ocular, pulmonary and topical etc. by improviing the bioavailability, reducing the dose, gastric irritation, decreasing intra subject variability and increasing adhesivness with intestinal membrane. Recently, nanosuspension has been received much interest as a way to resolve solubility and stability problem because of their cost-effectiveness and technical simplicity compare to other liposome and colloidal drug carriers. Nanosuspensions are engaged to control particle size, surface properties and release of pharmacologically active agents in order to achieve the site-specific action of the drug at the therapeutically optimal rate, improve the bioavaibility of drug with poor solubility and dose regimen. Application and preparation method of nanosuspension has been reported by research articles and patented in different countries. Most of the marketed nanosuspensions are in preclinical and clinical based study for its application. More than 100 patents have been published on nanosuspensions by the recent days. This patent reviews covers different methods of pharmaceutical preparation and applications in drug delivery as well as the recent marketed published or granted patent surveys. This patent review is useful in enhance the knowledge of controlled drug delivery and applications.

  14. Metastasizing patent claims on BRCA1.

    PubMed

    Kepler, Thomas B; Crossman, Colin; Cook-Deegan, Robert

    2010-05-01

    Many patents make claims on DNA sequences; some include claims on oligonucleotides related to the primary patented gene. We used bioinformatics to quantify the reach of one such claim from patent 4,747,282 on BRCA1. We find that human chromosome 1 (which does not contain BRCA1) contains over 300,000 oligonucleotides covered by this claim, and that 80% of cDNA and mRNA sequences contributed to GenBank before the patent application was filed also contain at least one claimed oligonucleotide. Any "isolated" DNA molecules that include such 15 bp nucleotide sequences would fall under the claim as granted by the US Patent and Trademark Office. Anyone making, using, selling, or importing such a molecule for any purpose within the United States would thus be infringing the claim. This claim and others like it turn out, on examination, to be surprisingly broad, and if enforced would have substantial implications for medical practice and scientific research.

  15. Why German? Motivation of Students Studying German at English Universities

    ERIC Educational Resources Information Center

    Busse, Vera; Williams, Marion

    2010-01-01

    What drives students to study German at university level? Although motivational research has been booming in recent years, students' motivation to pursue a modern foreign language beyond school level has not received much attention in the UK. This article sheds light on the various reasons that drive students in the UK to pursue a modern foreign…

  16. Electric Vehicle Battery Challenge

    ERIC Educational Resources Information Center

    Roman, Harry T.

    2014-01-01

    A serious drawback to electric vehicles [batteries only] is the idle time needed to recharge their batteries. In this challenge, students can develop ideas and concepts for battery change-out at automotive service stations. Such a capability would extend the range of electric vehicles.

  17. Sodium sulfur battery seal

    DOEpatents

    Topouzian, Armenag

    1980-01-01

    This invention is directed to a seal for a sodium sulfur battery in which a flexible diaphragm sealing elements respectively engage opposite sides of a ceramic component of the battery which separates an anode compartment from a cathode compartment of the battery.

  18. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.

    PubMed

    Matthews, Kirstin R W; Cuchiara, Maude L

    2014-03-01

    In June 2013, the US Supreme Court ruled that naturally occurring genes were unpatentable in the case Association for Molecular Pathology v. Myriad Genetics. Up until this decision, Myriad Genetics was the only company in the USA that could legally conduct diagnostic testing for BRCA1 and 2, genes that are linked to familial breast and ovarian cancer. The court case and rulings garnered discussion in public about patenting biological materials. This paper will describe the progression of the Myriad Genetics case, similar US rulings and biological intellectual property policies. In addition, it will discuss the impact of the case on biological patents - specifically those for human embryonic stem cells.

  19. Digital pathology: A systematic evaluation of the patent landscape

    PubMed Central

    Cucoranu, Ioan C.; Parwani, Anil V.; Vepa, Suryanarayana; Weinstein, Ronald S.; Pantanowitz, Liron

    2014-01-01

    Introduction: Digital pathology is a relatively new field. Inventors of technology in this field typically file for patents to protect their intellectual property. An understanding of the patent landscape is crucial for companies wishing to secure patent protection and market dominance for their products. To our knowledge, there has been no prior systematic review of patents related to digital pathology. Therefore, the aim of this study was to systematically identify and evaluate United States patents and patent applications related to digital pathology. Materials and Methods: Issued patents and patent applications related to digital pathology published in the United States Patent and Trademark Office (USPTO) database (www.uspto.gov) (through January 2014) were searched using the Google Patents search engine (Google Inc., Mountain View, California, USA). Keywords and phrases related to digital pathology, whole-slide imaging (WSI), image analysis, and telepathology were used to query the USPTO database. Data were downloaded and analyzed using the Papers application (Mekentosj BV, Aalsmeer, Netherlands). Results: A total of 588 United States patents that pertain to digital pathology were identified. In addition, 228 patent applications were identified, including 155 that were pending, 65 abandoned, and eight rejected. Of the 588 patents granted, 348 (59.18%) were specific to pathology, while 240 (40.82%) included more general patents also usable outside of pathology. There were 70 (21.12%) patents specific to pathology and 57 (23.75%) more general patents that had expired. Over 120 unique entities (individual inventors, academic institutions, and private companies) applied for pathology specific patents. Patents dealt largely with telepathology and image analysis. WSI related patents addressed image acquisition (scanning and focus), quality (z-stacks), management (storage, retrieval, and transmission of WSI files), and viewing (graphical user interface (GUI

  20. The impact of patent eligibility on biotech patents: A flow chart for determining patent eligibility and an immune therapy case study

    PubMed Central

    Chang, Bao-Chi; Wang, Shyh-Jen

    2015-01-01

    US common law recites a natural law, natural phenomenon or abstract idea as exceptions to the 4 statutory patentable categories to guard against the wholesale preemption of fundamental principles. The very recent evolutions of patent exceptions in the US may increase the difficulty of patenting and may create uncertainty in determining patent eligibility. To solve the thorny problem of eligibility, this study presents a flow chart based on the courts’ decisions that can serve as a set of guidelines for determining patent eligibility. A case related to prostate cancer immune therapy is presented for discussion. PMID:25714661

  1. Das deutsche Adverbialsystem (The German Adverbial System)

    ERIC Educational Resources Information Center

    Droescher, W. O.

    1974-01-01

    Describes the surface structure of German adverbs proceeding from the standpoint of dependence-valence grammar. On the basis of their meaning, adverbs are classified as modal, temporal and locational. (Text is in German.) (IFS/WGA)

  2. Levelling in the German Verb Paradigm

    ERIC Educational Resources Information Center

    Newman, John

    1974-01-01

    Levelling processes in the history of the German verb paradigm from Old High German to the present are discussed. It is asserted that the theory of transformational generative grammar provides a proper framework for the study of linguistic change. (RM)

  3. Patent information - towards simplicity or complexity?

    NASA Astrophysics Data System (ADS)

    Shenton, Written By Kathleen; Norton, Peter; Onodera, Translated By Natsuo

    Since the advent of online services, the ability to search and find chemical patent information has improved immeasurably. Recently, integration of a multitude of files (through file merging as well as cross-file/simultaneous searches), 'intelligent' interfaces and optical technology for large amounts of data seem to achieve greater simplicity and convenience in the retrieval of patent information. In spite of these progresses, there is more essential problem which increases complexity. It is a tendency to expand indefinitely the range of claim for chemical substances by a ultra-generic description of structure (overuse of optional substituents, variable divalent groups, repeating groups, etc.) and long listing of prophetic examples. Not only does this tendency worry producers and searchers of patent databases but also prevents truly worthy inventions in future.

  4. Patents, antibiotics, and autarky in Spain.

    PubMed

    Romero De Pablos, Ana

    2014-01-01

    Patents on antibiotics were introduced in Spain in 1949. Preliminary research reveals diversification in the types of antibiotics: patents relating to penicillin were followed by those relating to streptomycin, erythromycin and tetracycline. There was also diversification in the firms that applied for patents: while Merck & Co. Incorporated and Schenley Industries Inc. were the main partners with Spanish antibiotics manufacturers in the late 1940s, this industrial space also included many others, such as Eli Lilly & Company, Abbott Laboratories, Chas. Pfizer & Co. Incorporated, and American Cyanamid Company in the mid-1970s. The introduction of these drugs in Spain adds new elements to a re-evaluation of the autarkic politics of the early years of the Franco dictatorship.

  5. Biomedical patents and ethics: a Canadian solution.

    PubMed

    Gold, E R

    2000-05-01

    World Trade Organization member states are preparing for the upcoming renegotiation of the Agreement on Trade-Related Aspects of Intellectual Property Rights. One of the important elements of that renegotiation is the ethical considerations regarding the patenting of higher life forms and their component parts (e.g. DNA and cell-lines). The interface between the genetic revolution, patentability, and ethical considerations is the subject of this article. The author identifies, explores, and critiques four possible positions Canada may adopt in respect of patentability of biomedical material. First, Canada could do nothing. This approach would mean keeping biomedical materials outside the patent system and outside the stream of commerce. Canada would simply wait for an international consensus to develop before adopting a position of its own. Second, Canada could go it alone. It could implement a policy that balances the incentive effects of patents with the need to incorporate ethical and social values into the decision-making process regarding the use of biomedical materials. In respect of this option, the author proposes a model whereby non-profit bodies would hold the exclusive rights to research, use, and exploit biomedical materials. Third, Canada could follow the United States, Europe, and Japan by providing for almost unrestricted patenting of biomedical materials. This would be the most industry-friendly alternative. The fourth and final option is to use the medicare system to promote discussion of ethical considerations involved in the use of biomedical materials. The power of provincial health agencies may be used as a lever to ensure the discussion of ethical considerations concerning the use of biomedical materials. The author concludes that the fourth and final option is the best alternative for Canada while waiting for an international consensus to emerge.

  6. From Business to Technological German.

    ERIC Educational Resources Information Center

    Rockwood, H. M.

    Because many of the Georgia Institute of Technology students taking business German come from the sciences and engineering, the business language textbook used has been supplemented with more technologically oriented instructional materials. Highly technical texts are too advanced at the second year language learning stage, so one teacher selected…

  7. Saving German Studies, via Europe

    ERIC Educational Resources Information Center

    Donahue, William Collins; Kagel, Martin

    2012-01-01

    By most accounts, the position of German studies in the American academy is no longer secure. To a large extent, that is due to reasons beyond the control of individual faculty or departments, including the general crisis faced by the humanities and the diminished importance in the eyes of the public of literary criticism, a vital part of the…

  8. Atlanta Public Schools German Guide.

    ERIC Educational Resources Information Center

    Bolen, Helen; And Others

    This guide for teachers of German emphasizes the primacy of listening and speaking skills at all levels of instruction. Contents include information on: (1) philosophy and ultimate goals, (2) student recruitment, (3) program sequence, (4) English in the classroom, (5) grammar, (6) articulation, (7) independent study, (8) grouping for…

  9. A Functional Syntax of German.

    ERIC Educational Resources Information Center

    Fichtner, Edward G.

    Students in intermediate language courses, especially conversational courses, can benefit from a simple set of instructions for combining words and phrases into sentences. A description of the basic concepts determining word order in German--the fundamental sequence of clause elements, the "infrastructure," and the movement rules by which the…

  10. Instructional Methods in German (IMG).

    ERIC Educational Resources Information Center

    School of Education, Malmo (Sweden). Dept. of Educational and Psychological Research.

    This project report outlines a continuing investigation (1965-73) into the teaching of German in Swedish public schools and steps taken toward the compilation and construction of teaching materials for use in introductory courses. The work is reviewed following four principal phases of completed project research and development: (1) analysis of…

  11. Metrical Phonology: German Sound System.

    ERIC Educational Resources Information Center

    Tice, Bradley S.

    Metrical phonology, a linguistic process of phonological stress assessment and diagrammatic simplification of sentence and word stress, is discussed as it is found in the English and German languages. The objective is to promote use of metrical phonology as a tool for enhancing instruction in stress patterns in words and sentences, particularly in…

  12. German 1990: Intensive and Diverse.

    ERIC Educational Resources Information Center

    Kempf, Franz R.

    1990-01-01

    Suggests the following methods for improving university-level German language education curricula: reduce skill-development time through immersion programs, adopt Zertifikat Deutsch als Fremdsprache as the proficiency standard for advanced students, and include literature from a variety of liberal arts disciplines in the reading materials for…

  13. Bio-patents, development and society: on the patentability of human genes.

    PubMed

    Myszczuk, Ana Paula; de Meirelles, Jussara Maria Leal

    2012-01-01

    This study discusses the possibility of patenting inventions based on human genes and the need for an effective adaptation of the Patent Law system to enable the patenting of material derived from human genes. Furthermore, to allow for the inclusion of human gene-based inventions in the current patent system, many more amendments are required than those that have already become law during and since the twentieth century. It should be emphasized that one of the main characteristics of Patent Law is this changeability that requires the law to constantly respond to economic needs, advances in science and their resulting challenges in order to protect the product of human ingenuity. Therefore, new adaptations are required. In this context, the present paper adopts the understanding that human genes may serve as a basis for patentable inventions provided that the traditional requirements of novelty, inventiveness, utility and descriptive adequacy are adapted to the specific nature of living human matter. They should also be in line with the principles of legality and morality and not infringe human dignity, personality rights and should fulfill their social and environmental functions. Therefore, a bio-patent has a threefold function: economic, social and environmental. The economic function lies in the exclusive right to exploit an invention; the social function is implicit because there is no reason for the existence of a patent that solely benefits, its owner without society also enjoying its benefits and; the environmental function is that which guarantees that a bio-patent should preserve biodiversity and social diversity.

  14. Nanocellulose patents trends: a comprehensive review on patents on cellulose nanocrystals, microfibrillated and bacterial cellulose.

    PubMed

    Charreau, Hernan; Foresti, Maria L; Vazquez, Analia

    2013-01-01

    Cellulose nanoparticles (i.e. cellulose elements having at least one dimension in the 1-100 nm range) have received increasing attention during the last decade. This is not only evident in academic articles, but it is also manifested by the increasing number of nanocellulose patents that are published every year. In the current review, nanocellulose patents are reviewed using specific software which provides valuable information on the annual number of patents that have been published throughout the years, main patent owners, most prolific inventors, and patents on the field that have received more citations. Patent statistics on rod-like cellulose nanoparticles extracted from plants by acid hydrolysis (nanocrystals), mechanical treatment leading to microfibrillated cellulose (MFC), and microbially produced nanofibrils (bacterial cellulose, BC) are analyzed in detail. The aim of the current review is to provide researchers with patent information which may help them in visualizing the evolution of nanocellulose technology, both as a whole and also divided among the different nanosized particles that are currently the subject of outstanding scientific attention. Then, patents are not only analyzed by their content, but also by global statistics which will reveal the moment at which different cellulose nanoparticles technologies achieved a breakthrough, the relative interest received by different nanocellulose particles throughout the years, the companies that have been most interested in this technology, the most prolific inventors, and the patents that have had more influence in further developments. It is expected that the results showing the explosion that nanocellulose technology is experiencing in current days will still bring more research on the topic and contribute to the expansion of nanocellulosics applications.

  15. Enriching the Curriculum with Pennsylvania German

    ERIC Educational Resources Information Center

    Meindl, Joerg

    2016-01-01

    The German classroom should prepare students for the linguistic diversity of the target culture, including regional varieties and German spoken outside of the D-A-CH region. Because textbooks do not often include materials on regional varieties, this article presents a model to incorporate Pennsylvania German (PG) into the curriculum. The model…

  16. Verbal Aspects in Germanic, Slavic, and Baltic.

    ERIC Educational Resources Information Center

    Senn, Alfred

    1949-01-01

    This study examines the theory of Prokosch concerning the Germanic-Slavic-Baltic tense and aspect systems. The interrelatedness and influence of languages and dialects in Slavic (Russian and Old Church Slavic), Baltic (Lithuanian), and Germanic (Old High German and Gothic) are demonstrated. Examples illustrating the use of the perfective present…

  17. Alkaline quinone flow battery.

    PubMed

    Lin, Kaixiang; Chen, Qing; Gerhardt, Michael R; Tong, Liuchuan; Kim, Sang Bok; Eisenach, Louise; Valle, Alvaro W; Hardee, David; Gordon, Roy G; Aziz, Michael J; Marshak, Michael P

    2015-09-25

    Storage of photovoltaic and wind electricity in batteries could solve the mismatch problem between the intermittent supply of these renewable resources and variable demand. Flow batteries permit more economical long-duration discharge than solid-electrode batteries by using liquid electrolytes stored outside of the battery. We report an alkaline flow battery based on redox-active organic molecules that are composed entirely of Earth-abundant elements and are nontoxic, nonflammable, and safe for use in residential and commercial environments. The battery operates efficiently with high power density near room temperature. These results demonstrate the stability and performance of redox-active organic molecules in alkaline flow batteries, potentially enabling cost-effective stationary storage of renewable energy.

  18. Silicon Carbide Radioisotope Batteries

    NASA Technical Reports Server (NTRS)

    Rybicki, George C.

    2005-01-01

    The substantial radiation resistance and large bandgap of SiC semiconductor materials makes them an attractive candidate for application in a high efficiency, long life radioisotope battery. To evaluate their potential in this application, simulated batteries were constructed using SiC diodes and the alpha particle emitter Americium Am-241 or the beta particle emitter Promethium Pm-147. The Am-241 based battery showed high initial power output and an initial conversion efficiency of approximately 16%, but the power output decayed 52% in 500 hours due to radiation damage. In contrast the Pm-147 based battery showed a similar power output level and an initial conversion efficiency of approximately 0.6%, but no degradation was observed in 500 hours. However, the Pm-147 battery required approximately 1000 times the particle fluence as the Am-242 battery to achieve a similar power output. The advantages and disadvantages of each type of battery and suggestions for future improvements will be discussed.

  19. India: Court upholds patent law denying patents for slightly modified versions of existing drugs.

    PubMed

    Swamy, Madhavi

    2007-12-01

    In August 2007, the Madras High Court struck down a petition by the Swiss pharmaceutical company Novartis to declare the anti-evergreening provision in Indian patent law invalid. Evergreening is the practice of effectively extending the patent on a drug by filing a new patent for a marginal modification to that drug, such as a change in its shape, dosing range or color. The Court's decision is critical for global access to essential medicines in the form of affordable generic drugs from India

  20. 48 CFR 970.3102-05-30 - Patent costs.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 5 2010-10-01 2010-10-01 false Patent costs. 970.3102-05... SUPPLEMENTARY REGULATIONS DOE MANAGEMENT AND OPERATING CONTRACTS Contract Cost Principles and Procedures 970.3102-05-30 Patent costs....

  1. 48 CFR 970.3102-05-30 - Patent costs.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 5 2011-10-01 2011-10-01 false Patent costs. 970.3102-05... SUPPLEMENTARY REGULATIONS DOE MANAGEMENT AND OPERATING CONTRACTS Contract Cost Principles and Procedures 970.3102-05-30 Patent costs....

  2. 48 CFR 27.204 - Patented technology under trade agreements.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 48 Federal Acquisition Regulations System 1 2014-10-01 2014-10-01 false Patented technology under trade agreements. 27.204 Section 27.204 Federal Acquisition Regulations System FEDERAL ACQUISITION... Patented technology under trade agreements....

  3. 48 CFR 27.204 - Patented technology under trade agreements.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 48 Federal Acquisition Regulations System 1 2013-10-01 2013-10-01 false Patented technology under trade agreements. 27.204 Section 27.204 Federal Acquisition Regulations System FEDERAL ACQUISITION... Patented technology under trade agreements....

  4. 48 CFR 27.204 - Patented technology under trade agreements.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 48 Federal Acquisition Regulations System 1 2012-10-01 2012-10-01 false Patented technology under trade agreements. 27.204 Section 27.204 Federal Acquisition Regulations System FEDERAL ACQUISITION... Patented technology under trade agreements....

  5. 48 CFR 27.204 - Patented technology under trade agreements.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 1 2010-10-01 2010-10-01 false Patented technology under trade agreements. 27.204 Section 27.204 Federal Acquisition Regulations System FEDERAL ACQUISITION... Patented technology under trade agreements....

  6. 37 CFR 1.705 - Patent term adjustment determination.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ..., DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES Adjustment and Extension of Patent Term... by: (1) The fee set forth in § 1.18(f); and (2) A showing to the satisfaction of the Director...

  7. 37 CFR 1.705 - Patent term adjustment determination.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ..., DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES Adjustment and Extension of Patent Term... by: (1) The fee set forth in § 1.18(f); and (2) A showing to the satisfaction of the Director...

  8. 37 CFR 1.705 - Patent term adjustment determination.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ..., DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES Adjustment and Extension of Patent Term... showing to the satisfaction of the Director that, in spite of all due care, the applicant was unable...

  9. 37 CFR 1.705 - Patent term adjustment determination.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ..., DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES Adjustment and Extension of Patent Term... showing to the satisfaction of the Director that, in spite of all due care, the applicant was unable...

  10. 48 CFR 27.204 - Patented technology under trade agreements.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 1 2011-10-01 2011-10-01 false Patented technology under trade agreements. 27.204 Section 27.204 Federal Acquisition Regulations System FEDERAL ACQUISITION... Patented technology under trade agreements....

  11. An advanced search engine for patent analytics in medicinal chemistry.

    PubMed

    Pasche, Emilie; Gobeill, Julien; Teodoro, Douglas; Gaudinat, Arnaud; Vishnykova, Dina; Lovis, Christian; Ruch, Patrick

    2012-01-01

    Patent collections contain an important amount of medical-related knowledge, but existing tools were reported to lack of useful functionalities. We present here the development of TWINC, an advanced search engine dedicated to patent retrieval in the domain of health and life sciences. Our tool embeds two search modes: an ad hoc search to retrieve relevant patents given a short query and a related patent search to retrieve similar patents given a patent. Both search modes rely on tuning experiments performed during several patent retrieval competitions. Moreover, TWINC is enhanced with interactive modules, such as chemical query expansion, which is of prior importance to cope with various ways of naming biomedical entities. While the related patent search showed promising performances, the ad-hoc search resulted in fairly contrasted results. Nonetheless, TWINC performed well during the Chemathlon task of the PatOlympics competition and experts appreciated its usability.

  12. DNA Dilemma: A Perspective on Current U.S. Patent and Trademarh Office Philosophy Concerning Life Patents

    SciTech Connect

    Franz, K.; Faletra, P.

    2002-01-01

    The lack of a solid set of criteria for determining patentability of subject matter - particularly subject matter dealing with life - has recently been of increasing public concern in the United States. Alarm for patent practices related to life systems ranges from patents being granted on biochemical processes and the knowledge of these processes to the patenting of entire organisms. One of the most volatile concerns is the patenting of human genes or parts of genes since this genetic material is the basic informational molecule for all life. Current patent law, legislated in 1952, has been interpreted by the U.S. Supreme Court to allow broad patents of DNA, biochemical processes, and what are generally considered 'inventions' of life systems. Several issues are addressed in this paper regarding the unsound reasoning underlying both the interpretation and execution of patent law. Lapses in logic provide a gateway for businesses and individuals to take patenting to an illogical and unworkable extreme. Patent Office disorder of this magnitude is unnecessary and has great potential for harming the mission that the patent office was designed to serve. Recently disclosed patent-granting guidelines suggest the United States Patent and Trademark Office is not upholding its Constitutional responsibility of promoting the progress of science.

  13. 29 CFR 1926.441 - Batteries and battery charging.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 29 Labor 8 2013-07-01 2013-07-01 false Batteries and battery charging. 1926.441 Section 1926.441... for Special Equipment § 1926.441 Batteries and battery charging. (a) General requirements—(1) Batteries of the unsealed type shall be located in enclosures with outside vents or in well ventilated...

  14. 29 CFR 1926.441 - Batteries and battery charging.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 29 Labor 8 2012-07-01 2012-07-01 false Batteries and battery charging. 1926.441 Section 1926.441... for Special Equipment § 1926.441 Batteries and battery charging. (a) General requirements—(1) Batteries of the unsealed type shall be located in enclosures with outside vents or in well ventilated...

  15. 29 CFR 1926.441 - Batteries and battery charging.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 29 Labor 8 2014-07-01 2014-07-01 false Batteries and battery charging. 1926.441 Section 1926.441... for Special Equipment § 1926.441 Batteries and battery charging. (a) General requirements—(1) Batteries of the unsealed type shall be located in enclosures with outside vents or in well ventilated...

  16. 29 CFR 1926.441 - Batteries and battery charging.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 29 Labor 8 2011-07-01 2011-07-01 false Batteries and battery charging. 1926.441 Section 1926.441... for Special Equipment § 1926.441 Batteries and battery charging. (a) General requirements—(1) Batteries of the unsealed type shall be located in enclosures with outside vents or in well ventilated...

  17. 29 CFR 1926.441 - Batteries and battery charging.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 29 Labor 8 2010-07-01 2010-07-01 false Batteries and battery charging. 1926.441 Section 1926.441... for Special Equipment § 1926.441 Batteries and battery charging. (a) General requirements—(1) Batteries of the unsealed type shall be located in enclosures with outside vents or in well ventilated...

  18. Bioterrorism Countermeasure Development: Issues in Patents and Homeland Security

    DTIC Science & Technology

    2005-05-06

    patent life with respect to an unrelated product has been termed a “ wild card ” term extension.87 Under this regime, a countermeasure innovator could...for an additional period of six months to two years. Supporters of a wild card patent term extension urge that patent-based incentives on profitable...particular illnesses or medical conditions.89 S. 975 appears to employ this “ wild card ” patent term extension concept. That bill stipulates that

  19. Dictionary of surfactants English/German and German/English

    SciTech Connect

    Siekmann, K.

    1987-01-01

    This dictionary is supplement to the monograph ''Surfactants in Consumer Products'' edited by Professor Dr. J. Falbe. It comprises approximately 3.200 keywords of the chemistry, technology and applications of surfactants in English/German and German/English. In the monograph the physical-chemical principles of action of the surfactants, their production and their application in laundry detergents, dishwashing detergents and cleaning agents as well as in cosmetics and toiletries are discussed. The technological aspects of application and formulation along with those of production and manufacturing processes are illustrated. Ecological and toxicological questions are probed in depth. Finally, important economic data concerning this branch of industry as well as an attempt to provide a perspective with regard to the future of the surfactant market round out the picture.

  20. The German Economy and U.S.-German Economic Relations

    DTIC Science & Technology

    2009-11-30

    merchandise is also denoted by the term Exportweltmeister (world champion exporter ). At the same time, relatively weak consumer demand is a...world’s top exporter of merchandise or goods, surpassing the United States, Japan, and China.36 The title of Exportweltmeister ( export champion) is a... exporting than domestic investment and consumption. With few exceptions, German governments have generally been reluctant to advance what many economists

  1. [German Urological Associations under National Socialism].

    PubMed

    Krischel, M; Moll, F; Fangerau, H

    2011-09-01

    The Deutsche Gesellschaft für Urologie (German Urological Association), established in 1907, was a German-Austrian medical society in which Jewish physicians held important positions. When the Nazis seized power in 1933, the Austrian Hans Rubritius was president of the society. The non-German presidency and the exclusion of Jewish colleagues from the professional society and medical practice led to a halt of the society's activities. At the same time in the mid 1930s, German urologists founded the Gesellschaft Reichsdeutscher Urologen (Association of Reichs-German Urologists) whose members aligned themselves with Nazi health policies and in turn received professional and personal benefits.

  2. 78 FR 60256 - Initial Patent Applications

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-10-01

    ... should be directed to the attention of Raul Tamayo, Senior Legal Advisor, Office of Patent Legal... them will be submitted. The recordkeeping costs associated with keeping a copy of the electronically... suggests, but does not require, that applicants keep copies of their electronically-filed applications....

  3. Careers in Patent Law for Physics Majors

    ERIC Educational Resources Information Center

    Oliver, Douglas L.

    2010-01-01

    An important question that many undergraduate physics students ask is, "What can one do with a physics degree?" Of course there are many answers to this question. Often a general reference to becoming a lawyer is given as a possible answer. This paper is intended to explain the field of patent law and how a physics degree can lead to an…

  4. 76 FR 72000 - Patent, Trademark & Copyright Acts

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-11-21

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF THE INTERIOR Geological Survey Patent, Trademark & Copyright Acts AGENCY: U.S. Geological Survey, Interior. ACTION: Notice of Prospective Intent to Award Exclusive License. SUMMARY: The United States Geological Survey...

  5. Patent foramen ovale presenting as visual loss

    PubMed Central

    Liu, Xiaoxuan; Calvert, Patrick A; Arif, Sayqa; Keane, Pearse A

    2016-01-01

    Retinal artery occlusion in an otherwise healthy, young patient is rare. In this context it is important to consider patent foramen ovale as a differential. Early referral to a cardiology specialist for diagnosis and treatment is important for preventing further ocular and non-ocular events. PMID:28203381

  6. Patent and Copyright Policies at Selected Universities.

    ERIC Educational Resources Information Center

    National Association of College and University Business Officers, Washington, DC.

    Gathered are statements of copyright and patent policies in effect at 13 universities. In some cases policies concerning publication and sponsored research are included. The statements are reproduced exactly as received from the institutions, without interpretation. The universities participating are: Boston University (Massachusetts); California…

  7. Stem cell technologies: regulation, patents and problems.

    PubMed

    Then, Shih-Ning

    2004-11-01

    Human embryonic stem cell research promises to deliver in the future a whole range of therapeutic treatments, but currently governments in different jurisdictions must try to regulate this burgeoning area. Part of the problem has been, and continues to be, polarised community opinion on the use of human embryonic stem cells for research. This article compares the approaches of the Australian, United Kingdom and United States governments in regulating human embryonic stem cell research. To date, these governments have approached the issue through implementing legislation or policy to control research. Similarly, the three jurisdictions have viewed the patentability of human embryonic stem cell technologies in their own ways with different policies being adopted by the three patent offices. This article examines these different approaches and discusses the inevitable concerns that have been raised due to the lack of a universal approach in relation to the regulation of research; the patenting of stem cell technologies; and the effects patents granted are having on further human embryonic stem cell research.

  8. Glidden's Patent Application for Barbed Wire.

    ERIC Educational Resources Information Center

    Ray, Emily; Schamel, Wynell

    1997-01-01

    Describes a series of teaching activities to be used in conjunction with a reproduction of Joseph Glidden's patent for barbed wire fencing. These include document analysis, creative interpretation, and personal experience. Presents a brief history of the social and economic effects of the introduction of barbed wire to the West. (MJP)

  9. Savannah River Site Patented Technologies Summaries

    SciTech Connect

    Rabold, D.E.

    1995-07-18

    This information represents SRS`s contribution of the DOE technology information network, an internet service coordinated out of Los Alamos. The information provided is strictly DOE-SR-titled and-issued patented technologies including environmental remediation, robotics, sensors, materials science, biomedical applications, hydrogen, and consumer products.

  10. The Applicability of Patented Technologies to Sonobuoys

    DTIC Science & Technology

    1989-06-30

    to Navy suppliers. F. Contact: Darryl Mexic, Esquire Patent Counsel Sughrue, Mion, Zinn , Macpeak & Seas 2100 Pennsylvania Avenue, NW Washington, DC...Bovernack Auoney, Agent. or Firm- Howard P. Terry; Seymour (75) Inventor: D d H. MeMa , Carlisle, Mass. Levine [73] Assignee: Sperry Corporatloin, New York

  11. Vehicle Technologies Program Awards and Patents

    SciTech Connect

    2011-12-13

    Award-winning technologies and processes are hallmarks of the programs funded by the U.S. Department of Energy, Office of Energy Efficiency and Renewable Energy, and industrial partners. Awards, patents, and other recognition validate the products of research undertaken as part of the Vehicle Technologies Program.

  12. 77 FR 4887 - DOE Patent Licensing Regulations

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-02-01

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF ENERGY 10 CFR..., Department of Energy. ACTION: Final rule. SUMMARY: The Department of Energy (DOE) is amending its patent... for Technology Transfer and Procurement shall hear and decide appeals relating to licensing...

  13. Update on Brazil's pharma patent landscape.

    PubMed

    Gosain, Rana

    2016-09-01

    Brazil's Pharma market is a dynamic and promising one. It ranks within the top ten market. There are peculiar hurdles that patentees have to overcome, such as, a two-tier examination, a serious backlog at the Brazilian Patent and Trademark Office. Several measures to accelerate examination have been adopted given the meager number of Examiners.

  14. 75 FR 17380 - Patents Ombudsman Pilot Program

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-06

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE... and Trademark Office, Commerce. ACTION: Notice. SUMMARY: The United States Patent and Trademark Office... satisfaction level of the participants will be monitored. If a participant is not satisfied with the...

  15. 77 FR 269 - Matters Related to Patent Appeals

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-01-04

    ... United States Patent and Trademark Office Matters Related to Patent Appeals ACTION: Proposed collection...: Email: InformationCollection@uspto.gov . Include ``0651- 00xx Matters Related to Patent Appeals comment... protection to which he or she is entitled. Where the differences of opinion on such matters concern...

  16. 48 CFR 31.205-30 - Patent costs.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 1 2010-10-01 2010-10-01 false Patent costs. 31.205-30... CONTRACTING REQUIREMENTS CONTRACT COST PRINCIPLES AND PROCEDURES Contracts With Commercial Organizations 31.205-30 Patent costs. (a) The following patent costs are allowable to the extent that they are...

  17. 48 CFR 31.205-30 - Patent costs.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 1 2011-10-01 2011-10-01 false Patent costs. 31.205-30... CONTRACTING REQUIREMENTS CONTRACT COST PRINCIPLES AND PROCEDURES Contracts With Commercial Organizations 31.205-30 Patent costs. (a) The following patent costs are allowable to the extent that they are...

  18. Biotechnology Firms Gird for Clash over Patent Claims.

    ERIC Educational Resources Information Center

    Webber, David

    1984-01-01

    Examines issues and trends related to biotechnology patents, providing data that show that foreign concerns have gained a large share of United States patents. Also lists the number of patents assigned to companies, foreign countries, and universities during 1983 and 1984. (JN)

  19. 77 FR 48755 - Office Patent Trial Practice Guide

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-14

    ...The Leahy-Smith America Invents Act (AIA) establishes several new trial proceedings to be conducted by the Patent Trial and Appeal Board (Board) including inter partes review, post-grant review, the transitional program for covered business method patents, and derivation proceedings. In separate rulemakings, the United States Patent and Trademark Office (Office or USPTO) is revising the rules......

  20. 7 CFR 1230.88 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Patents, copyrights, inventions, and publications... Information Order Miscellaneous § 1230.88 Patents, copyrights, inventions, and publications. Any patents, copyrights, trademarks, inventions, or publications developed through the use of funds collected under...

  1. 7 CFR 1160.505 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 9 2011-01-01 2011-01-01 false Patents, copyrights, inventions and publications. 1160... PROGRAM Fluid Milk Promotion Order Miscellaneous § 1160.505 Patents, copyrights, inventions and publications. (a) Any patents, copyrights, trademarks, inventions or publications developed through the use...

  2. 7 CFR 1230.88 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Patents, copyrights, inventions, and publications... Information Order Miscellaneous § 1230.88 Patents, copyrights, inventions, and publications. Any patents, copyrights, trademarks, inventions, or publications developed through the use of funds collected under...

  3. 7 CFR 1260.215 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Patents, copyrights, inventions and publications..., copyrights, inventions and publications. (a) Any patents, copyrights, inventions or publications developed... patents, copyrights, inventions, or publications, ensure to the benefit of the Board. Upon termination...

  4. 7 CFR 1160.505 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 9 2013-01-01 2013-01-01 false Patents, copyrights, inventions and publications. 1160... PROGRAM Fluid Milk Promotion Order Miscellaneous § 1160.505 Patents, copyrights, inventions and publications. (a) Any patents, copyrights, trademarks, inventions or publications developed through the use...

  5. 7 CFR 1260.215 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Patents, copyrights, inventions and publications..., copyrights, inventions and publications. (a) Any patents, copyrights, inventions or publications developed... patents, copyrights, inventions, or publications, ensure to the benefit of the Board. Upon termination...

  6. 7 CFR 1160.505 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Patents, copyrights, inventions and publications. 1160... PROGRAM Fluid Milk Promotion Order Miscellaneous § 1160.505 Patents, copyrights, inventions and publications. (a) Any patents, copyrights, trademarks, inventions or publications developed through the use...

  7. 7 CFR 1230.88 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Patents, copyrights, inventions, and publications... Information Order Miscellaneous § 1230.88 Patents, copyrights, inventions, and publications. Any patents, copyrights, trademarks, inventions, or publications developed through the use of funds collected under...

  8. 7 CFR 1150.184 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 9 2014-01-01 2013-01-01 true Patents, copyrights, inventions and publications. 1150... Dairy Promotion and Research Order Miscellaneous § 1150.184 Patents, copyrights, inventions and publications. Any patents, copyrights, trademarks, inventions or publications developed through the use...

  9. 7 CFR 1150.184 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 9 2011-01-01 2011-01-01 false Patents, copyrights, inventions and publications. 1150... Dairy Promotion and Research Order Miscellaneous § 1150.184 Patents, copyrights, inventions and publications. Any patents, copyrights, trademarks, inventions or publications developed through the use...

  10. 7 CFR 1150.184 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 9 2013-01-01 2013-01-01 false Patents, copyrights, inventions and publications. 1150... Dairy Promotion and Research Order Miscellaneous § 1150.184 Patents, copyrights, inventions and publications. Any patents, copyrights, trademarks, inventions or publications developed through the use...

  11. 7 CFR 1150.184 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Patents, copyrights, inventions and publications. 1150... Dairy Promotion and Research Order Miscellaneous § 1150.184 Patents, copyrights, inventions and publications. Any patents, copyrights, trademarks, inventions or publications developed through the use...

  12. 7 CFR 1160.505 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 9 2014-01-01 2013-01-01 true Patents, copyrights, inventions and publications. 1160... PROGRAM Fluid Milk Promotion Order Miscellaneous § 1160.505 Patents, copyrights, inventions and publications. (a) Any patents, copyrights, trademarks, inventions or publications developed through the use...

  13. 7 CFR 1260.215 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Patents, copyrights, inventions and publications..., copyrights, inventions and publications. (a) Any patents, copyrights, inventions or publications developed... patents, copyrights, inventions, or publications, ensure to the benefit of the Board. Upon termination...

  14. 7 CFR 1260.215 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Patents, copyrights, inventions and publications..., copyrights, inventions and publications. (a) Any patents, copyrights, inventions or publications developed... patents, copyrights, inventions, or publications, ensure to the benefit of the Board. Upon termination...

  15. 7 CFR 1230.88 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Patents, copyrights, inventions, and publications... Information Order Miscellaneous § 1230.88 Patents, copyrights, inventions, and publications. Any patents, copyrights, trademarks, inventions, or publications developed through the use of funds collected under...

  16. Invisible genomes: the genomics revolution and patenting practice.

    PubMed

    Bostanci, Adam; Calvert, Jane

    2008-03-01

    In the mid-1990s, the company Human Genome Sciences submitted three potentially revolutionary patent applications to the US Patent and Trademark Office, each of which claimed the entire genome sequence of a microorganism. The patent examiners, however, objected to these applications, and after negotiation they were eventually re-written to resemble more traditional gene patents. In this paper, which is based on a study of the patent examination files, we examine the reasons why these patent applications were unsuccessful in their original form. We show that with respect to utility and novelty, the patent attorney's case built on an understanding of the genome as a computer-related invention. The patent examiners did not object to the patenting of complete genome sequences as computer-related inventions on moral grounds or in terms of the distinction between a discovery and an invention. Instead, their objections were based on classification, rules and procedure. Rather than patent examiners having a notion of a genome that should not be patented, the notion of a 'genome', and the ways in which it may be different from a 'gene', played no role in these debates. We discuss the consequences of our findings for patenting in the biosciences.

  17. 45 CFR 650.2 - National Science Foundation patent policy.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 45 Public Welfare 3 2011-10-01 2011-10-01 false National Science Foundation patent policy. 650.2 Section 650.2 Public Welfare Regulations Relating to Public Welfare (Continued) NATIONAL SCIENCE FOUNDATION PATENTS § 650.2 National Science Foundation patent policy. As authorized by the National...

  18. 45 CFR 650.2 - National Science Foundation patent policy.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 45 Public Welfare 3 2010-10-01 2010-10-01 false National Science Foundation patent policy. 650.2 Section 650.2 Public Welfare Regulations Relating to Public Welfare (Continued) NATIONAL SCIENCE FOUNDATION PATENTS § 650.2 National Science Foundation patent policy. As authorized by the National...

  19. Annotated chemical patent corpus: a gold standard for text mining.

    PubMed

    Akhondi, Saber A; Klenner, Alexander G; Tyrchan, Christian; Manchala, Anil K; Boppana, Kiran; Lowe, Daniel; Zimmermann, Marc; Jagarlapudi, Sarma A R P; Sayle, Roger; Kors, Jan A; Muresan, Sorel

    2014-01-01

    Exploring the chemical and biological space covered by patent applications is crucial in early-stage medicinal chemistry activities. Patent analysis can provide understanding of compound prior art, novelty checking, validation of biological assays, and identification of new starting points for chemical exploration. Extracting chemical and biological entities from patents through manual extraction by expert curators can take substantial amount of time and resources. Text mining methods can help to ease this process. To validate the performance of such methods, a manually annotated patent corpus is essential. In this study we have produced a large gold standard chemical patent corpus. We developed annotation guidelines and selected 200 full patents from the World Intellectual Property Organization, United States Patent and Trademark Office, and European Patent Office. The patents were pre-annotated automatically and made available to four independent annotator groups each consisting of two to ten annotators. The annotators marked chemicals in different subclasses, diseases, targets, and modes of action. Spelling mistakes and spurious line break due to optical character recognition errors were also annotated. A subset of 47 patents was annotated by at least three annotator groups, from which harmonized annotations and inter-annotator agreement scores were derived. One group annotated the full set. The patent corpus includes 400,125 annotations for the full set and 36,537 annotations for the harmonized set. All patents and annotated entities are publicly available at www.biosemantics.org.

  20. 7 CFR 1220.254 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Patents, copyrights, inventions, and publications... Miscellaneous § 1220.254 Patents, copyrights, inventions, and publications. (a) Any patents, copyrights, inventions, or publications developed through the use of funds remitted to the Board under the provisions...

  1. 34 CFR 6.1 - Publication or patenting of inventions.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 34 Education 1 2010-07-01 2010-07-01 false Publication or patenting of inventions. 6.1 Section 6.1 Education Office of the Secretary, Department of Education INVENTIONS AND PATENTS (GENERAL) § 6.1 Publication or patenting of inventions. It is the general policy of the Department that the results...

  2. 7 CFR 1230.88 - Patents, copyrights, inventions, and publications.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Patents, copyrights, inventions, and publications... Information Order Miscellaneous § 1230.88 Patents, copyrights, inventions, and publications. Any patents, copyrights, trademarks, inventions, or publications developed through the use of funds collected under...

  3. 77 FR 71004 - Patents and Inventions; Delegation of Authority

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-11-28

    ... HUMAN SERVICES Centers for Disease Control and Prevention Patents and Inventions; Delegation of... administer and make decisions regarding the invention and patent program of CDC and the authority to make determinations of rights in inventions and patents in which CDC and the Department have an interest....

  4. 50 CFR 82.19 - Patents and inventions.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 50 Wildlife and Fisheries 6 2010-10-01 2010-10-01 false Patents and inventions. 82.19 Section 82...-IN-AID (MARINE MAMMAL PROTECTION ACT OF 1972) Administration § 82.19 Patents and inventions. Determination of the patent rights in any inventions or discoveries resulting from work under...

  5. 7 CFR 1160.505 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Patents, copyrights, inventions and publications. 1160... PROGRAM Fluid Milk Promotion Order Miscellaneous § 1160.505 Patents, copyrights, inventions and publications. (a) Any patents, copyrights, trademarks, inventions or publications developed through the use...

  6. 50 CFR 401.21 - Patents and inventions.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 50 Wildlife and Fisheries 7 2010-10-01 2010-10-01 false Patents and inventions. 401.21 Section 401... CONSERVATION, DEVELOPMENT AND ENHANCEMENT § 401.21 Patents and inventions. Determination of the patent rights in any inventions or discoveries resulting from work under project agreements entered into...

  7. 7 CFR 1260.215 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Patents, copyrights, inventions and publications..., copyrights, inventions and publications. (a) Any patents, copyrights, inventions or publications developed... patents, copyrights, inventions, or publications, ensure to the benefit of the Board. Upon termination...

  8. 7 CFR 1150.184 - Patents, copyrights, inventions and publications.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Patents, copyrights, inventions and publications. 1150... Dairy Promotion and Research Order Miscellaneous § 1150.184 Patents, copyrights, inventions and publications. Any patents, copyrights, trademarks, inventions or publications developed through the use...

  9. Glidden's Patent Application for Barbed Wire. Teaching with Documents.

    ERIC Educational Resources Information Center

    National Archives and Records Administration, Washington, DC.

    Life in the western United States was reshaped by a series of patents for a simple tool that helped ranchers tame the land: barbed wire. Nine patents for improvements to wire fencing were granted by the U.S. Patent Office to U.S. inventors beginning with Michael Kelly in 1868 and ending with Joseph Glidden in 1874. Vast and undefined prairies and…

  10. 25 CFR 152.5 - Issuance of patent in fee.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 25 Indians 1 2010-04-01 2010-04-01 false Issuance of patent in fee. 152.5 Section 152.5 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  11. 48 CFR 52.227-3 - Patent Indemnity.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 48 Federal Acquisition Regulations System 2 2014-10-01 2014-10-01 false Patent Indemnity. 52.227-3... AND FORMS SOLICITATION PROVISIONS AND CONTRACT CLAUSES Text of Provisions and Clauses 52.227-3 Patent Indemnity. As prescribed in 27.201-2(c)(1), insert the following clause: Patent Indemnity (APR 1984) (a)...

  12. 25 CFR 152.5 - Issuance of patent in fee.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 25 Indians 1 2014-04-01 2014-04-01 false Issuance of patent in fee. 152.5 Section 152.5 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  13. 25 CFR 152.5 - Issuance of patent in fee.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 25 Indians 1 2011-04-01 2011-04-01 false Issuance of patent in fee. 152.5 Section 152.5 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  14. 25 CFR 152.4 - Application for patent in fee.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 25 Indians 1 2010-04-01 2010-04-01 false Application for patent in fee. 152.4 Section 152.4 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  15. 25 CFR 152.5 - Issuance of patent in fee.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 25 Indians 1 2012-04-01 2011-04-01 true Issuance of patent in fee. 152.5 Section 152.5 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  16. 25 CFR 152.5 - Issuance of patent in fee.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 25 Indians 1 2013-04-01 2013-04-01 false Issuance of patent in fee. 152.5 Section 152.5 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  17. 25 CFR 152.4 - Application for patent in fee.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 25 Indians 1 2014-04-01 2014-04-01 false Application for patent in fee. 152.4 Section 152.4 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  18. 25 CFR 152.4 - Application for patent in fee.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 25 Indians 1 2013-04-01 2013-04-01 false Application for patent in fee. 152.4 Section 152.4 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  19. 25 CFR 152.4 - Application for patent in fee.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 25 Indians 1 2012-04-01 2011-04-01 true Application for patent in fee. 152.4 Section 152.4 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  20. 25 CFR 152.4 - Application for patent in fee.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 25 Indians 1 2011-04-01 2011-04-01 false Application for patent in fee. 152.4 Section 152.4 Indians BUREAU OF INDIAN AFFAIRS, DEPARTMENT OF THE INTERIOR LAND AND WATER ISSUANCE OF PATENTS IN FEE, CERTIFICATES OF COMPETENCY, REMOVAL OF RESTRICTIONS, AND SALE OF CERTAIN INDIAN LANDS Issuing Patents in...

  1. 48 CFR 52.227-3 - Patent Indemnity.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 48 Federal Acquisition Regulations System 2 2012-10-01 2012-10-01 false Patent Indemnity. 52.227-3... AND FORMS SOLICITATION PROVISIONS AND CONTRACT CLAUSES Text of Provisions and Clauses 52.227-3 Patent Indemnity. As prescribed in 27.201-2(c)(1), insert the following clause: Patent Indemnity (APR 1984) (a)...

  2. Annotated Chemical Patent Corpus: A Gold Standard for Text Mining

    PubMed Central

    Akhondi, Saber A.; Klenner, Alexander G.; Tyrchan, Christian; Manchala, Anil K.; Boppana, Kiran; Lowe, Daniel; Zimmermann, Marc; Jagarlapudi, Sarma A. R. P.; Sayle, Roger; Kors, Jan A.; Muresan, Sorel

    2014-01-01

    Exploring the chemical and biological space covered by patent applications is crucial in early-stage medicinal chemistry activities. Patent analysis can provide understanding of compound prior art, novelty checking, validation of biological assays, and identification of new starting points for chemical exploration. Extracting chemical and biological entities from patents through manual extraction by expert curators can take substantial amount of time and resources. Text mining methods can help to ease this process. To validate the performance of such methods, a manually annotated patent corpus is essential. In this study we have produced a large gold standard chemical patent corpus. We developed annotation guidelines and selected 200 full patents from the World Intellectual Property Organization, United States Patent and Trademark Office, and European Patent Office. The patents were pre-annotated automatically and made available to four independent annotator groups each consisting of two to ten annotators. The annotators marked chemicals in different subclasses, diseases, targets, and modes of action. Spelling mistakes and spurious line break due to optical character recognition errors were also annotated. A subset of 47 patents was annotated by at least three annotator groups, from which harmonized annotations and inter-annotator agreement scores were derived. One group annotated the full set. The patent corpus includes 400,125 annotations for the full set and 36,537 annotations for the harmonized set. All patents and annotated entities are publicly available at www.biosemantics.org. PMID:25268232

  3. 43 CFR 3862.8-1 - Land descriptions in patents.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... notes of survey and the plat thereof for a more particular description and the patent shall expressly... 43 Public Lands: Interior 2 2012-10-01 2012-10-01 false Land descriptions in patents. 3862.8-1... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode...

  4. 43 CFR 3862.8-1 - Land descriptions in patents.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... notes of survey and the plat thereof for a more particular description and the patent shall expressly... 43 Public Lands: Interior 2 2013-10-01 2013-10-01 false Land descriptions in patents. 3862.8-1... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode...

  5. 43 CFR 3862.8-1 - Land descriptions in patents.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... notes of survey and the plat thereof for a more particular description and the patent shall expressly... 43 Public Lands: Interior 2 2014-10-01 2014-10-01 false Land descriptions in patents. 3862.8-1... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode...

  6. 76 FR 55364 - Rules for Patent Maintenance Fees

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-07

    ... United States Patent and Trademark Office Rules for Patent Maintenance Fees ACTION: Proposed collection... Office (USPTO) charges fees for maintaining in force all utility patents based on applications filed on or after December 12, 1980. Payment of these maintenance fees is due at 3\\1/2\\, 7\\1/2\\, and...

  7. 43 CFR 3862.1-1 - Application for patent.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode Mining...) Every application for patent, based on a mining claim located after August 1, 1946, shall state whether... materials in the lands covered by his application. (c) In applying for patent to a mining claim...

  8. 43 CFR 3862.1-1 - Application for patent.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... MANAGEMENT, DEPARTMENT OF THE INTERIOR MINERALS MANAGEMENT (3000) MINERAL PATENT APPLICATIONS Lode Mining...) Every application for patent, based on a mining claim located after August 1, 1946, shall state whether... materials in the lands covered by his application. (c) In applying for patent to a mining claim...

  9. 78 FR 4211 - Setting and Adjusting Patent Fees

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-01-18

    ... Sustainable Funding Model for Operations As explained in the Strategic Plan, the Office's objective of... Timeliness The Office developed the strategic goal of optimizing patent quality and timeliness in response to... sustainable funding model, reduce the current patent application backlog, decrease patent application...

  10. 14 CFR § 1274.911 - Patent rights.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 14 Aeronautics and Space 5 2014-01-01 2014-01-01 false Patent rights. § 1274.911 Section § 1274.911 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION COOPERATIVE AGREEMENTS WITH COMMERCIAL FIRMS Other Provisions and Special Conditions § 1274.911 Patent rights. Patent Rights July 2002...

  11. 34 CFR 6.1 - Publication or patenting of inventions.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 34 Education 1 2012-07-01 2012-07-01 false Publication or patenting of inventions. 6.1 Section 6.1 Education Office of the Secretary, Department of Education INVENTIONS AND PATENTS (GENERAL) § 6.1 Publication or patenting of inventions. It is the general policy of the Department that the results...

  12. Hidden Treasures for Science Teaching: United States Patents.

    ERIC Educational Resources Information Center

    Anderson, Norman D.

    United States patents are a source of historical information with many implications for science teaching. Using patents as science teaching devices has been largely ignored by science educators. Some of these devices can be easily modified for use in today's classrooms; in addition, patents serve as great examples of how our knowledge of science…

  13. 45 CFR 650.2 - National Science Foundation patent policy.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 45 Public Welfare 3 2014-10-01 2014-10-01 false National Science Foundation patent policy. 650.2 Section 650.2 Public Welfare Regulations Relating to Public Welfare (Continued) NATIONAL SCIENCE FOUNDATION PATENTS § 650.2 National Science Foundation patent policy. As authorized by the National...

  14. 45 CFR 650.2 - National Science Foundation patent policy.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 45 Public Welfare 3 2012-10-01 2012-10-01 false National Science Foundation patent policy. 650.2 Section 650.2 Public Welfare Regulations Relating to Public Welfare (Continued) NATIONAL SCIENCE FOUNDATION PATENTS § 650.2 National Science Foundation patent policy. As authorized by the National...

  15. 45 CFR 650.2 - National Science Foundation patent policy.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 45 Public Welfare 3 2013-10-01 2013-10-01 false National Science Foundation patent policy. 650.2 Section 650.2 Public Welfare Regulations Relating to Public Welfare (Continued) NATIONAL SCIENCE FOUNDATION PATENTS § 650.2 National Science Foundation patent policy. As authorized by the National...

  16. Practical aspects of the preparation and filing of patent applications.

    PubMed

    Bessoth, Fiona

    2013-01-01

    This chapter is intended to give a brief introduction into the most important patent basics. More importantly, it provides some practical advice to scientists on various considerations when contemplating and preparing the filing of a patent application, irrespective of whether this is assisted by a patent professional or not.

  17. Joint Battery Industry Sector Study.

    DTIC Science & Technology

    1994-08-31

    prototp Fmr ectdc Vehicle uses nickel cadmium batteries PSA’s WEIT A uses nickel cadmium batteries Table 8-19. Nickel Cadmium Batteries in Electric...BMDO to develop a nickel oxidedhydrogen multilayer bipolar battery for pulsed power. These batteries will be used to operate directed energy weapons in

  18. The 1975 GSFC Battery Workshop

    NASA Technical Reports Server (NTRS)

    1975-01-01

    The proceedings of the 1975 Goddard Space Flight Center Battery Workshop are presented. The major topics of discussion were nickel cadmium batteries and, to a lesser extent, nickel hydrogen batteries. Battery design, manufacturing techniques, testing programs, and electrochemical characteristics were considered. The utilization of these batteries for spacecraft power supplies was given particular attention.

  19. NASA patent abstracts bibliography: A continuing bibliography. Section 1: Abstracts (supplement 06)

    NASA Technical Reports Server (NTRS)

    1975-01-01

    Patents and applications for patent introduced into the NASA scientific and technical information system are cited. Each entry consists of a citation, an abstract, and a key illustration selected from the patent or application for patent. The patent and application for patent citations are indexed according to subject, inventor, source, number, and accession number.

  20. Pressure induced metallization of Germane

    NASA Astrophysics Data System (ADS)

    Martinez-Canales, M.; Bergara, A.; Feng, J.; Grochala, W.

    2006-09-01

    Recently reported superconductivity in lithium under pressure has renewed the interest on hydrogen and hydrogen-rich systems in the long standing quest for room temperature superconductivity. Although the required metallization of pure hydrogen cannot be achieved within correct experimental capabilities, chemical precompression exerted by heavier atoms in compounds with a large hydrogen content is expected to imply that lower pressures might be required to attain the metallic transition in these alloys. In this article, we present an ab initio analysis of pressure induced metallization of germane, as a particular case between group IVa hydrides. According to our calculations, metallization of germane is predicted to occur at an experimentally accessible pressure of around 70 GPa, which corresponds to a compression factor of 3.4.

  1. Patent and Trademark Depository Libraries and the United States Patent and Trademark Office: A Model for Information Dissemination

    ERIC Educational Resources Information Center

    Jenda, Claudine Arnold

    2005-01-01

    This paper describes the network of Patent and Trademark Depository Libraries (PTDLs), a collaborative partnership with the United States Patent and Trademark Office (USPTO) for disseminating patent and trademark information in every state plus the District of Columbia and Puerto Rico. Typical information sources and services provided at PTDLs are…

  2. 37 CFR 3.24 - Requirements for documents and cover sheets relating to patents and patent applications.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... and cover sheets relating to patents and patent applications. 3.24 Section 3.24 Patents, Trademarks..., RECORDING AND RIGHTS OF ASSIGNEE Requirements for Recording § 3.24 Requirements for documents and cover..., the paper used should be flexible, strong white, non-shiny, and durable. The Office will not...

  3. Facility management in German hospitals.

    PubMed

    Gudat, H

    2000-04-01

    Facility management and optimum building management offer for hospitals a chance to reduce costs and to increase quality, process sequences, employee motivation and customer satisfaction. Some years ago simple services such as cleaning, catering or laundry were outsourced. Now, German hospitals progress to more complex fields such as building and medical technology, clinical support processes such as pharmacy, central laboratory and sterilization, goods and logistics services.

  4. Potassium Secondary Batteries.

    PubMed

    Eftekhari, Ali; Jian, Zelang; Ji, Xiulei

    2017-02-08

    Potassium may exhibit advantages over lithium or sodium as a charge carrier in rechargeable batteries. Analogues of Prussian blue can provide millions of cyclic voltammetric cycles in aqueous electrolyte. Potassium intercalation chemistry has recently been demonstrated compatible with both graphite and nongraphitic carbons. In addition to potassium-ion batteries, potassium-O2 (or -air) and potassium-sulfur batteries are emerging. Additionally, aqueous potassium-ion batteries also exhibit high reversibility and long cycling life. Because of potentially low cost, availability of basic materials, and intriguing electrochemical behaviors, this new class of secondary batteries is attracting much attention. This mini-review summarizes the current status, opportunities, and future challenges of potassium secondary batteries.

  5. A desalination battery.

    PubMed

    Pasta, Mauro; Wessells, Colin D; Cui, Yi; La Mantia, Fabio

    2012-02-08

    Water desalination is an important approach to provide fresh water around the world, although its high energy consumption, and thus high cost, call for new, efficient technology. Here, we demonstrate the novel concept of a "desalination battery", which operates by performing cycles in reverse on our previously reported mixing entropy battery. Rather than generating electricity from salinity differences, as in mixing entropy batteries, desalination batteries use an electrical energy input to extract sodium and chloride ions from seawater and to generate fresh water. The desalination battery is comprised by a Na(2-x)Mn(5)O(10) nanorod positive electrode and Ag/AgCl negative electrode. Here, we demonstrate an energy consumption of 0.29 Wh l(-1) for the removal of 25% salt using this novel desalination battery, which is promising when compared to reverse osmosis (~ 0.2 Wh l(-1)), the most efficient technique presently available.

  6. Current issues in German healthcare.

    PubMed

    Graf von der Schulenburg, J M; Uber, A

    1997-11-01

    Germany has developed a model of social health insurance for financing healthcare. The basic characteristics of this model are compulsory membership, income-dependent contributions paid by employers and employees, a comprehensive package of healthcare entitlements, stringent government regulation and implementation by not-for-profit health insurers--the sickness funds--which operate under public law. Since the mid-1970s, when health care cost containment gradually evolved as a new issue in German healthcare policy-making, a long series of reform programmes have been initiated. Two recent development can be noted: the introduction of market competition in health insurance and the introduction of fixed budgets. Market competition in health insurance is now an explicit policy tool in Germany. This article analyses the German healthcare system, the history of healthcare reforms and the current healthcare acts. Special emphasis is given to the German drug market and its regulation. The paper describes the present cost-containment policy for pharmaceutical products, especially the global budget concept which was introduced for medicines and patients' copayments.

  7. Patenting genes and genetic research: good or bad for innovation?

    PubMed

    Arnold, Beth E; Ogielska-Zei, Eva

    2002-01-01

    Our goal with this article is to inform the debate over gene patenting, by providing an understanding of (a) the scope of patent claims that are actually being issued on genetic inventions in the United States, (b) the issues that impact their enforcement, and (c) the role that patents and patent licensing play in the commercialization of genetic technologies and products. We conclude by discussing whether the current legal regime effectively balances the beneficial role of patents in the development of new genetic technologies and products against negative impacts on genetic research or clinical genetic testing, or whether the current laws should be amended.

  8. Patenting human genes: when economic interests trump logic and ethics.

    PubMed

    Kluge, Eike-Henner W

    2003-06-01

    To date, over 5,000 applications have been filed with United States Patent Office for patents on human genes. More than 1,500 of these applications have been granted. Other jurisdictions are experiencing a similar rush to mine and protect genomic gold. This paper argues that although many jurisdictions allow the patenting of human genes, this is ethically indefensible and amounts to an unjustified appropriation of a general human heritage. Economic and legal arguments in favour of patenting are considered and rejected. Reference is made to the Wellcome Trust Consortium's initiative and the Merck Gene Index Project, which place patented genetic information into the public domain.

  9. Viking lander spacecraft battery

    NASA Technical Reports Server (NTRS)

    Newell, D. R.

    1976-01-01

    The Viking Lander was the first spacecraft to fly a sterilized nickel-cadmium battery on a mission to explore the surface of a planet. The significant results of the battery development program from its inception through the design, manufacture, and test of the flight batteries which were flown on the two Lander spacecraft are documented. The flight performance during the early phase of the mission is also presented.

  10. Satellite battery testing status

    NASA Technical Reports Server (NTRS)

    Haag, R.; Hall, S.

    1986-01-01

    Because of the large numbers of satellite cells currently being tested and anticipated at the Naval Weapons Support Center (NAVWPNSUPPCEN) Crane, Indiana, satellite cell testing is being integrated into the Battery Test Automation Project (BTAP). The BTAP, designed to meet the growing needs for battery testing at the NAVWPNSUPPCEN Crane, will consist of several Automated Test Stations (ATSs) which monitor batteries under test. Each ATS will interface with an Automation Network Controller (ANC) which will collect test data for reduction.

  11. Battery utilizing ceramic membranes

    DOEpatents

    Yahnke, Mark S.; Shlomo, Golan; Anderson, Marc A.

    1994-01-01

    A thin film battery is disclosed based on the use of ceramic membrane technology. The battery includes a pair of conductive collectors on which the materials for the anode and the cathode may be spin coated. The separator is formed of a porous metal oxide ceramic membrane impregnated with electrolyte so that electrical separation is maintained while ion mobility is also maintained. The entire battery can be made less than 10 microns thick while generating a potential in the 1 volt range.

  12. Polyoxometalate flow battery

    DOEpatents

    Anderson, Travis M.; Pratt, Harry D.

    2016-03-15

    Flow batteries including an electrolyte of a polyoxometalate material are disclosed herein. In a general embodiment, the flow battery includes an electrochemical cell including an anode portion, a cathode portion and a separator disposed between the anode portion and the cathode portion. Each of the anode portion and the cathode portion comprises a polyoxometalate material. The flow battery further includes an anode electrode disposed in the anode portion and a cathode electrode disposed in the cathode portion.

  13. Lithium battery management system

    DOEpatents

    Dougherty, Thomas J [Waukesha, WI

    2012-05-08

    Provided is a system for managing a lithium battery system having a plurality of cells. The battery system comprises a variable-resistance element electrically connected to a cell and located proximate a portion of the cell; and a device for determining, utilizing the variable-resistance element, whether the temperature of the cell has exceeded a predetermined threshold. A method of managing the temperature of a lithium battery system is also included.

  14. Electronically configured battery pack

    SciTech Connect

    Kemper, D.

    1997-03-01

    Battery packs for portable equipment must sometimes accommodate conflicting requirements to meet application needs. An electronically configurable battery pack was developed to support two highly different operating modes, one requiring very low power consumption at a low voltage and the other requiring high power consumption at a higher voltage. The configurable battery pack optimizes the lifetime and performance of the system by making the best use of all available energy thus enabling the system to meet its goals of operation, volume, and lifetime. This paper describes the cell chemistry chosen, the battery pack electronics, and tradeoffs made during the evolution of its design.

  15. Nonleaking battery terminals

    NASA Technical Reports Server (NTRS)

    Snider, W. E.; Nagle, W. J.

    1972-01-01

    Three different terminals were designed for usage in a 40 ampere/hour silver zinc battery which has a 45 percent KOH by weight electrolyte in a plastic battery case. Life tests, including thermal cycling, electrical charge and discharge for up to three years duration, were conducted on these three different terminal designs. Tests for creep rate and tensile strength were conducted on the polyphenylene oxide (PPO) plastic battery cases. Some cases were unused and others containing KOH electrolyte were placed on life tests. The design and testing of nonleaking battery terminals for use with a potassium hydroxide (KOH) electrolyte in a plastic case are discussed.

  16. Nonleaking battery terminals.

    NASA Technical Reports Server (NTRS)

    Snider, W. E.; Nagle, W. J.

    1972-01-01

    Three different terminals were designed for usage in a 40 ampere/hour silver zinc battery which has a 45% KOH by weight electrolyte in a plastic battery case. Life tests, including thermal cycling, electrical charge and discharge for up to three years duration, were conducted on these three different terminal designs. Tests for creep rate and tensile strength were conducted on the polyphenylene oxide plastic battery cases. Some cases were unused and others containing KOH electrolyte were placed on life tests. The design and testing of nonleaking battery terminals for use with a KOH electrolyte in a plastic case are considered.

  17. Battery Thermal Characterization

    SciTech Connect

    Keyser, Matthew; Saxon, Aron; Powell, Mitchell; Shi, Ying

    2016-06-07

    This poster shows the progress in battery thermal characterization over the previous year. NREL collaborated with U.S. DRIVE and USABC battery developers to obtain thermal properties of their batteries, obtained heat capacity and heat generation of cells under various power profiles, obtained thermal images of the cells under various drive cycles, and used the measured results to validate thermal models. Thermal properties are used for the thermal analysis and design of improved battery thermal management systems to support achieve life and performance targets.

  18. THE OTHER PATENT AGENCY: CONGRESSIONAL REGULATION OF THE ITC

    PubMed Central

    Kumar, Sapna

    2009-01-01

    The United States International Trade Commission has recently experienced a dramatic increase in patent infringement investigations under § 337 of the Tariff Act of 1930. In fact, the number of patent enforcement actions submitted to the ITC has nearly doubled in the last five years. Patent holders are selecting this forum because of its speedy proceedings and its ability to award broad exclusion orders. This rise in ITC patent litigation, however, has revealed weaknesses in the structure of § 337. In broadening the provision to facilitate the enforcement of patent rights, Congress failed to consider the impact of this change on technological innovation and on the coherence of the patent system. In particular, Congress did not clarify the relationship between § 337 and the Patent Act, thereby jeopardizing the uniformity of the patent system. Nor did it consider the effect that patent-related exclusion orders would have on innovation and on strategic behavior. This Article recommends that Congress harmonize ITC patent law with the Patent Act and related federal precedent, or alternatively, abolish § 337. PMID:20671808

  19. Key points in biotechnological patents to be exploited.

    PubMed

    García, Alfredo Mateos; López-Moya, José Rafael; Ramos, Patricia

    2013-08-01

    Patents in some biotechnological fields are controversial. Despite this fact, the number of patent applications increases every year. Total revenues in the global biotechnology market are expected to increase in the middle term. Nowadays, the bioeconomy is an important socio-economic area, which is reflected in the number of firms dedicated to or using biotechnology. The exploitation of biotechnological patents is an essential task in the management of intellectual capital. This paper explains the multiplicity of factors that influence the exploitation of biotechnological patents; specifically, the internal and external key points of patents exploitation. The external determining factors for patents are: (i) the market need for biotechnological products and services, (ii) the importance of the freedom to operate analysis before entering the market, and (iii) efficiency in prosecution by Patent Offices. This paper primarily focuses on the internal determining factors, more particularly, the characteristics that the patent's owner must take into consideration in order to have a strong, broad subject-matter in the granted patent. The experimentation needed to obtain an adequate scope of the subject- matter in the claims is a critical issue in the exploitation of a patent or patent application.

  20. THE OTHER PATENT AGENCY: CONGRESSIONAL REGULATION OF THE ITC.

    PubMed

    Kumar, Sapna

    2009-07-01

    The United States International Trade Commission has recently experienced a dramatic increase in patent infringement investigations under section sign 337 of the Tariff Act of 1930. In fact, the number of patent enforcement actions submitted to the ITC has nearly doubled in the last five years. Patent holders are selecting this forum because of its speedy proceedings and its ability to award broad exclusion orders. This rise in ITC patent litigation, however, has revealed weaknesses in the structure of section sign 337. In broadening the provision to facilitate the enforcement of patent rights, Congress failed to consider the impact of this change on technological innovation and on the coherence of the patent system. In particular, Congress did not clarify the relationship between section sign 337 and the Patent Act, thereby jeopardizing the uniformity of the patent system. Nor did it consider the effect that patent-related exclusion orders would have on innovation and on strategic behavior. This Article recommends that Congress harmonize ITC patent law with the Patent Act and related federal precedent, or alternatively, abolish section sign 337.

  1. Electric vehicle battery research and development

    NASA Technical Reports Server (NTRS)

    Schwartz, H. J.

    1973-01-01

    High energy battery technology for electric vehicles is reviewed. The state-of-the-art in conventional batteries, metal-gas batteries, alkali-metal high temperature batteries, and organic electrolyte batteries is reported.

  2. Patenting and the gender gap: should women be encouraged to patent more?

    PubMed

    de Melo-Martín, Inmaculada

    2013-06-01

    The commercialization of academic science has come to be understood as economically desirable for institutions, individual researchers, and the public. Not surprisingly, commercial activity, particularly that which results from patenting, appears to be producing changes in the standards used to evaluate scientists' performance and contributions. In this context, concerns about a gender gap in patenting activity have arisen and some have argued for the need to encourage women to seek more patents. They believe that because academic advancement is mainly dependent on productivity (Stuart and Ding in American Journal of Sociology 112:97-144, 2006; Azoulay et al. in Journal of Economic Behavior & Organization 63:599-623, 2007), differences in research output have the power to negatively impact women's careers. Moreover, in the case of patenting activity, they claim that the gender gap also has the potential to negatively affect society. This is so because scientific and technological advancement and innovation play a crucial role in contemporary societies. Thus, women's more limited involvement in the commercialization of science and technology can also be detrimental to innovation itself. Nevertheless, calls to encourage women to patent on grounds that such activity is likely to play a significant role in the betterment of both women's careers and society seem to be based on two problematic assumptions: (1) that the methods to determine women's productivity in patenting activities are an appropriate way to measure their research efforts and the impact of their work, and (2) that patenting, particularly in academia, benefits society. The purpose of this paper is to call into question these two assumptions.

  3. Government patent policy: An analysis of the effects of three alternative patent policies on technology of goverment inventions

    NASA Technical Reports Server (NTRS)

    Matousek, M.

    1979-01-01

    The effects of present and proposed Government patent policies on the process of technology transfer and the commercialization of inventions resulting from Government sponsored research are addressed. The function of the patent system in Government research and the value of patents resulting from government sponsored research are examined. Three alternative patent policies, title in the contractor, title in the Government, and the waiver policy, are examined in terms of their effect on the commercialization of inventions, industrial competitions, disclosure of inventions, participation of research contractors and administrative costs. Efforts to reform the present Government patent policy are also described.

  4. Category and Perceptual Interference in Second-Language Phoneme Learning: An Examination of English /w/-/v/ Learning by Sinhala, German, and Dutch Speakers

    ERIC Educational Resources Information Center

    Iverson, Paul; Ekanayake, Dulika; Hamann, Silke; Sennema, Anke; Evans, Bronwen G.

    2008-01-01

    The present study investigated the perception and production of English /w/ and /v/ by native speakers of Sinhala, German, and Dutch, with the aim of examining how their native language phonetic processing affected the acquisition of these phonemes. Subjects performed a battery of tests that assessed their identification accuracy for natural…

  5. Transdermal delivery: product and patent update.

    PubMed

    Gupta, Himanshu; Babu, R J

    2013-12-01

    Transdermal drug delivery is an attractive alternative to the oral and parenteral drug delivery. Drugs which are prone to first-pass metabolism can be delivered easily in small doses with sustained blood levels through this method. An update to available products along with a review of clinical trials and patents are discussed in this study. In this review, we have compiled 16 drugs, i.e. Buprenorphine, Clonidine, Estradiol, Fentanyl, Granisetron, Lidocaine, Methylphenidate, Nicotine, Nitroglycerin, Oxybutynin, Rivastigmine, Rotigotine, Scopolamine, Selegiline, Testosterone, Influenza virus vaccine (Microneedle) and covering about 22 marketed products on the transdermal system. We present instrumental information on them along with the compilation of current clinical trials on transdermal systems. We summarize the contents of patents granted in last 5 years under different pharmacological categories. This article serves, accordingly as a source of available information focused on transdermal drug delivery research.

  6. Recent Patents, Formulation and Characterization of Nanoliposomes.

    PubMed

    Rohilla, Seema; Dureja, Harish

    2015-01-01

    Nanoliposome has been introduced for nanoscale bilayer lipid vesicles. These are the nano version of liposomes, having cell-specific targeting, required to achieve a desired drug concentration at the target site for optimum therapeutic efficacy, possibly by minimizing the adverse effects on healthy cells and tissues. Nanoliposomes possess impending applications in the fields of nanotechnology, e.g. cancer therapy, cosmetics, diagnosis, gene delivery, agriculture and food technology. Nano liposomes can be formulated by Sonication technique, Extrusion method, Emulsification evaporation method and Lipid layer hydration method. Authors have performed detailed patent and literature survey on PubMed, PubMed Central, Spingerlink and Elsevier based reviews and research articles on nanoliposomes. An attempt has been made to highlight the various formulation methods including the patented technologies, applications and characterization of nanoliposomes.

  7. Drug patents and intellectual property rights.

    PubMed

    Raj, Gerard Marshall; Priyadarshini, Rekha; Mathaiyan, Jayanthi

    2015-04-01

    Inquisitive scientists are untiring and relentless in the hard work they perform day in and day out. In this pursuit, a researcher has to exercise their intellectual expertise in its entirety. Eventually, all credit of the invention is vested with the inventor who has the right of control over their intellectual creation. Likewise, pharmaceutical companies spend extravagantly in successfully introducing a novel drug from hundreds and thousands of lead compounds. Hence, it is a prerogative for every company to protect its innovative products from unauthorized duplication. Certainly, "patents" are the sole custodians of these products of medical intelligence - the drugs! This review focuses on the various intricacies of the drug patent system all over the world with special emphasis on India, Europe, and the United States. A note on other intellectual properties such as copyrights, trademarks, and designs is also added.

  8. Text mining patents for biomedical knowledge.

    PubMed

    Rodriguez-Esteban, Raul; Bundschus, Markus

    2016-06-01

    Biomedical text mining of scientific knowledge bases, such as Medline, has received much attention in recent years. Given that text mining is able to automatically extract biomedical facts that revolve around entities such as genes, proteins, and drugs, from unstructured text sources, it is seen as a major enabler to foster biomedical research and drug discovery. In contrast to the biomedical literature, research into the mining of biomedical patents has not reached the same level of maturity. Here, we review existing work and highlight the associated technical challenges that emerge from automatically extracting facts from patents. We conclude by outlining potential future directions in this domain that could help drive biomedical research and drug discovery.

  9. Paying for On-Patent Pharmaceuticals

    PubMed Central

    Goldfield, Norbert

    2016-01-01

    In this article we propose a new approach to pricing for patent-protected (on-patent) pharmaceuticals. We describe and define limit pricing as a method for drug companies to maximize revenue for their investment by offering budget-neutral pricing to encourage early adoption by payers. Under this approach, payers are incentivized to adopt innovative but expensive drugs more quickly if drug companies provide detailed analyses of the net impact of the new pharmaceutical upon total health budgets. For payers to adopt use of a new pharmaceutical, they would require objective third-party evaluation and pharmaceutical manufacturer accountability for projected outcomes efficacy of their treatments on population health. The pay for outcomes underpinning of this approach falls within the wider aspirations of health reform. PMID:26945298

  10. Are Pharmaceutical Patents Protected By Human Rights?

    PubMed Central

    Millum, Joseph

    2016-01-01

    The International Bill of Rights enshrines a right to health, which includes a right to access essential medicines. This right frequently appears to conflict with the intellectual property regime that governs pharmaceutical patents. However, there is also a human right that protects creative works, including scientific productions. Does this right support intellectual property protections, even when they may negatively affect health? This article examines the recent attempt by the Committee on Economic, Social and Cultural Rights to resolve this issue and argues that it fails. This is problematic because it means defenders of the present patent regime can continue using human rights documents to support their position. I offer a new framework for resolving the problem by examining the values that underlie human rights. PMID:18974405

  11. Patented herbal formulations and their therapeutic applications.

    PubMed

    Musthaba, Mohamed; Baboota, Sanjula; Athar, Tanwir M D; Thajudeen, Kamal Y; Ahmed, Sayeed; Ali, Javed

    2010-11-01

    Recently, there is a greater global interest in non synthetic, natural medicines derived from plant sources due to better tolerance and minimum adverse drug reactions as compared to synthetic medicines. Herbal products are also commonly used by the patients with certain chronic medical conditions, including breast cancer, liver disease, human immunodeficiency, asthma and rheumatological disorders. WHO estimates that about three-quarters of the world's population currently uses herbs and other forms of traditional medicines for the treatment of various diseases. The herbs are formulated in different modern dosage forms, such as Tablets, Capsules, Topical cream, Gel, Ointment and even some novel drug delivery forms, like extended release, sustained release, and microencapsules dosage forms. Patenting of herbal formulations has increased over the past few years and scientific evidence of therapeutic activity has been reported by performing various in vitro and in vivo experiments. This manuscript deals with various patented herbal formulations with their therapeutic application against various diseases.

  12. A review of nanostructured lithium ion battery materials via low temperature synthesis.

    PubMed

    Chen, Jiajun

    2013-01-01

    Nanostructured materials afford us new opportunities to improve the current technology for synthesizing Li ion batteries. Generating nanomaterials with new properties via an inexpensive approach offers a tremendous potential for realizing high performance Li-ion batteries. In this review, I mainly summarize some of the recent progress made, and describe the patents awarded on synthesizing nanostructured cathode materials for these batteries via low temperature wet- chemistry methods. From an economical view, such syntheses, especially hydrothermal synthesis, may offer the opportunities for significantly lowering the cost of manufacturing battery materials, while conferring distinct environmental advantages. Recent advances in in-situ (real time) X-ray diffraction for studying hydrothermal synthesis have great potential for bettering the rational design of advanced lithium-electrode materials. The development of this technique also will be discussed.

  13. Indexing Flower Patent Images using Domain Knowledge

    DTIC Science & Technology

    1998-01-01

    approach is illustrated by using it to provide a solution to the problem of indexing images of flowers for searching a flower patents database by color...The flower region is isolated from the background by using an automatic iterative segmentation algorithm with domain knowledge driven feedback. The...color of the flower is defined by the color names present in the flower region and their relative proportions. The database can be queried by example

  14. Patent ductus arteriosus: an analysis of management.

    PubMed

    Wardle, Andrew J; Osman, Ahmed; Tulloh, Robert; Luyt, Karen

    2014-10-01

    To compare differences in the management of the neonatal patent ductus arteriosus between neonatologists and paediatric cardiologists, physicians throughout the South-West were contacted. In treatment-refractory cases, neonatologists considered ligation less frequently than paediatric cardiologists (0% versus 40%; p<0.05) and held haemodynamic effects more important for ligation decisions [median: 5 (range 2-5) versus median: 4 (range 2-5); p<0.05]. Furthermore, 81% felt the current guidelines were insufficient.

  15. Bioethics commission to review gene patenting

    SciTech Connect

    Rothenburg, L.

    1995-12-01

    In October, in an unexpected development, U.S. President Bill Clinton created a national ethics advisory board, the National Bioethics Advisory Commission (NBAC, Washington, DC), to study both research ethics and the management and use of genetic information. Of particular interest to biotechnology companies and researchers is the fact that the commission`s brief encompasses issues about human gene patenting, a subject not contained in earlier proposals for the commission.

  16. The Applicability of Patented Technologies to Sonobuoys

    DTIC Science & Technology

    1988-06-30

    levels, with a high power pulse mode capability. D. Further Development Needed: None E. Availibility: Imediate F. Contact: Elliot I. Pollock , Esquire... Pollock , VandeSande & Priddy 1990 "M" Street, NW - Suite 800 Washington, DC 20036 (202) 331-7111 - 22- Patent No. Owner: Expires: 4,186,370 Raytheon...i-- 1. Hewlett-Packard 3-29 4,017,903 Valet Incomplete 2. Sec Def of UK 3-7 4,185,143 Pollock

  17. Synthetic biology, patenting, health and global justice.

    PubMed

    van den Belt, Henk

    2013-09-01

    The legal and moral issues that synthetic biology (SB) and its medical applications are likely to raise with regard to intellectual property (IP) and patenting are best approached through the lens of a theoretical framework highlighting the "co-construction" or "co-evolution" of patent law and technology. The current situation is characterized by a major contest between the so-called IP frame and the access-to-knowledge frame. In SB this contest is found in the contrasting approaches of Craig Venter's chassis school and the BioBricks school. The stakes in this contest are high as issues of global health and global justice are implied. Patents are not simply to be seen as neutral incentives, but must also be judged on their effects for access to essential medicines, a more balanced pattern of innovation and the widest possible social participation in innovative activity. We need moral imagination to design new institutional systems and new ways of practising SB that meet the new demands of global justice.

  18. Anticancer hybrids--a patent survey.

    PubMed

    Nepali, Kunal; Sharma, Sahil; Kumar, Dinesh; Budhiraja, Abhishek; Dhar, Kanaya L

    2014-01-01

    The molecular hybridization (MH) is a strategy of rational design of such ligands or prototypes based on the recognition of pharmacophoric sub-units in the molecular structure of two or more known bioactive derivatives which, through the adequate fusion of these sub-units, lead to the design of new hybrid architectures that maintain pre-selected characteristics of the original templates. The concept of molecular hybridization and the promises/challenges associated with these hybrid molecules along with recent advances on anticancer hybrids and critical discussions on the future aspects of the hybrid drugs have already been presented through a number of reports. However, this article presents the structures of potent hybrids reported during the last two decades along with a detailed account of the patent literature. Significant number of patents on the molecules designed through this valuable drug design technique clearly highlight the present focus of the researchers all around the globe towards hybrid molecules capable of amplifying the effect of individual functionalities through action on another bio target or to interact with multiple targets as one single molecule lowering the risk of drug-drug interactions and minimizing the drug resistance. This review article basically emphasizes the patent literature along with an overview of potent hybrid structures, their IC50 /GI50 values against the various cell lines employed. The present compilation can be utilized as a guide for the medicinal chemists focusing on this area of drug design.

  19. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.

    PubMed

    Halliburton, M

    2009-01-01

    This article highlights potential public health effects of India's Patents Act of 2005, which was implemented to conform to the requirements of the World Trade Organisation's Trade-Related Aspects of Intellectual Property Agreement (TRIPS), a new legal regime that will likely have a significant impact on access to HIV/AIDS medications in much of the world. This new patent law may play a role in keeping new antiretroviral (ARV) medications, including improved first-line medications and second-line drugs that are being developed for first-line drug resistant HIV, financially out of reach for many people living with HIV/AIDS in poor countries. India's drug industry, which had thrived under earlier patent laws that protected processes but not products in the case of medications, had brought down the price of ARV drugs in South Asia and Africa by more than 90%. While most existing drugs are grandfathered under the new patent laws, newer ARV medications may be barred from manufacture by Indian companies. This article analyses the effects of the coming together of this new legal regime, the global political economy and emerging resistance to HIV/AIDS medications, and evaluates efforts to mitigate the negative public health effects of the new patent laws.

  20. Battery thermal management unit

    NASA Astrophysics Data System (ADS)

    Sanders, Nicholas A.

    1989-03-01

    A battery warming device has been designed which uses waste heat from an operating internal combustion engine to warm a battery. A portion of the waste heat is stored in the sensible and latent heat of a phase change type material for use in maintaining the battery temperature after the engine is shut off. The basic design of the device consists of a Phase Change Material (PCM) reservoir and a simple heat exchanger connected to the engineer's cooling system. Two types of units were built, tested and field trialed. A strap-on type which was strapped to the side of an automotive battery and was intended for the automotive after-market and a tray type on which a battery or batteries sat. This unit was intended for the heavy duty truck market. It was determined that both types of units increased the average cranking power of the batteries they were applied to. Although there were several design problems with the units such as the need for an automatic thermostatically controlled bypass valve, the overall feeling is that there is a market opportunity for both the strap-on and tray type battery warming units.

  1. Aerospace applications of batteries

    NASA Technical Reports Server (NTRS)

    Habib, Shahid

    1993-01-01

    NASA has developed battery technology to meet the demanding requirements for aerospace applications; specifically, the space vacuum, launch loads, and high duty cycles. Because of unique requirements and operating environments associated with space applications, NASA has written its own standards and specifications for batteries.

  2. Battery Particle Simulation

    SciTech Connect

    2014-09-15

    Two simulations show the differences between a battery being drained at a slower rate, over a full hour, versus a faster rate, only six minutes (a tenth of an hour). In both cases battery particles go from being fully charged (green) to fully drained (red), but there are significant differences in the patterns of discharge based on the rate.

  3. The GSFC Battery Workshop

    NASA Technical Reports Server (NTRS)

    1974-01-01

    The proceedings of a conference on electric storage batteries are presented. The subjects discussed include the following: (1) a low cost/standardization program, (2) test and flight experience, (3) materials and cell components, and (4) new developments in the nickel/hydrogen system. The application of selected batteries in specific space vehicles is examined.

  4. Hydrophobic, Porous Battery Boxes

    NASA Technical Reports Server (NTRS)

    Bragg, Bobby J.; Casey, John E., Jr.

    1995-01-01

    Boxes made of porous, hydrophobic polymers developed to contain aqueous potassium hydroxide electrolyte solutions of zinc/air batteries while allowing air to diffuse in as needed for operation. Used on other types of batteries for in-cabin use in which electrolytes aqueous and from which gases generated during operation must be vented without allowing electrolytes to leak out.

  5. Evaluation of Brazilian biotechnology patent activity from 1975 to 2010.

    PubMed

    Dias, F; Delfim, F; Drummond, I; Carmo, A O; Barroca, T M; Horta, C C; Kalapothakis, E

    2012-08-01

    The analysis of patent activity is one methodology used for technological monitoring. In this paper, the activity of biotechnology-related patents in Brazil were analyzed through 30 International Patent Classification (IPC) codes published by the Organization for Economic Cooperation and Development (OECD). We developed a program to analyse the dynamics of the major patent applicants, countries and IPC codes extracted from the Brazilian Patent Office (INPI) database. We also identified Brazilian patent applicants who tried to expand protection abroad via the Patent Cooperation Treaty (PCT). We had access to all patents published online at the INPI from 1975 to July 2010, including 9,791 biotechnology patent applications in Brazil, and 163 PCTs published online at World Intellectual Property Organization (WIPO) from 1997 to December 2010. To our knowledge, there are no other online reports of biotechnology patents previous to the years analyzed here. Most of the biotechnology patents filed in the INPI (10.9%) concerned measuring or testing processes involving nucleic acids. The second and third places belonged to patents involving agro-technologies (recombinant DNA technology for plant cells and new flowering plants, i.e. angiosperms, or processes for obtaining them, and reproduction of flowering plants by tissue culture techniques). The majority of patents (87.2%) were filed by nonresidents, with USA being responsible for 51.7% of all biotechnology patents deposited in Brazil. Analyzing the resident applicants per region, we found a hub in the southeast region of Brazil. Among the resident applicants for biotechnology patents filed in the INPI, 43.5% were from São Paulo, 18.3% were from Rio de Janeiro, and 9.7% were from Minas Gerais. Pfizer, Novartis, and Sanofi were the largest applicants in Brazil, with 339, 288, and 245 biotechnology patents filed, respectively. For residents, the largest applicant was the governmental institution FIOCRUZ (Oswaldo Cruz

  6. [History of the German Spine Society].

    PubMed

    Wilke, H-J; Carstens, C

    2015-12-01

    The objective of this article is to summarize the history of the German Spine Society (DWG). This society resulted in the year 2006 after several attempts from the fusion of two established German societies, which were dealing with topics around the spine, der "German Society for Spine Research" founded in the year 1958 and the "German Society for Spine Surgery" founded in the year 1987. This fusion was the beginning of a success story, as from this time on the annual membership increased so much that the DWG became the largest spine society in Europe and one of all spine societies worldwide.

  7. German Unification and Its Ramifications

    DTIC Science & Technology

    1991-01-01

    national iden- tity. Yet the unification of Germany will do more than finally bring to an end the painful realities of German partition; it will also...the Unite Sn-w te4 esn omomic Polly Groi Meet- * irg in B"d we Ju 7-9 190. %9ý Gerniwu OECD £waomk 8wwpy 1990 M (OECD UVW- Seeavo Pao% 1980). i+ i I Ii...also force painful changes within Germany, as it will open or break up a variety of arrangements that have previously protected uncompetitive sectors of

  8. Battery Pack Thermal Design

    SciTech Connect

    Pesaran, Ahmad

    2016-06-14

    This presentation describes the thermal design of battery packs at the National Renewable Energy Laboratory. A battery thermal management system essential for xEVs for both normal operation during daily driving (achieving life and performance) and off-normal operation during abuse conditions (achieving safety). The battery thermal management system needs to be optimized with the right tools for the lowest cost. Experimental tools such as NREL's isothermal battery calorimeter, thermal imaging, and heat transfer setups are needed. Thermal models and computer-aided engineering tools are useful for robust designs. During abuse conditions, designs should prevent cell-to-cell propagation in a module/pack (i.e., keep the fire small and manageable). NREL's battery ISC device can be used for evaluating the robustness of a module/pack to cell-to-cell propagation.

  9. Impact of gene patents on the development of molecular diagnostics.

    PubMed

    Toneguzzo, Frances

    2011-07-01

    There is a widely held view that gene patents in particular and patents in general, because of the exclusionary rights that they provide, are inhibiting the development of and access to critical molecular diagnostic testing. This is a highly relevant issue for healthcare delivery as we move towards personalized medicine, which relies heavily on genetic testing to tailor treatments that are specific for individual characteristics. Critics of the patent system hope to void or diminish the exclusionary aspect of patents by removing genes from the definition of what is patentable, by increasing the number of activities that fall within the research use exemption, or by compelling patent holders to license their rights non-exclusively. Although a re-examination of what constitutes patentable subject matter is an important undertaking, narrowing the definition of patentable subject matter is at best only a partial solution. Erosion of the patent system through compulsory licensing or expansion of the research use exemption runs the risk of destroying important incentives without also fully addressing the problem. To promote solutions that truly address the issues, this article distinguishes documented facts from perceptions and suggests alternative approaches to explore. The author believes that efforts to undermine the patent system are simply counterproductive and that time would be better spent addressing the real issues that lie within molecular diagnostic development.

  10. Patents Associated with High-Cost Drugs in Australia

    PubMed Central

    Christie, Andrew F.; Dent, Chris; McIntyre, Peter; Wilson, Lachlan; Studdert, David M.

    2013-01-01

    Australia, like most countries, faces high and rapidly-rising drug costs. There are longstanding concerns about pharmaceutical companies inappropriately extending their monopoly position by “evergreening” blockbuster drugs, through misuse of the patent system. There is, however, very little empirical information about this behaviour. We fill the gap by analysing all of the patents associated with 15 of the costliest drugs in Australia over the last 20 years. Specifically, we search the patent register to identify all the granted patents that cover the active pharmaceutical ingredient of the high-cost drugs. Then, we classify the patents by type, and identify their owners. We find a mean of 49 patents associated with each drug. Three-quarters of these patents are owned by companies other than the drug's originator. Surprisingly, the majority of all patents are owned by companies that do not have a record of developing top-selling drugs. Our findings show that a multitude of players seek monopoly control over innovations to blockbuster drugs. Consequently, attempts to control drug costs by mitigating misuse of the patent system are likely to miss the mark if they focus only on the patenting activities of originators. PMID:23577165

  11. Patent Foramen Ovale: Is Stroke Due to Paradoxical Embolism?

    NASA Technical Reports Server (NTRS)

    Ranoux, D.; Cohen, A.; Cabanes, L.; Amarenco, P.; Bousser, M. G.; Mas, J. L.

    1993-01-01

    Background and Purpose: A patent foramen ovale has been reported to be significantly more frequent in young stroke patients than in matched control subjects, and paradoxical embolism has been suggested as the main mechanism of stroke in-this situation. The present study was designed to test this hypothesis. Methods: Sixty-eight consecutive patients under 55 years of age presenting with an ischemic stroke had an extensive workup, including transesophageal echocardiography with contrast. We compared the prevalence of criteria for the diagnosis of paradoxical embolism in patients with and without a patent foramen ovale. Results: A patent foramen ovale was found in 32 patients (47%). A Valsalva-provoking activity was present at stroke onset in six patients with a patent foramen ovale and in eight patients with no patent foramen ovale (X(sup 2)=0.1, nonsignificant). Clinical/radiological features suggestive of an embolic mechanism were not more frequent in patients with a patent foramen ovale. Clinical evidence of deep vein thrombosis was present in one patient with a patent foramen ovale and in none of the others. No occult venous thrombosis was found in a subgroup of patients with a patent foramen ovale and no definite cause for stroke who underwent venography (n=13). Conclusions. Our results do not support the hypothesis that paradoxical embolism is the primary mechanism of stroke in patients with a patent foramen ovale. (Stroke 1993;24:31-34) KEY WORDS e cerebral ischemia e embolism foramen ovale, patent

  12. 78 FR 62307 - German-American Day, 2013

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-10-16

    ... Documents#0;#0; ] Proclamation 9035 of October 4, 2013 German-American Day, 2013 By the President of the... German-American Day, we celebrate the vibrant threads of German heritage woven into our national fabric..., as German-American Day. I encourage all Americans to learn more about the history of German...

  13. Process for preparing negative plates for use in a dry charge battery

    SciTech Connect

    Wegner, P.C.

    1986-02-11

    This patent describes a process for the production of lead-containing negative plates for use in a dry charge battery. The process cnsists of drying wet negative plates while protecting them from oxidation. This improvement is accomplished by treating the wet negative plates prior to the drying operation with an aqueous soluton of an oxidation inhibiting agent selected from salicylic acid, and 2-naphtol. The plates are then protected against oxidation during drying; and dry negative plates are obtained which are resistant to the absorption of water from the atmosphere on storage but are wet immediately by battery acid in use.

  14. Polyacene (PAS) batteries

    SciTech Connect

    Yata, Shizukuni

    1995-12-31

    Human activity has been recognized to seriously influence the earth`s environment. Therefore, a clean battery with long-life and safe-use is important and its demand has increased at present. Of the ``clean`` batteries proposed, polymer batteries are the best candidate for environment-friendly and highly-reliable because they do not contain a toxic heavy metal such as cadmium and mercury. The author has developed polyacenic semiconductor (PAS) materials prepared from pyrolytic treatment of phenol-formaldehyde resin. PAS is a conductive polymer which can be doped to either P-type or N-type quite successfully and is extremely resistant to oxidation, chemicals and heat. Because PAS can be doped with both electron acceptors and donors, it is possible to design an all polymer battery using PAS for both electrodes. By taking advantage of stability of PAS, PAS battery can embody greater and longer-lasting reliability than conventional secondary batteries. Usually, lithium metal, which is used in the lithium secondary batteries for an anode-active material, makes dendrites during charging/discharging cycles, which limits the life of the batteries to a few dozen cycles. Furthermore, the dendrites of lithium metal have a safety problem because of its reactivity with water. An investigation of a new anode-material aiming to replace the lithium metal with another safety electrode, is one of the major trend, in secondary batteries. In this paper, the author first describes the structure and the properties of the PAS material, and second its application as an electrode material for rechargeable batteries.

  15. Creating Germans Abroad: White Education and the Colonial Condition in German Southwest Africa, 1894-1914

    ERIC Educational Resources Information Center

    Walther, Daniel Joseph

    2013-01-01

    From the perspective of German colonial supporters and authorities, appropriate white education in the settler colony of Southwest Africa (SWA) was essential for maintaining German hegemony in the territory. In order to reach this objective, the German colonial administration in SWA, with assistance from pedagogues and institutions in Germany,…

  16. Business German: The Use of Simulations in a Total Immersion German Business Class.

    ERIC Educational Resources Information Center

    Weber, Ellen

    At Concordia College's Institute of German Studies (Minnesota), an immersion program, a 1-month course entitled "German in the Business World" concentrates on development of written and oral communication skills needed in firms dealing with German-speakers. As part of its emphasis on banking, insurance, and business, the course includes…

  17. Ludolph Brauer, German aeromedical pioneer.

    PubMed

    Harsch, Viktor

    2004-08-01

    Ludolph Brauer (1865-1951) played an influential role in the history of aviation medicine in Germany. The Treaty of Versailles had put a stop to the development of German aviation and associated medical activities at the end of World War I. Brauer deserves credit for restarting civilian aviation medicine in Germany in the 1920s, paving the way for it to flourish in the 1930s. As Medical Director of the Hamburg-Eppendorf General Hospital, Brauer established the first German Institute of Aviation Medicine (GIAM) in 1927 in affiliation with the Tuberculosis Research Institute with its two large pneumatic chambers. The GIAM was active in altitude research and the selection of pilots, as well as educating medical students in aviation medicine, training Aviation Medical Examiners, and exploring clinical applications of hypobaric and climatic therapy. Brauer was forced to retire in 1934 for political reasons as the GIAM came under the influence of the military; in 1939 it was made part of the Aeromedical Research Institute of the "Reichsluftfahrt" Ministry. Brauer was a co-editor of the journal Luftfahrtmedizin in the 1930s and 1940s. He died in Munich on November 25th, 1951.

  18. Commentary on patents: Don`t dismiss Rifkin`s damning of gene patents

    SciTech Connect

    Hoyle, R.

    1995-07-01

    Biotech may have less to fear from Rifkin than from its own inclination to dismiss the fact that the evolution of ethics and patent laws applying to patenting genes has been haphazard. Perhaps it is time for the biotechnology industry to get behind the establishment of an effective forum for opening much-needed dialogue. Perhaps a Senate proposal to establish a bioethics commission, which reportedly has bogged down in partisan politics, is just such a venue for the government and private sector to begin to hash out the ethical and legal dilemmas that are indisputably at the heart of the biotechnology industry, and its future success.

  19. [INDENA SPA company's patent portfolio of Ginkgo biloba preparation].

    PubMed

    Wang, Nan; Guo, Kai; Cheng, Xin-min; Liu, Wei

    2015-10-01

    INDENA SPA Company in Italy is a multi-national company that produces and sells plant extracts. Based on its own re- search advantages in the field of Ginkgo biloba preparation, the company protects its own products market effectively through building patent portfolio around the patents of its opponent. Based on the multi-angle analysis for patent portfolio of G. biloba preparation from the aspects of application time, legal status, technical development route, and patent portfolio layout, this article provides technical reference on research and development of G. biloba preparation, and the author suggest that Chinese applicants learn techniques and layout experiences of other patents fully to enhance the level of research and patent protection level.

  20. Japan's patent issues relating to life science therapeutic inventions.

    PubMed

    Tessensohn, John A

    2014-09-01

    Japan has made 'innovation in science and technology' as one of its central pillars to ensure high growth in its next stage of economic development and its life sciences market which hosts regenerative medicine was proclaimed to be 'the best market in the world right now.' Although life science therapeutic inventions are patentable subject matter under Japanese patent law, there are nuanced obviousness and enablement challenges under Japanese patent law that can be surmounted in view of some encouraging Japanese court developments in fostering a pro-patent applicant environment in the life sciences therapeutic patent field. Nevertheless, great care must be taken when drafting and prosecuting such patent applications in the world's second most important life sciences therapeutic market.

  1. Regulation and the circulation of knowledge: penicillin patents in Spain.

    PubMed

    Romero de Pablos, Ana

    2011-01-01

    This paper tells the early history of penicillin patenting in Spain. Patents turn out to be useful instruments for analysing the management of knowledge and its circulation in different professional and geographical domains. They protected knowledge while contributing to standardisation. Patents also ensured quality and guaranteed reliability in manufacturing, delivering and prescribing new drugs. They gained special prominence by allowing the creation of a network in which political, economic and business, industrial power, public health and international cooperation fields came together. The main source of information used for this purpose has been the earliest patent applications for penicillin in Spain between 1948 and 1950, which are kept in the Historical Archives of the Oficina Española de Patentes y Marcas. The study of these patents for penicillin shows their role as agents in introducing this drug in Spain.

  2. Assessment of battery technologies for electric vehicles

    SciTech Connect

    Ratner, E.Z. ); Henriksen, G.L. )

    1990-02-01

    This document, Part 2 of Volume 2, provides appendices to this report and includes the following technologies, zinc/air battery; lithium/molybdenum disulfide battery; sodium/sulfur battery; nickel/cadmium battery; nickel/iron battery; iron/oxygen battery and iron/air battery. (FI)

  3. HST Replacement Battery Initial Performance

    NASA Technical Reports Server (NTRS)

    Krol, Stan; Waldo, Greg; Hollandsworth, Roger

    2009-01-01

    The Hubble Space Telescope (HST) original Nickel-Hydrogen (NiH2) batteries were replaced during the Servicing Mission 4 (SM4) after 19 years and one month on orbit.The purpose of this presentation is to highlight the findings from the assessment of the initial sm4 replacement battery performance. The batteries are described, the 0 C capacity is reviewed, descriptions, charts and tables reviewing the State Of Charge (SOC) Performance, the Battery Voltage Performance, the battery impedance, the minimum voltage performance, the thermal performance, the battery current, and the battery system recharge ratio,

  4. Battery equalization active methods

    NASA Astrophysics Data System (ADS)

    Gallardo-Lozano, Javier; Romero-Cadaval, Enrique; Milanes-Montero, M. Isabel; Guerrero-Martinez, Miguel A.

    2014-01-01

    Many different battery technologies are available for the applications which need energy storage. New researches are being focused on Lithium-based batteries, since they are becoming the most viable option for portable energy storage applications. As most of the applications need series battery strings to meet voltage requirements, battery imbalance is an important matter to be taken into account, since it leads the individual battery voltages to drift apart over time, and premature cells degradation, safety hazards, and capacity reduction will occur. A large number of battery equalization methods can be found, which present different advantages/disadvantages and are suitable for different applications. The present paper presents a summary, comparison and evaluation of the different active battery equalization methods, providing a table that compares them, which is helpful to select the suitable equalization method depending on the application. By applying the same weight to the different parameters of comparison, switch capacitor and double-tiered switching capacitor have the highest ratio. Cell bypass methods are cheap and cell to cell ones are efficient. Cell to pack, pack to cell and cell to pack to cell methods present a higher cost, size, and control complexity, but relatively low voltage and current stress in high-power applications.

  5. Patent Reform: Issues in the Biomedical and Software Industries

    DTIC Science & Technology

    2006-04-07

    Patents, Innovation, and Access to New Pharmaceuticals , p. 852. 34 The Economics of Human Gene Patents, p. 1352. 35 For more information see CRS...Federal Reserve Bank of Boston, March 2003, available at [http://www.findarticles.com]. 28 Henry G. Grabowski, “Patents, Innovation, and Access to New ... Pharmaceuticals ,” Journal of International Economic Law, 2002, p. 851. 29 Iain Cockburn, “The Changing Structure of the Pharmaceutical Industry,” Health

  6. [Patenting human genetic material: ethical and legal implications].

    PubMed

    Bergel, S D

    2001-01-01

    If we introduce the subject of patents on human genetic material in a Bioethics Conference we must answer two questions. Firstly, whether the debate can be universalized, bearing in mind the national nature of norms governing intellectual property, and, secondly, whether there are links between patent law and ethics. Using the example of the patenting of biological material, we will see how this impacts on society, which, beyond the technical or legal knowledge required, is voicing its concern on the ethical level.

  7. Expanding opportunities for mining bioactive chemistry from patents.

    PubMed

    Southan, Christopher

    2015-07-01

    Bioactive structures published in medicinal chemistry patents typically exceed those in papers by at least twofold and may precede them by several years. The Big-Bang of open automated extraction since 2012 has contributed to over 15 million patent-derived compounds in PubChem. While mapping between chemical structures, assay results and protein targets from patent documents is challenging, these relationships can be harvested using open tools and are beginning to be curated into databases.

  8. Bioterrorism Countermeasure Development: Issues in Patents and Homeland Security

    DTIC Science & Technology

    2006-11-27

    countermeasure innovator could enjoy expanded patent life with respect to an unrelated product has been termed a “ wild card ” term extension.87 Under...thereby shielding it from generic competition for an additional period of six months to two years. Supporters of a wild card patent term extension urge...the purchase of medications to treat their particular illnesses or medical conditions.89 S. 975 appeared to employ this “ wild card ” patent term

  9. Expanding opportunities for mining bioactive chemistry from patents

    PubMed Central

    Southan, Christopher

    2015-01-01

    Bioactive structures published in medicinal chemistry patents typically exceed those in papers by at least twofold and may precede them by several years. The Big-Bang of open automated extraction since 2012 has contributed to over 15 million patent-derived compounds in PubChem. While mapping between chemical structures, assay results and protein targets from patent documents is challenging, these relationships can be harvested using open tools and are beginning to be curated into databases. PMID:26194581

  10. 8. VIEW OF SOUTHWEST END OF GERMAN VILLAGE LOOKING NORTHEAST. ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    8. VIEW OF SOUTHWEST END OF GERMAN VILLAGE LOOKING NORTHEAST. - Dugway Proving Ground, German-Japanese Village, German Village, South of Stark Road, in WWII Incendiary Test Area, Dugway, Tooele County, UT

  11. 9. DETAIL OF BRICKWORK ON SOUTHEAST SIDE OF GERMAN VILLAGE. ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    9. DETAIL OF BRICKWORK ON SOUTHEAST SIDE OF GERMAN VILLAGE. - Dugway Proving Ground, German-Japanese Village, German Village, South of Stark Road, in WWII Incendiary Test Area, Dugway, Tooele County, UT

  12. 2. OVERALL VIEW OF GERMAN VILLAGE LOOKING SOUTHWEST TOWARD BUILDING ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    2. OVERALL VIEW OF GERMAN VILLAGE LOOKING SOUTHWEST TOWARD BUILDING T-8100. BUNKER, BUILDING T-8104, IN FOREGROUND. - Dugway Proving Ground, German-Japanese Village, German Village, South of Stark Road, in WWII Incendiary Test Area, Dugway, Tooele County, UT

  13. 4. VIEW OF NORTHWEST SIDE OF GERMAN VILLAGE LOOKING SOUTHEAST. ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    4. VIEW OF NORTHWEST SIDE OF GERMAN VILLAGE LOOKING SOUTHEAST. - Dugway Proving Ground, German-Japanese Village, German Village, South of Stark Road, in WWII Incendiary Test Area, Dugway, Tooele County, UT

  14. Health Information in German (Deutsch): MedlinePlus

    MedlinePlus

    ... Tools You Are Here: Home → Multiple Languages → German (Deutsch) URL of this page: https://medlineplus.gov/languages/german.html Health Information in German (Deutsch) To use the sharing features on this page, ...

  15. German Spelling Reform: Kangaroos, Emus, and Cockatoos.

    ERIC Educational Resources Information Center

    Ohlendorf, Harald

    1997-01-01

    The latest movement to reform German spelling is discussed, focusing on the need for greater consistency in spelling of words from other languages and the major changes proposed. Issues addressed include capitalization, specific idiosyncracies in German spelling, concerns related to computerization, public opinion, and the scope of the reform.…

  16. Teaching German for Musicians: A Practical Perspective.

    ERIC Educational Resources Information Center

    Matthias, Bettina

    2003-01-01

    Explores the opportunities for teaching German for musicians and offers it as an approach to teaching beginning German in general. A short theoretical discussion of the impact of music on foreign language learning precedes the presentation of various teaching tools and ideas that map the territory in which musical foreign language teaching can…

  17. The Role of German in Japan.

    ERIC Educational Resources Information Center

    Sang, Juergen

    This historical overview of German studies in Japan, dating from the birth of modern Japan in the 1870's to the present time, includes commentary on the nature and scope of existing language programs. The importance of German idealism--reflected in the philosophy of Kant, Hegel, Schopenhauer, Nietzsche, and Marx--on Japanese culture is noted.…

  18. German Library Networks in the Web Age.

    ERIC Educational Resources Information Center

    Baker, Thomas

    1996-01-01

    Discusses German libraries' access to the Internet and World Wide Web, and reviews German library development and organization. Topics include state libraries; research library networks; national scientific service organizations that provide specialized information services; funding; standards; online catalog software; document delivery and…

  19. The First Suggestopedia German Course in Australia.

    ERIC Educational Resources Information Center

    Gassner-Roberts, Sigrid

    An account of personal experiences and experiments with a suggestopedic German course taught at the University of Adelaide in Australia is presented. Summaries of the students' background and of their continuous achievements in the German class are provided. The class was conducted primarily according to the "Manual of Classroom Procedures…

  20. German for Communication: A Teacher's Guide.

    ERIC Educational Resources Information Center

    Green, Jens-Peter; Grittner, Frank M.

    This guide is designed to: (1) offer a rationale for German instruction and student enrollment; (2) give suggestions for proficiency-oriented lesson planning; and (3) provide classroom activities for students at various proficiency levels. A section on promoting the study of German discusses its role as a major world language, in tourism and world…

  1. German-Speaking People of Europe.

    ERIC Educational Resources Information Center

    Brigham Young Univ., Provo, UT. Language Research Center.

    This book attempts to provide cultural information which will enable an American to communicate effectively with German-speaking people of Europe. The book discusses differences between American and Germanic culture in such areas as food, laws, customs, religion, language, dress, and basic attitudes. Background information is given on Austria,…

  2. German Schools Abroad: Hotspots of Elite Multilingualism?

    ERIC Educational Resources Information Center

    Sander, Anne E; Admiraal, Wilfried

    2016-01-01

    While multilingualism itself is a widely analyzed topic, a study about multilingualism at German schools abroad is so far unique. This quantitative study investigates the differences in the size of German expressive and receptive vocabulary between monolingual and multilingual students, aged between 5 and 11 years. A cohort of 65 multilingual…

  3. The Hypermetric Line in Germanic Alliterative Verse

    ERIC Educational Resources Information Center

    Hartman, Megan E.

    2011-01-01

    My dissertation undertakes a complete study of the stress patterns, syntactic construction, and rhetorical style of hypermetric verse in Germanic alliterative poetry. This project allows me to fill a gap in the study of Germanic meter while simultaneously investigating the connection between metrical and literary scholarship. Hypermetric meter…

  4. Leadership Practices in German and UK Organisations

    ERIC Educational Resources Information Center

    McCarthy, Grace

    2005-01-01

    Purpose: The aim of this research was to determine whether leadership practices vary between German and UK organisations. Design/methodology/approach: The author used self-assessment documents submitted by German and UK organisations to the European Foundation for Quality Management (EFQM), to identify leadership practices in both countries. A…

  5. Language History for Teaching and Learning German

    ERIC Educational Resources Information Center

    Lightfoot, Douglas

    2007-01-01

    This article presents information about the history of the German language and makes pertinent suggestions for teaching German as a Foreign Language. The reasoning for such an approach is presented, along with supportive new empirical data and a related professional directive. A selected survey of historical, explanatory points from the literature…

  6. Facebook Used in a German Film Project

    ERIC Educational Resources Information Center

    Leier, Vera

    2011-01-01

    Looking for a way to make German language study more relevant and to step out of the conventional classroom setting, I introduced Facebook (FB) as a learning platform to my intermediate German students at the University of Canterbury, New Zealand. The students took part in a film competition. A FB group was created and the films were uploaded. The…

  7. German Rap Music in the Classroom.

    ERIC Educational Resources Information Center

    Schmidt, Johannes

    2003-01-01

    Provides background information on German rap artists and bands and discusses how to implement the music in various classroom situations at all levels. Highlights some of the available material on German rap music and provides information on how to locate rap texts, information, and other material via the Internet and other sources. (Author/VWL)

  8. The Teaching of German Literature in Translation.

    ERIC Educational Resources Information Center

    Rippley, LaVern J.

    The present-day status of language instruction at St. Olaf College is viewed in the perspective of past requirements at the college. Reasons for student interest in German, the most popular modern language, focus on the influence of family ties with speakers of Norwegian. A discussion of methods of teaching German literature in translation is…

  9. Advanced Thermal Batteries.

    DTIC Science & Technology

    1980-03-01

    demonstrated that a thermal battery with a LiAl alloy anode, a NaAlCl4 anolyte , and a catholyte made primarily with MoCl5 was at least feasible. However, the...Varying Amounts of Mg Arranged In order Of Increasing Magnesiun 33 Battery Test Data For Batteries Made With 102 Anodes That Contained Anolyte and LiAl...1.75 gm anolyte , and 1.9 grams catholyte, to prepare the first McO 3 cells. The cells averaged 0.081 inches thick. These cells were tested on the

  10. Magnesium battery disposal characteristics

    NASA Astrophysics Data System (ADS)

    Soffer, Louis; Atwater, Terrill

    1994-12-01

    This study assesses the disposal characteristics of U.S. Army procured military magnesium batteries under current Resource Conservation and Recovery Act (RCRA) hazardous waste identification regulations administered by the U.S. Environmental Protection Agency. Magnesium batteries were tested at 100, 50, 10 and 0 percent remaining state of charge. Present findings indicate that magnesium batteries with less than 50 percent remaining charge do not exceed the federal regulatory limit of 5.0 mg/L for chromium. All other RCRA contaminates were below regulatory limits at all levels of remaining charge. Assay methods, findings, disposal requirements and design implications are discussed.

  11. Battery scanning system

    SciTech Connect

    Dieu, L.F.

    1984-11-20

    A battery scanning system which is capable of monitoring and displaying the voltage of each cell in a battery or upon command provides the cell voltage distribution by displaying the cell number and voltage value of highest and lowest cell. The system has a digital logic system, display, input switches for operator generated variables, an alarm, relays, relay selection gates, an optically coupled isolation amplifier, power source and an analog-digital converter. The optically coupled analog amplifier electrically isolates the system from the battery so that large voltage offsets will not adversely affect the automatic measuring of the cells.

  12. BEEST: Electric Vehicle Batteries

    SciTech Connect

    2010-07-01

    BEEST Project: The U.S. spends nearly a $1 billion per day to import petroleum, but we need dramatically better batteries for electric and plug-in hybrid vehicles (EV/PHEV) to truly compete with gasoline-powered cars. The 10 projects in ARPA-E’s BEEST Project, short for “Batteries for Electrical Energy Storage in Transportation,” could make that happen by developing a variety of rechargeable battery technologies that would enable EV/PHEVs to meet or beat the price and performance of gasoline-powered cars, and enable mass production of electric vehicles that people will be excited to drive.

  13. Battery utilizing ceramic membranes

    DOEpatents

    Yahnke, M.S.; Shlomo, G.; Anderson, M.A.

    1994-08-30

    A thin film battery is disclosed based on the use of ceramic membrane technology. The battery includes a pair of conductive collectors on which the materials for the anode and the cathode may be spin coated. The separator is formed of a porous metal oxide ceramic membrane impregnated with electrolyte so that electrical separation is maintained while ion mobility is also maintained. The entire battery can be made less than 10 microns thick while generating a potential in the 1 volt range. 2 figs.

  14. Battery Technology Stores Clean Energy

    NASA Technical Reports Server (NTRS)

    2008-01-01

    Headquartered in Fremont, California, Deeya Energy Inc. is now bringing its flow batteries to commercial customers around the world after working with former Marshall Space Flight Center scientist, Lawrence Thaller. Deeya's liquid-cell batteries have higher power capability than Thaller's original design, are less expensive than lead-acid batteries, are a clean energy alternative, and are 10 to 20 times less expensive than nickel-metal hydride batteries, lithium-ion batteries, and fuel cell options.

  15. Nano/micro-electro mechanical systems: a patent view

    NASA Astrophysics Data System (ADS)

    Hu, Guangyuan; Liu, Weishu

    2015-12-01

    Combining both bibliometrics and citation network analysis, this research evaluates the global development of micro-electro mechanical systems (MEMS) research based on the Derwent Innovations Index database. We found that worldwide, the growth trajectory of MEMS patents demonstrates an approximate S shape, with United States, Japan, China, and Korea leading the global MEMS race. Evidenced by Derwent class codes, the technology structure of global MEMS patents remains steady over time. Yet there does exist a national competitiveness component among the top country players. The latecomer China has become the second most prolific country filing MEMS patents, but its patent quality still lags behind the global average.

  16. Must an inventor "possess" an invention to patent it?

    PubMed

    Woessner, Warren D; Chadwick, Robin A

    2014-09-18

    The requirements for patenting inventions relating to biotechnology have become increasingly strict and complicated in recent years. Despite early patent rulings that there is no need for an inventor to "reduce to practice" an invention, the courts are now ruling that an inventor must "possess" his or her invention before filing for patent. This review discusses what such "possession" may mean and describes decisions in which courts have found that an inventor has met or failed the possession test before filing for patent protection.

  17. The impact of patenting on DNA diagnostic practice.

    PubMed

    Matthijs, Gert; Hodgson, Shirley

    2008-02-01

    Patents on genes often cover the gene sequence and the link between a disease and mutations in a gene, rather than a technology for the identification of mutations per se. Normally, patents are important for encouraging the development of new diagnostic tools and kits, but there is evidence that they can have severely deleterious effects on the delivery of genetic services. The difference largely depends on the licensing policy of the patent holder. This article describes different ways in which patents are used in this context and how the effects may be mitigated.

  18. Academic Patents and Access to Medicines in Developing Countries

    PubMed Central

    2009-01-01

    There is a widespread and growing concern that patents hinder access to life-saving drugs in developing countries. Recent student movements and legislative initiatives emphasize the potential role that research universities in developed countries could have in ameliorating this “access gap.” These efforts are based on the assumption that universities own patents on a substantial number of drugs and that patents on these drugs are currently filed in developing countries. I provide empirical evidence regarding these issues and explore the feasibility and desirability of proposals to change university patenting and licensing practices to promote access to medicines in the developing world. PMID:19008514

  19. Trends in nanotechnology patents applied to the health sector.

    PubMed

    Antunes, Adelaide Maria de Souza; Alencar, Maria Simone de Menezes; da Silva, Cicera Henrique; Nunes, Jeziel; Mendes, Flavia Maria Lins

    2012-01-01

    The aim of the article is to present a method for identifying trends in patent applications for nanotechnology applied to the health sector around the world, based on the International Patent Classification. This classification divides the sector into: dental care, drugs, diagnostic kits, and medical apparatus & medical care. The Derwent database was mined for patent documents using nanotechnology terms associated with the IPC subclasses from the health subsectors. The number of patents was found to be rising, led by the United States, particularly universities and R centers. In the dental care subsector, nanotechnology was found to be used in composite material for manufacturing dental appliances. In drugs, the focus is on the use of nanoparticulate compositions comprising agents that are useful for a variety of diseases. In diagnostic kits, nanostructures have been patented that are capable of detecting target analytes. Meanwhile, in medical apparatus & medical care, patent applications have been made for nanocapsules and/or nanocomposite materials inserted in devices and guide catheters. A study was also made of patents in Brazil, where the same assignees and the same country (United States) as in the survey of global patents were found to be the leading patent applicants / holders.

  20. 37 CFR 1.56 - Duty to disclose information material to patentability.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2012-07-01 2012-07-01 false Duty to disclose information material to patentability. 1.56 Section 1.56 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND... carefully examine: (1) Prior art cited in search reports of a foreign patent office in a...